survtype,datasource,countryname,yearweek,pathogen,indicator,age,value,detectableprevalence
SARS-CoV-2 variant,GISAID,Austria,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Austria,2025-W03,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Austria,2025-W02,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Austria,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Austria,2024-W52,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W51,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Austria,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Austria,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Austria,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Austria,2024-W46,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W45,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W44,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W43,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W42,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W41,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W40,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W39,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2024-W38,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2024-W37,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W36,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W35,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W34,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W33,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2024-W32,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2024-W31,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2024-W30,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2024-W29,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W28,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W27,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W26,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W25,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W24,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W23,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W22,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W21,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W20,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W19,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W18,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W17,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W16,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W15,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W14,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W13,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W12,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W11,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W10,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W09,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W08,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W07,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Austria,2024-W06,SARS-CoV-2,2-week count of sequences,total,51,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2024-W05,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2024-W04,SARS-CoV-2,2-week count of sequences,total,72,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2024-W03,SARS-CoV-2,2-week count of sequences,total,118,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2024-W02,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2024-W01,SARS-CoV-2,2-week count of sequences,total,224,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W52,SARS-CoV-2,2-week count of sequences,total,226,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W51,SARS-CoV-2,2-week count of sequences,total,298,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W50,SARS-CoV-2,2-week count of sequences,total,360,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W49,SARS-CoV-2,2-week count of sequences,total,415,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W48,SARS-CoV-2,2-week count of sequences,total,517,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W47,SARS-CoV-2,2-week count of sequences,total,495,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W46,SARS-CoV-2,2-week count of sequences,total,370,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W45,SARS-CoV-2,2-week count of sequences,total,311,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W44,SARS-CoV-2,2-week count of sequences,total,314,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W43,SARS-CoV-2,2-week count of sequences,total,297,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W42,SARS-CoV-2,2-week count of sequences,total,267,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W41,SARS-CoV-2,2-week count of sequences,total,230,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W40,SARS-CoV-2,2-week count of sequences,total,200,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W39,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W38,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W37,SARS-CoV-2,2-week count of sequences,total,140,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W36,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W35,SARS-CoV-2,2-week count of sequences,total,118,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W34,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2023-W33,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2023-W32,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Austria,2023-W31,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Austria,2023-W30,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Austria,2023-W29,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Austria,2023-W28,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Austria,2023-W27,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2023-W26,SARS-CoV-2,2-week count of sequences,total,421,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W25,SARS-CoV-2,2-week count of sequences,total,508,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W24,SARS-CoV-2,2-week count of sequences,total,574,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W23,SARS-CoV-2,2-week count of sequences,total,703,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W22,SARS-CoV-2,2-week count of sequences,total,689,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W21,SARS-CoV-2,2-week count of sequences,total,591,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W20,SARS-CoV-2,2-week count of sequences,total,341,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W19,SARS-CoV-2,2-week count of sequences,total,376,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2023-W18,SARS-CoV-2,2-week count of sequences,total,845,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W17,SARS-CoV-2,2-week count of sequences,total,1261,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W16,SARS-CoV-2,2-week count of sequences,total,1553,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W15,SARS-CoV-2,2-week count of sequences,total,1708,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W14,SARS-CoV-2,2-week count of sequences,total,2071,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W13,SARS-CoV-2,2-week count of sequences,total,3991,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W12,SARS-CoV-2,2-week count of sequences,total,6376,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W11,SARS-CoV-2,2-week count of sequences,total,8031,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W10,SARS-CoV-2,2-week count of sequences,total,9698,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W09,SARS-CoV-2,2-week count of sequences,total,9849,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W08,SARS-CoV-2,2-week count of sequences,total,9400,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W07,SARS-CoV-2,2-week count of sequences,total,8845,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W06,SARS-CoV-2,2-week count of sequences,total,8086,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W05,SARS-CoV-2,2-week count of sequences,total,7415,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W04,SARS-CoV-2,2-week count of sequences,total,6385,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W03,SARS-CoV-2,2-week count of sequences,total,6576,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W02,SARS-CoV-2,2-week count of sequences,total,7440,≤1%
SARS-CoV-2 variant,GISAID,Austria,2023-W01,SARS-CoV-2,2-week count of sequences,total,7774,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W52,SARS-CoV-2,2-week count of sequences,total,7988,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W51,SARS-CoV-2,2-week count of sequences,total,8647,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W50,SARS-CoV-2,2-week count of sequences,total,9299,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W49,SARS-CoV-2,2-week count of sequences,total,10085,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W48,SARS-CoV-2,2-week count of sequences,total,10299,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W47,SARS-CoV-2,2-week count of sequences,total,10160,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W46,SARS-CoV-2,2-week count of sequences,total,10323,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W45,SARS-CoV-2,2-week count of sequences,total,10036,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W44,SARS-CoV-2,2-week count of sequences,total,10303,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W43,SARS-CoV-2,2-week count of sequences,total,11201,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W42,SARS-CoV-2,2-week count of sequences,total,11619,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W41,SARS-CoV-2,2-week count of sequences,total,11530,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W40,SARS-CoV-2,2-week count of sequences,total,11688,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W39,SARS-CoV-2,2-week count of sequences,total,12314,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W38,SARS-CoV-2,2-week count of sequences,total,11594,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W37,SARS-CoV-2,2-week count of sequences,total,10585,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W36,SARS-CoV-2,2-week count of sequences,total,11572,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W35,SARS-CoV-2,2-week count of sequences,total,10732,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W34,SARS-CoV-2,2-week count of sequences,total,10996,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W33,SARS-CoV-2,2-week count of sequences,total,11937,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W32,SARS-CoV-2,2-week count of sequences,total,11570,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W31,SARS-CoV-2,2-week count of sequences,total,11954,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W30,SARS-CoV-2,2-week count of sequences,total,11089,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W29,SARS-CoV-2,2-week count of sequences,total,11481,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W28,SARS-CoV-2,2-week count of sequences,total,11186,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W27,SARS-CoV-2,2-week count of sequences,total,11253,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W26,SARS-CoV-2,2-week count of sequences,total,12605,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W25,SARS-CoV-2,2-week count of sequences,total,11318,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W24,SARS-CoV-2,2-week count of sequences,total,10549,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W23,SARS-CoV-2,2-week count of sequences,total,10727,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W22,SARS-CoV-2,2-week count of sequences,total,8959,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W21,SARS-CoV-2,2-week count of sequences,total,9230,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W20,SARS-CoV-2,2-week count of sequences,total,9621,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W19,SARS-CoV-2,2-week count of sequences,total,8812,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W18,SARS-CoV-2,2-week count of sequences,total,9841,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W17,SARS-CoV-2,2-week count of sequences,total,9695,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W16,SARS-CoV-2,2-week count of sequences,total,9776,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W15,SARS-CoV-2,2-week count of sequences,total,10060,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W14,SARS-CoV-2,2-week count of sequences,total,7581,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W13,SARS-CoV-2,2-week count of sequences,total,6963,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W12,SARS-CoV-2,2-week count of sequences,total,8266,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W11,SARS-CoV-2,2-week count of sequences,total,7607,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W10,SARS-CoV-2,2-week count of sequences,total,7314,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W09,SARS-CoV-2,2-week count of sequences,total,8175,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W08,SARS-CoV-2,2-week count of sequences,total,7804,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W07,SARS-CoV-2,2-week count of sequences,total,7885,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W06,SARS-CoV-2,2-week count of sequences,total,7148,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W05,SARS-CoV-2,2-week count of sequences,total,5345,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W04,SARS-CoV-2,2-week count of sequences,total,5231,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W03,SARS-CoV-2,2-week count of sequences,total,7046,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W02,SARS-CoV-2,2-week count of sequences,total,9289,≤1%
SARS-CoV-2 variant,GISAID,Austria,2022-W01,SARS-CoV-2,2-week count of sequences,total,7220,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W52,SARS-CoV-2,2-week count of sequences,total,3452,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W51,SARS-CoV-2,2-week count of sequences,total,1485,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W50,SARS-CoV-2,2-week count of sequences,total,1286,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W49,SARS-CoV-2,2-week count of sequences,total,2276,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W48,SARS-CoV-2,2-week count of sequences,total,2049,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W47,SARS-CoV-2,2-week count of sequences,total,1636,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W46,SARS-CoV-2,2-week count of sequences,total,1944,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W45,SARS-CoV-2,2-week count of sequences,total,1557,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W44,SARS-CoV-2,2-week count of sequences,total,1731,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W43,SARS-CoV-2,2-week count of sequences,total,3339,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W42,SARS-CoV-2,2-week count of sequences,total,3858,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W41,SARS-CoV-2,2-week count of sequences,total,2714,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W40,SARS-CoV-2,2-week count of sequences,total,2848,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W39,SARS-CoV-2,2-week count of sequences,total,2571,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W38,SARS-CoV-2,2-week count of sequences,total,1968,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W37,SARS-CoV-2,2-week count of sequences,total,2722,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W36,SARS-CoV-2,2-week count of sequences,total,3578,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W35,SARS-CoV-2,2-week count of sequences,total,4874,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W34,SARS-CoV-2,2-week count of sequences,total,4123,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W33,SARS-CoV-2,2-week count of sequences,total,3253,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W32,SARS-CoV-2,2-week count of sequences,total,3581,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W31,SARS-CoV-2,2-week count of sequences,total,2987,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W30,SARS-CoV-2,2-week count of sequences,total,2757,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W29,SARS-CoV-2,2-week count of sequences,total,2477,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W28,SARS-CoV-2,2-week count of sequences,total,1777,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W27,SARS-CoV-2,2-week count of sequences,total,1483,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W26,SARS-CoV-2,2-week count of sequences,total,1395,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W25,SARS-CoV-2,2-week count of sequences,total,1601,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W24,SARS-CoV-2,2-week count of sequences,total,2651,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W23,SARS-CoV-2,2-week count of sequences,total,2494,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W22,SARS-CoV-2,2-week count of sequences,total,1983,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W21,SARS-CoV-2,2-week count of sequences,total,3507,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W20,SARS-CoV-2,2-week count of sequences,total,6127,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W19,SARS-CoV-2,2-week count of sequences,total,6800,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W18,SARS-CoV-2,2-week count of sequences,total,6448,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W17,SARS-CoV-2,2-week count of sequences,total,9956,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W16,SARS-CoV-2,2-week count of sequences,total,11715,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W15,SARS-CoV-2,2-week count of sequences,total,7098,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W14,SARS-CoV-2,2-week count of sequences,total,4575,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W13,SARS-CoV-2,2-week count of sequences,total,6527,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W12,SARS-CoV-2,2-week count of sequences,total,6883,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W11,SARS-CoV-2,2-week count of sequences,total,5579,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W10,SARS-CoV-2,2-week count of sequences,total,3905,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W09,SARS-CoV-2,2-week count of sequences,total,1798,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W08,SARS-CoV-2,2-week count of sequences,total,1383,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W07,SARS-CoV-2,2-week count of sequences,total,1981,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W06,SARS-CoV-2,2-week count of sequences,total,2800,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W05,SARS-CoV-2,2-week count of sequences,total,4518,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W04,SARS-CoV-2,2-week count of sequences,total,4336,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W03,SARS-CoV-2,2-week count of sequences,total,2271,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W02,SARS-CoV-2,2-week count of sequences,total,1033,≤1%
SARS-CoV-2 variant,GISAID,Austria,2021-W01,SARS-CoV-2,2-week count of sequences,total,755,≤1%
SARS-CoV-2 variant,GISAID,Austria,2020-W53,SARS-CoV-2,2-week count of sequences,total,737,≤1%
SARS-CoV-2 variant,GISAID,Austria,2020-W52,SARS-CoV-2,2-week count of sequences,total,334,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2020-W51,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2020-W50,SARS-CoV-2,2-week count of sequences,total,103,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2020-W49,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2020-W48,SARS-CoV-2,2-week count of sequences,total,134,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2020-W47,SARS-CoV-2,2-week count of sequences,total,190,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2020-W46,SARS-CoV-2,2-week count of sequences,total,281,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Austria,2020-W45,SARS-CoV-2,2-week count of sequences,total,184,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Austria,2020-W44,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2020-W43,SARS-CoV-2,2-week count of sequences,total,76,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2020-W42,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,GISAID,Austria,2020-W41,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W40,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W39,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2020-W38,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W37,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2020-W36,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2020-W35,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Austria,2020-W34,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W33,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W32,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W31,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W30,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W29,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W28,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W27,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W26,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Austria,2020-W25,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Belgium,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Belgium,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Belgium,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Belgium,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Belgium,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Belgium,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Belgium,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Belgium,2024-W49,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W48,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W47,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W46,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W45,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W44,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W43,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W42,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W41,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W40,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W39,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2024-W38,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W37,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W36,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W35,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W34,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W33,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W32,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2024-W31,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W30,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2024-W29,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2024-W28,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2024-W27,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2024-W26,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2024-W25,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W24,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W23,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W22,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W21,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W20,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W19,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W18,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W17,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W16,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W15,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W14,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W13,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W12,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W11,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W10,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W09,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W08,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W07,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W06,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2024-W05,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W04,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W03,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W02,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2024-W01,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W52,SARS-CoV-2,2-week count of sequences,total,286,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W51,SARS-CoV-2,2-week count of sequences,total,514,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W50,SARS-CoV-2,2-week count of sequences,total,711,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W49,SARS-CoV-2,2-week count of sequences,total,576,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W48,SARS-CoV-2,2-week count of sequences,total,518,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W47,SARS-CoV-2,2-week count of sequences,total,445,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W46,SARS-CoV-2,2-week count of sequences,total,326,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W45,SARS-CoV-2,2-week count of sequences,total,524,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W44,SARS-CoV-2,2-week count of sequences,total,548,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W43,SARS-CoV-2,2-week count of sequences,total,399,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W42,SARS-CoV-2,2-week count of sequences,total,539,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W41,SARS-CoV-2,2-week count of sequences,total,602,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W40,SARS-CoV-2,2-week count of sequences,total,535,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W39,SARS-CoV-2,2-week count of sequences,total,526,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W38,SARS-CoV-2,2-week count of sequences,total,478,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W37,SARS-CoV-2,2-week count of sequences,total,490,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W36,SARS-CoV-2,2-week count of sequences,total,417,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W35,SARS-CoV-2,2-week count of sequences,total,347,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W34,SARS-CoV-2,2-week count of sequences,total,308,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W33,SARS-CoV-2,2-week count of sequences,total,205,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W32,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W31,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2023-W30,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2023-W29,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Belgium,2023-W28,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Belgium,2023-W27,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Belgium,2023-W26,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2023-W25,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2023-W24,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2023-W23,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2023-W22,SARS-CoV-2,2-week count of sequences,total,124,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W21,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W20,SARS-CoV-2,2-week count of sequences,total,234,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W19,SARS-CoV-2,2-week count of sequences,total,301,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W18,SARS-CoV-2,2-week count of sequences,total,345,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W17,SARS-CoV-2,2-week count of sequences,total,377,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W16,SARS-CoV-2,2-week count of sequences,total,445,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W15,SARS-CoV-2,2-week count of sequences,total,575,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W14,SARS-CoV-2,2-week count of sequences,total,678,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W13,SARS-CoV-2,2-week count of sequences,total,766,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W12,SARS-CoV-2,2-week count of sequences,total,819,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W11,SARS-CoV-2,2-week count of sequences,total,954,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W10,SARS-CoV-2,2-week count of sequences,total,1070,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W09,SARS-CoV-2,2-week count of sequences,total,1078,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W08,SARS-CoV-2,2-week count of sequences,total,925,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W07,SARS-CoV-2,2-week count of sequences,total,816,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W06,SARS-CoV-2,2-week count of sequences,total,758,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W05,SARS-CoV-2,2-week count of sequences,total,534,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W04,SARS-CoV-2,2-week count of sequences,total,457,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W03,SARS-CoV-2,2-week count of sequences,total,521,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2023-W02,SARS-CoV-2,2-week count of sequences,total,661,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2023-W01,SARS-CoV-2,2-week count of sequences,total,705,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W52,SARS-CoV-2,2-week count of sequences,total,764,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W51,SARS-CoV-2,2-week count of sequences,total,922,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W50,SARS-CoV-2,2-week count of sequences,total,956,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W49,SARS-CoV-2,2-week count of sequences,total,863,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W48,SARS-CoV-2,2-week count of sequences,total,783,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W47,SARS-CoV-2,2-week count of sequences,total,732,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W46,SARS-CoV-2,2-week count of sequences,total,638,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W45,SARS-CoV-2,2-week count of sequences,total,614,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W44,SARS-CoV-2,2-week count of sequences,total,843,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W43,SARS-CoV-2,2-week count of sequences,total,1304,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W42,SARS-CoV-2,2-week count of sequences,total,1805,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W41,SARS-CoV-2,2-week count of sequences,total,2297,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W40,SARS-CoV-2,2-week count of sequences,total,2427,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W39,SARS-CoV-2,2-week count of sequences,total,2114,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W38,SARS-CoV-2,2-week count of sequences,total,1851,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W37,SARS-CoV-2,2-week count of sequences,total,1752,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W36,SARS-CoV-2,2-week count of sequences,total,1669,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W35,SARS-CoV-2,2-week count of sequences,total,1592,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W34,SARS-CoV-2,2-week count of sequences,total,1684,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W33,SARS-CoV-2,2-week count of sequences,total,1947,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W32,SARS-CoV-2,2-week count of sequences,total,2152,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W31,SARS-CoV-2,2-week count of sequences,total,2615,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W30,SARS-CoV-2,2-week count of sequences,total,2926,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W29,SARS-CoV-2,2-week count of sequences,total,3339,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W28,SARS-CoV-2,2-week count of sequences,total,3853,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W27,SARS-CoV-2,2-week count of sequences,total,3728,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W26,SARS-CoV-2,2-week count of sequences,total,4052,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W25,SARS-CoV-2,2-week count of sequences,total,3811,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W24,SARS-CoV-2,2-week count of sequences,total,2975,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W23,SARS-CoV-2,2-week count of sequences,total,2442,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W22,SARS-CoV-2,2-week count of sequences,total,1759,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W21,SARS-CoV-2,2-week count of sequences,total,1727,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W20,SARS-CoV-2,2-week count of sequences,total,2444,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W19,SARS-CoV-2,2-week count of sequences,total,2975,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W18,SARS-CoV-2,2-week count of sequences,total,3120,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W17,SARS-CoV-2,2-week count of sequences,total,3225,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W16,SARS-CoV-2,2-week count of sequences,total,3732,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W15,SARS-CoV-2,2-week count of sequences,total,4049,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W14,SARS-CoV-2,2-week count of sequences,total,4333,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W13,SARS-CoV-2,2-week count of sequences,total,4841,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W12,SARS-CoV-2,2-week count of sequences,total,5073,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W11,SARS-CoV-2,2-week count of sequences,total,5556,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W10,SARS-CoV-2,2-week count of sequences,total,5501,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W09,SARS-CoV-2,2-week count of sequences,total,5828,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W08,SARS-CoV-2,2-week count of sequences,total,6815,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W07,SARS-CoV-2,2-week count of sequences,total,6874,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W06,SARS-CoV-2,2-week count of sequences,total,6836,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W05,SARS-CoV-2,2-week count of sequences,total,7118,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W04,SARS-CoV-2,2-week count of sequences,total,8052,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W03,SARS-CoV-2,2-week count of sequences,total,8110,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W02,SARS-CoV-2,2-week count of sequences,total,7162,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2022-W01,SARS-CoV-2,2-week count of sequences,total,6294,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W52,SARS-CoV-2,2-week count of sequences,total,4784,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W51,SARS-CoV-2,2-week count of sequences,total,4635,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W50,SARS-CoV-2,2-week count of sequences,total,5125,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W49,SARS-CoV-2,2-week count of sequences,total,4880,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W48,SARS-CoV-2,2-week count of sequences,total,4682,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W47,SARS-CoV-2,2-week count of sequences,total,4666,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W46,SARS-CoV-2,2-week count of sequences,total,4272,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W45,SARS-CoV-2,2-week count of sequences,total,3338,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W44,SARS-CoV-2,2-week count of sequences,total,3253,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W43,SARS-CoV-2,2-week count of sequences,total,3977,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W42,SARS-CoV-2,2-week count of sequences,total,3942,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W41,SARS-CoV-2,2-week count of sequences,total,3364,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W40,SARS-CoV-2,2-week count of sequences,total,3096,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W39,SARS-CoV-2,2-week count of sequences,total,2938,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W38,SARS-CoV-2,2-week count of sequences,total,2931,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W37,SARS-CoV-2,2-week count of sequences,total,3119,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W36,SARS-CoV-2,2-week count of sequences,total,3925,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W35,SARS-CoV-2,2-week count of sequences,total,4519,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W34,SARS-CoV-2,2-week count of sequences,total,4488,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W33,SARS-CoV-2,2-week count of sequences,total,4561,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W32,SARS-CoV-2,2-week count of sequences,total,4625,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W31,SARS-CoV-2,2-week count of sequences,total,4027,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W30,SARS-CoV-2,2-week count of sequences,total,3721,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W29,SARS-CoV-2,2-week count of sequences,total,4011,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W28,SARS-CoV-2,2-week count of sequences,total,3806,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W27,SARS-CoV-2,2-week count of sequences,total,2719,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W26,SARS-CoV-2,2-week count of sequences,total,1448,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W25,SARS-CoV-2,2-week count of sequences,total,1205,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W24,SARS-CoV-2,2-week count of sequences,total,1523,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W23,SARS-CoV-2,2-week count of sequences,total,2022,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W22,SARS-CoV-2,2-week count of sequences,total,2412,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W21,SARS-CoV-2,2-week count of sequences,total,2969,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W20,SARS-CoV-2,2-week count of sequences,total,3235,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W19,SARS-CoV-2,2-week count of sequences,total,3123,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W18,SARS-CoV-2,2-week count of sequences,total,3302,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W17,SARS-CoV-2,2-week count of sequences,total,3372,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W16,SARS-CoV-2,2-week count of sequences,total,3233,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W15,SARS-CoV-2,2-week count of sequences,total,2948,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W14,SARS-CoV-2,2-week count of sequences,total,3080,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W13,SARS-CoV-2,2-week count of sequences,total,3472,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W12,SARS-CoV-2,2-week count of sequences,total,3299,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W11,SARS-CoV-2,2-week count of sequences,total,2963,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W10,SARS-CoV-2,2-week count of sequences,total,2495,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W09,SARS-CoV-2,2-week count of sequences,total,2242,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W08,SARS-CoV-2,2-week count of sequences,total,2227,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W07,SARS-CoV-2,2-week count of sequences,total,1817,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W06,SARS-CoV-2,2-week count of sequences,total,1723,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W05,SARS-CoV-2,2-week count of sequences,total,1838,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W04,SARS-CoV-2,2-week count of sequences,total,1770,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W03,SARS-CoV-2,2-week count of sequences,total,1377,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W02,SARS-CoV-2,2-week count of sequences,total,780,≤1%
SARS-CoV-2 variant,GISAID,Belgium,2021-W01,SARS-CoV-2,2-week count of sequences,total,471,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W53,SARS-CoV-2,2-week count of sequences,total,241,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W52,SARS-CoV-2,2-week count of sequences,total,299,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W51,SARS-CoV-2,2-week count of sequences,total,347,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W50,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W49,SARS-CoV-2,2-week count of sequences,total,151,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W48,SARS-CoV-2,2-week count of sequences,total,182,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W47,SARS-CoV-2,2-week count of sequences,total,249,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W46,SARS-CoV-2,2-week count of sequences,total,208,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W45,SARS-CoV-2,2-week count of sequences,total,218,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W44,SARS-CoV-2,2-week count of sequences,total,423,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W43,SARS-CoV-2,2-week count of sequences,total,366,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W42,SARS-CoV-2,2-week count of sequences,total,216,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W41,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W40,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W39,SARS-CoV-2,2-week count of sequences,total,246,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W38,SARS-CoV-2,2-week count of sequences,total,199,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W37,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2020-W36,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2020-W35,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2020-W34,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2020-W33,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W32,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W31,SARS-CoV-2,2-week count of sequences,total,147,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Belgium,2020-W30,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,GISAID,Belgium,2020-W29,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2020-W28,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2020-W27,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2020-W26,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Belgium,2020-W25,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W51,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W50,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W46,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W45,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W42,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W41,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W40,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W39,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W38,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W37,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W36,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W35,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W34,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W33,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W32,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W31,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W30,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W29,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W28,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W27,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W20,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W19,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W09,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W08,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W07,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W06,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W05,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W04,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W03,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W02,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2024-W01,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W52,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W51,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W50,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W49,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W48,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W47,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W46,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W45,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W44,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W43,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W42,SARS-CoV-2,2-week count of sequences,total,71,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W41,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W40,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W39,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W38,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W37,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W36,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W35,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W34,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W33,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W32,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W31,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W30,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W29,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W28,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W27,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W26,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W25,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W24,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W23,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W22,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W21,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W20,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W19,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W18,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W17,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W16,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W15,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W14,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W13,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W12,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W11,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W10,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W09,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W08,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W07,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W06,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W05,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W04,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W03,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W02,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2023-W01,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W52,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W51,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W50,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W49,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W48,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W47,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W46,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W45,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W44,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W43,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W42,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W41,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W40,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W39,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W38,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W37,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W36,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W35,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W34,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W33,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W32,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W31,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W30,SARS-CoV-2,2-week count of sequences,total,171,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W29,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W28,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W27,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W26,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W25,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W24,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W23,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W22,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W21,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W20,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W19,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W18,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W17,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W16,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W15,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W14,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W13,SARS-CoV-2,2-week count of sequences,total,315,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W12,SARS-CoV-2,2-week count of sequences,total,437,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W11,SARS-CoV-2,2-week count of sequences,total,438,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W10,SARS-CoV-2,2-week count of sequences,total,447,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W09,SARS-CoV-2,2-week count of sequences,total,601,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W08,SARS-CoV-2,2-week count of sequences,total,812,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W07,SARS-CoV-2,2-week count of sequences,total,1086,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W06,SARS-CoV-2,2-week count of sequences,total,1315,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W05,SARS-CoV-2,2-week count of sequences,total,1478,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W04,SARS-CoV-2,2-week count of sequences,total,1556,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W03,SARS-CoV-2,2-week count of sequences,total,1449,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W02,SARS-CoV-2,2-week count of sequences,total,1189,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2022-W01,SARS-CoV-2,2-week count of sequences,total,749,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W52,SARS-CoV-2,2-week count of sequences,total,518,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W51,SARS-CoV-2,2-week count of sequences,total,630,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W50,SARS-CoV-2,2-week count of sequences,total,743,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W49,SARS-CoV-2,2-week count of sequences,total,878,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W48,SARS-CoV-2,2-week count of sequences,total,973,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W47,SARS-CoV-2,2-week count of sequences,total,903,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W46,SARS-CoV-2,2-week count of sequences,total,927,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W45,SARS-CoV-2,2-week count of sequences,total,959,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W44,SARS-CoV-2,2-week count of sequences,total,924,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W43,SARS-CoV-2,2-week count of sequences,total,1035,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W42,SARS-CoV-2,2-week count of sequences,total,1057,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W41,SARS-CoV-2,2-week count of sequences,total,1001,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W40,SARS-CoV-2,2-week count of sequences,total,961,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W39,SARS-CoV-2,2-week count of sequences,total,882,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W38,SARS-CoV-2,2-week count of sequences,total,828,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W37,SARS-CoV-2,2-week count of sequences,total,739,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W36,SARS-CoV-2,2-week count of sequences,total,750,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W35,SARS-CoV-2,2-week count of sequences,total,864,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W34,SARS-CoV-2,2-week count of sequences,total,936,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W33,SARS-CoV-2,2-week count of sequences,total,800,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W32,SARS-CoV-2,2-week count of sequences,total,612,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W31,SARS-CoV-2,2-week count of sequences,total,495,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W30,SARS-CoV-2,2-week count of sequences,total,375,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W29,SARS-CoV-2,2-week count of sequences,total,240,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W28,SARS-CoV-2,2-week count of sequences,total,160,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W27,SARS-CoV-2,2-week count of sequences,total,176,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W26,SARS-CoV-2,2-week count of sequences,total,176,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W25,SARS-CoV-2,2-week count of sequences,total,125,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W24,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W23,SARS-CoV-2,2-week count of sequences,total,103,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W22,SARS-CoV-2,2-week count of sequences,total,72,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W21,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W20,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W19,SARS-CoV-2,2-week count of sequences,total,118,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W18,SARS-CoV-2,2-week count of sequences,total,193,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W17,SARS-CoV-2,2-week count of sequences,total,255,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W16,SARS-CoV-2,2-week count of sequences,total,305,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W15,SARS-CoV-2,2-week count of sequences,total,372,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W14,SARS-CoV-2,2-week count of sequences,total,458,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W13,SARS-CoV-2,2-week count of sequences,total,560,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W12,SARS-CoV-2,2-week count of sequences,total,667,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W11,SARS-CoV-2,2-week count of sequences,total,638,≤1%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W10,SARS-CoV-2,2-week count of sequences,total,543,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W09,SARS-CoV-2,2-week count of sequences,total,410,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W08,SARS-CoV-2,2-week count of sequences,total,275,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W07,SARS-CoV-2,2-week count of sequences,total,251,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W06,SARS-CoV-2,2-week count of sequences,total,260,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W05,SARS-CoV-2,2-week count of sequences,total,220,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W04,SARS-CoV-2,2-week count of sequences,total,139,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W03,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W02,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2021-W01,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W53,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W52,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W51,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W50,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W49,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W48,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W47,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W46,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W45,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W44,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W43,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W42,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W41,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W40,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W39,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W38,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W37,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W36,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W35,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W34,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W33,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W32,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W31,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W29,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W28,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Bulgaria,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2025-W02,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Croatia,2025-W01,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W52,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W51,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W50,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W49,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W48,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W47,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W46,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W45,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W44,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W43,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W42,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W41,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W40,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W39,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W38,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W37,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W36,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W35,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W34,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W33,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W32,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W31,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W30,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W29,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W28,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W27,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W26,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W25,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W24,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W23,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W13,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W12,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2024-W10,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W09,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W08,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W07,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W06,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W05,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W04,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W03,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Croatia,2024-W02,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Croatia,2024-W01,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Croatia,2023-W52,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Croatia,2023-W51,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W50,SARS-CoV-2,2-week count of sequences,total,204,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W49,SARS-CoV-2,2-week count of sequences,total,171,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W48,SARS-CoV-2,2-week count of sequences,total,157,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W47,SARS-CoV-2,2-week count of sequences,total,142,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W46,SARS-CoV-2,2-week count of sequences,total,133,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W45,SARS-CoV-2,2-week count of sequences,total,124,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W44,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W43,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W42,SARS-CoV-2,2-week count of sequences,total,167,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W41,SARS-CoV-2,2-week count of sequences,total,219,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W40,SARS-CoV-2,2-week count of sequences,total,233,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W39,SARS-CoV-2,2-week count of sequences,total,220,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W38,SARS-CoV-2,2-week count of sequences,total,198,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W37,SARS-CoV-2,2-week count of sequences,total,194,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W36,SARS-CoV-2,2-week count of sequences,total,167,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W35,SARS-CoV-2,2-week count of sequences,total,153,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W34,SARS-CoV-2,2-week count of sequences,total,108,>5% to 10%
SARS-CoV-2 variant,GISAID,Croatia,2023-W33,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W32,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W31,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W30,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W29,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W28,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W27,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W26,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W25,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W24,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W23,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Croatia,2023-W22,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Croatia,2023-W21,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Croatia,2023-W20,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W19,SARS-CoV-2,2-week count of sequences,total,169,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W18,SARS-CoV-2,2-week count of sequences,total,215,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W17,SARS-CoV-2,2-week count of sequences,total,273,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W16,SARS-CoV-2,2-week count of sequences,total,255,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W15,SARS-CoV-2,2-week count of sequences,total,202,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W14,SARS-CoV-2,2-week count of sequences,total,195,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W13,SARS-CoV-2,2-week count of sequences,total,224,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W12,SARS-CoV-2,2-week count of sequences,total,215,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W11,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W10,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W09,SARS-CoV-2,2-week count of sequences,total,171,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W08,SARS-CoV-2,2-week count of sequences,total,131,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W07,SARS-CoV-2,2-week count of sequences,total,131,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W06,SARS-CoV-2,2-week count of sequences,total,167,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W05,SARS-CoV-2,2-week count of sequences,total,192,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W04,SARS-CoV-2,2-week count of sequences,total,221,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W03,SARS-CoV-2,2-week count of sequences,total,291,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W02,SARS-CoV-2,2-week count of sequences,total,329,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2023-W01,SARS-CoV-2,2-week count of sequences,total,347,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W52,SARS-CoV-2,2-week count of sequences,total,405,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W51,SARS-CoV-2,2-week count of sequences,total,282,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W50,SARS-CoV-2,2-week count of sequences,total,245,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W49,SARS-CoV-2,2-week count of sequences,total,360,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W48,SARS-CoV-2,2-week count of sequences,total,392,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W47,SARS-CoV-2,2-week count of sequences,total,372,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W46,SARS-CoV-2,2-week count of sequences,total,350,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W45,SARS-CoV-2,2-week count of sequences,total,355,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W44,SARS-CoV-2,2-week count of sequences,total,449,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W43,SARS-CoV-2,2-week count of sequences,total,545,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W42,SARS-CoV-2,2-week count of sequences,total,542,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W41,SARS-CoV-2,2-week count of sequences,total,577,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W40,SARS-CoV-2,2-week count of sequences,total,649,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W39,SARS-CoV-2,2-week count of sequences,total,647,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W38,SARS-CoV-2,2-week count of sequences,total,669,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W37,SARS-CoV-2,2-week count of sequences,total,787,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W36,SARS-CoV-2,2-week count of sequences,total,759,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W35,SARS-CoV-2,2-week count of sequences,total,631,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W34,SARS-CoV-2,2-week count of sequences,total,602,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W33,SARS-CoV-2,2-week count of sequences,total,693,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W32,SARS-CoV-2,2-week count of sequences,total,655,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W31,SARS-CoV-2,2-week count of sequences,total,783,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W30,SARS-CoV-2,2-week count of sequences,total,978,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W29,SARS-CoV-2,2-week count of sequences,total,900,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W28,SARS-CoV-2,2-week count of sequences,total,821,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W27,SARS-CoV-2,2-week count of sequences,total,785,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W26,SARS-CoV-2,2-week count of sequences,total,585,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W25,SARS-CoV-2,2-week count of sequences,total,383,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W24,SARS-CoV-2,2-week count of sequences,total,394,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W23,SARS-CoV-2,2-week count of sequences,total,353,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W22,SARS-CoV-2,2-week count of sequences,total,425,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W21,SARS-CoV-2,2-week count of sequences,total,503,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W20,SARS-CoV-2,2-week count of sequences,total,509,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W19,SARS-CoV-2,2-week count of sequences,total,556,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W18,SARS-CoV-2,2-week count of sequences,total,572,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W17,SARS-CoV-2,2-week count of sequences,total,567,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W16,SARS-CoV-2,2-week count of sequences,total,570,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2022-W15,SARS-CoV-2,2-week count of sequences,total,775,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W14,SARS-CoV-2,2-week count of sequences,total,952,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W13,SARS-CoV-2,2-week count of sequences,total,1006,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W12,SARS-CoV-2,2-week count of sequences,total,940,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W11,SARS-CoV-2,2-week count of sequences,total,967,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W10,SARS-CoV-2,2-week count of sequences,total,1152,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W09,SARS-CoV-2,2-week count of sequences,total,1085,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W08,SARS-CoV-2,2-week count of sequences,total,1269,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W07,SARS-CoV-2,2-week count of sequences,total,1895,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W06,SARS-CoV-2,2-week count of sequences,total,2157,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W05,SARS-CoV-2,2-week count of sequences,total,2137,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W04,SARS-CoV-2,2-week count of sequences,total,2210,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W03,SARS-CoV-2,2-week count of sequences,total,2991,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W02,SARS-CoV-2,2-week count of sequences,total,3337,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2022-W01,SARS-CoV-2,2-week count of sequences,total,2970,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W52,SARS-CoV-2,2-week count of sequences,total,2958,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W51,SARS-CoV-2,2-week count of sequences,total,3179,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W50,SARS-CoV-2,2-week count of sequences,total,2718,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W49,SARS-CoV-2,2-week count of sequences,total,1510,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W48,SARS-CoV-2,2-week count of sequences,total,982,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W47,SARS-CoV-2,2-week count of sequences,total,844,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W46,SARS-CoV-2,2-week count of sequences,total,734,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W45,SARS-CoV-2,2-week count of sequences,total,751,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W44,SARS-CoV-2,2-week count of sequences,total,721,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W43,SARS-CoV-2,2-week count of sequences,total,702,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W42,SARS-CoV-2,2-week count of sequences,total,744,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W41,SARS-CoV-2,2-week count of sequences,total,666,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W40,SARS-CoV-2,2-week count of sequences,total,628,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W39,SARS-CoV-2,2-week count of sequences,total,694,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W38,SARS-CoV-2,2-week count of sequences,total,728,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W37,SARS-CoV-2,2-week count of sequences,total,741,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W36,SARS-CoV-2,2-week count of sequences,total,865,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W35,SARS-CoV-2,2-week count of sequences,total,993,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W34,SARS-CoV-2,2-week count of sequences,total,893,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W33,SARS-CoV-2,2-week count of sequences,total,770,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W32,SARS-CoV-2,2-week count of sequences,total,623,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W31,SARS-CoV-2,2-week count of sequences,total,512,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W30,SARS-CoV-2,2-week count of sequences,total,500,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W29,SARS-CoV-2,2-week count of sequences,total,407,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W28,SARS-CoV-2,2-week count of sequences,total,368,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W27,SARS-CoV-2,2-week count of sequences,total,369,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W26,SARS-CoV-2,2-week count of sequences,total,274,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W25,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W24,SARS-CoV-2,2-week count of sequences,total,200,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W23,SARS-CoV-2,2-week count of sequences,total,313,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W22,SARS-CoV-2,2-week count of sequences,total,342,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W21,SARS-CoV-2,2-week count of sequences,total,370,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W20,SARS-CoV-2,2-week count of sequences,total,497,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W19,SARS-CoV-2,2-week count of sequences,total,639,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W18,SARS-CoV-2,2-week count of sequences,total,727,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W17,SARS-CoV-2,2-week count of sequences,total,786,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W16,SARS-CoV-2,2-week count of sequences,total,553,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W15,SARS-CoV-2,2-week count of sequences,total,375,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W14,SARS-CoV-2,2-week count of sequences,total,607,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W13,SARS-CoV-2,2-week count of sequences,total,749,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W12,SARS-CoV-2,2-week count of sequences,total,674,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W11,SARS-CoV-2,2-week count of sequences,total,628,≤1%
SARS-CoV-2 variant,GISAID,Croatia,2021-W10,SARS-CoV-2,2-week count of sequences,total,573,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W09,SARS-CoV-2,2-week count of sequences,total,584,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W08,SARS-CoV-2,2-week count of sequences,total,543,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W07,SARS-CoV-2,2-week count of sequences,total,394,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W06,SARS-CoV-2,2-week count of sequences,total,335,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W05,SARS-CoV-2,2-week count of sequences,total,159,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Croatia,2021-W04,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Croatia,2021-W03,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Croatia,2021-W02,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Croatia,2021-W01,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W53,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W52,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W51,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W47,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W46,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W42,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W41,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W40,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W39,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W38,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W37,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W36,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W35,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W34,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W33,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Croatia,2020-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Croatia,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Cyprus,2024-W10,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W09,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W08,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W07,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W06,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W05,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W04,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W03,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W02,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2024-W01,SARS-CoV-2,2-week count of sequences,total,116,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W52,SARS-CoV-2,2-week count of sequences,total,115,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W51,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W50,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W49,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W48,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W47,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W46,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W45,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W44,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W43,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W42,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W41,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W40,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W39,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W38,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W37,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W36,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W35,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W34,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W33,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W32,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W31,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W30,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W29,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W28,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W27,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W26,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W25,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W24,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W23,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W22,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W21,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W20,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W19,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W18,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W17,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W16,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W15,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W14,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W13,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W12,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W11,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W10,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W09,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W08,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W07,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W06,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W05,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W04,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W03,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W02,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2023-W01,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W52,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W51,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W50,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W49,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W48,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W47,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W46,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W45,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W44,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W43,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W42,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W41,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W40,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W39,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W38,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W37,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W36,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W35,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W34,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W33,SARS-CoV-2,2-week count of sequences,total,71,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W32,SARS-CoV-2,2-week count of sequences,total,76,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W31,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W30,SARS-CoV-2,2-week count of sequences,total,159,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W29,SARS-CoV-2,2-week count of sequences,total,140,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W28,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W27,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W26,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W25,SARS-CoV-2,2-week count of sequences,total,157,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W24,SARS-CoV-2,2-week count of sequences,total,127,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W23,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W22,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W21,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W20,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W19,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W18,SARS-CoV-2,2-week count of sequences,total,121,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W17,SARS-CoV-2,2-week count of sequences,total,144,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W16,SARS-CoV-2,2-week count of sequences,total,220,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W15,SARS-CoV-2,2-week count of sequences,total,333,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W14,SARS-CoV-2,2-week count of sequences,total,409,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W13,SARS-CoV-2,2-week count of sequences,total,428,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W12,SARS-CoV-2,2-week count of sequences,total,414,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W11,SARS-CoV-2,2-week count of sequences,total,393,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W10,SARS-CoV-2,2-week count of sequences,total,415,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W09,SARS-CoV-2,2-week count of sequences,total,441,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W08,SARS-CoV-2,2-week count of sequences,total,385,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W07,SARS-CoV-2,2-week count of sequences,total,352,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W06,SARS-CoV-2,2-week count of sequences,total,341,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W05,SARS-CoV-2,2-week count of sequences,total,348,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W04,SARS-CoV-2,2-week count of sequences,total,378,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W03,SARS-CoV-2,2-week count of sequences,total,382,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W02,SARS-CoV-2,2-week count of sequences,total,420,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2022-W01,SARS-CoV-2,2-week count of sequences,total,352,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W52,SARS-CoV-2,2-week count of sequences,total,204,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W51,SARS-CoV-2,2-week count of sequences,total,281,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W50,SARS-CoV-2,2-week count of sequences,total,387,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W49,SARS-CoV-2,2-week count of sequences,total,312,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W48,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W47,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W46,SARS-CoV-2,2-week count of sequences,total,156,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W45,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W44,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W43,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W42,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W41,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W40,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W39,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W38,SARS-CoV-2,2-week count of sequences,total,121,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W37,SARS-CoV-2,2-week count of sequences,total,157,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W36,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W35,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W34,SARS-CoV-2,2-week count of sequences,total,51,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W33,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W32,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W31,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W30,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W29,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W28,SARS-CoV-2,2-week count of sequences,total,111,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W27,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W26,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W25,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W24,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W23,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W22,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W21,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W20,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W19,SARS-CoV-2,2-week count of sequences,total,159,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W18,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W17,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W16,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W15,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W14,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W13,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W12,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W11,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W10,SARS-CoV-2,2-week count of sequences,total,115,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W09,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W08,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W07,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W06,SARS-CoV-2,2-week count of sequences,total,97,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W05,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W04,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W03,SARS-CoV-2,2-week count of sequences,total,113,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W02,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2021-W01,SARS-CoV-2,2-week count of sequences,total,192,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W53,SARS-CoV-2,2-week count of sequences,total,159,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W52,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W51,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W50,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W49,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W48,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W47,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W46,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W45,SARS-CoV-2,2-week count of sequences,total,165,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W44,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W43,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W42,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W41,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W40,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W39,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W38,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W37,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W36,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W35,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W34,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W33,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W32,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W31,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W30,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W29,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W28,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W27,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W26,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Cyprus,2020-W25,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Czechia,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W44,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W43,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W42,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W41,SARS-CoV-2,2-week count of sequences,total,71,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2024-W40,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2024-W39,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2024-W38,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W37,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W36,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W35,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W34,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W33,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W32,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W31,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W30,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W29,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W28,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W27,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W26,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W25,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W24,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W23,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W22,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W21,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W20,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W19,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W16,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W15,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2024-W13,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W12,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W11,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W10,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W09,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W08,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W07,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W06,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W05,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W04,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W03,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W02,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2024-W01,SARS-CoV-2,2-week count of sequences,total,64,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W52,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W51,SARS-CoV-2,2-week count of sequences,total,166,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W50,SARS-CoV-2,2-week count of sequences,total,217,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W49,SARS-CoV-2,2-week count of sequences,total,223,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W48,SARS-CoV-2,2-week count of sequences,total,150,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W47,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W46,SARS-CoV-2,2-week count of sequences,total,111,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W45,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W44,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W43,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W42,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W41,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W40,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W39,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W38,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W37,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W36,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W35,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W34,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W33,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W32,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W31,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W30,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W29,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W28,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W27,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W26,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W25,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W24,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Czechia,2023-W22,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W21,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W20,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W19,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W18,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W17,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2023-W16,SARS-CoV-2,2-week count of sequences,total,108,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W15,SARS-CoV-2,2-week count of sequences,total,129,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W14,SARS-CoV-2,2-week count of sequences,total,147,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W13,SARS-CoV-2,2-week count of sequences,total,278,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W12,SARS-CoV-2,2-week count of sequences,total,384,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W11,SARS-CoV-2,2-week count of sequences,total,384,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W10,SARS-CoV-2,2-week count of sequences,total,337,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W09,SARS-CoV-2,2-week count of sequences,total,291,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W08,SARS-CoV-2,2-week count of sequences,total,279,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W07,SARS-CoV-2,2-week count of sequences,total,198,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W06,SARS-CoV-2,2-week count of sequences,total,128,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W05,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W04,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W03,SARS-CoV-2,2-week count of sequences,total,103,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2023-W02,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2023-W01,SARS-CoV-2,2-week count of sequences,total,128,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W52,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2022-W51,SARS-CoV-2,2-week count of sequences,total,134,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W50,SARS-CoV-2,2-week count of sequences,total,255,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W49,SARS-CoV-2,2-week count of sequences,total,287,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W48,SARS-CoV-2,2-week count of sequences,total,264,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W47,SARS-CoV-2,2-week count of sequences,total,282,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W46,SARS-CoV-2,2-week count of sequences,total,306,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W45,SARS-CoV-2,2-week count of sequences,total,372,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W44,SARS-CoV-2,2-week count of sequences,total,494,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W43,SARS-CoV-2,2-week count of sequences,total,728,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W42,SARS-CoV-2,2-week count of sequences,total,1033,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W41,SARS-CoV-2,2-week count of sequences,total,1077,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W40,SARS-CoV-2,2-week count of sequences,total,984,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W39,SARS-CoV-2,2-week count of sequences,total,1318,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W38,SARS-CoV-2,2-week count of sequences,total,1493,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W37,SARS-CoV-2,2-week count of sequences,total,1290,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W36,SARS-CoV-2,2-week count of sequences,total,1169,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W35,SARS-CoV-2,2-week count of sequences,total,1022,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W34,SARS-CoV-2,2-week count of sequences,total,1137,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W33,SARS-CoV-2,2-week count of sequences,total,1254,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W32,SARS-CoV-2,2-week count of sequences,total,1296,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W31,SARS-CoV-2,2-week count of sequences,total,1178,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W30,SARS-CoV-2,2-week count of sequences,total,1179,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W29,SARS-CoV-2,2-week count of sequences,total,1313,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W28,SARS-CoV-2,2-week count of sequences,total,978,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W27,SARS-CoV-2,2-week count of sequences,total,912,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W26,SARS-CoV-2,2-week count of sequences,total,1120,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W25,SARS-CoV-2,2-week count of sequences,total,1018,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W24,SARS-CoV-2,2-week count of sequences,total,803,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W23,SARS-CoV-2,2-week count of sequences,total,582,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W22,SARS-CoV-2,2-week count of sequences,total,475,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W21,SARS-CoV-2,2-week count of sequences,total,604,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2022-W20,SARS-CoV-2,2-week count of sequences,total,660,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W19,SARS-CoV-2,2-week count of sequences,total,892,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W18,SARS-CoV-2,2-week count of sequences,total,1462,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W17,SARS-CoV-2,2-week count of sequences,total,1605,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W16,SARS-CoV-2,2-week count of sequences,total,1492,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W15,SARS-CoV-2,2-week count of sequences,total,1826,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W14,SARS-CoV-2,2-week count of sequences,total,2117,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W13,SARS-CoV-2,2-week count of sequences,total,2032,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W12,SARS-CoV-2,2-week count of sequences,total,1928,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W11,SARS-CoV-2,2-week count of sequences,total,1965,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W10,SARS-CoV-2,2-week count of sequences,total,2055,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W09,SARS-CoV-2,2-week count of sequences,total,2306,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W08,SARS-CoV-2,2-week count of sequences,total,2363,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W07,SARS-CoV-2,2-week count of sequences,total,2043,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W06,SARS-CoV-2,2-week count of sequences,total,1911,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W05,SARS-CoV-2,2-week count of sequences,total,2050,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W04,SARS-CoV-2,2-week count of sequences,total,2304,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W03,SARS-CoV-2,2-week count of sequences,total,2413,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W02,SARS-CoV-2,2-week count of sequences,total,2670,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2022-W01,SARS-CoV-2,2-week count of sequences,total,2427,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W52,SARS-CoV-2,2-week count of sequences,total,1592,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W51,SARS-CoV-2,2-week count of sequences,total,1455,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W50,SARS-CoV-2,2-week count of sequences,total,2090,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W49,SARS-CoV-2,2-week count of sequences,total,2531,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W48,SARS-CoV-2,2-week count of sequences,total,2361,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W47,SARS-CoV-2,2-week count of sequences,total,2083,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W46,SARS-CoV-2,2-week count of sequences,total,1679,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W45,SARS-CoV-2,2-week count of sequences,total,1713,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W44,SARS-CoV-2,2-week count of sequences,total,2234,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W43,SARS-CoV-2,2-week count of sequences,total,2504,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W42,SARS-CoV-2,2-week count of sequences,total,2221,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W41,SARS-CoV-2,2-week count of sequences,total,1791,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W40,SARS-CoV-2,2-week count of sequences,total,1627,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W39,SARS-CoV-2,2-week count of sequences,total,1390,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W38,SARS-CoV-2,2-week count of sequences,total,1327,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W37,SARS-CoV-2,2-week count of sequences,total,1386,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W36,SARS-CoV-2,2-week count of sequences,total,1189,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W35,SARS-CoV-2,2-week count of sequences,total,853,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W34,SARS-CoV-2,2-week count of sequences,total,669,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W33,SARS-CoV-2,2-week count of sequences,total,879,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W32,SARS-CoV-2,2-week count of sequences,total,884,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W31,SARS-CoV-2,2-week count of sequences,total,567,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W30,SARS-CoV-2,2-week count of sequences,total,444,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W29,SARS-CoV-2,2-week count of sequences,total,531,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W28,SARS-CoV-2,2-week count of sequences,total,594,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W27,SARS-CoV-2,2-week count of sequences,total,503,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W26,SARS-CoV-2,2-week count of sequences,total,345,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W25,SARS-CoV-2,2-week count of sequences,total,222,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W24,SARS-CoV-2,2-week count of sequences,total,294,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W23,SARS-CoV-2,2-week count of sequences,total,388,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W22,SARS-CoV-2,2-week count of sequences,total,306,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W21,SARS-CoV-2,2-week count of sequences,total,277,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W20,SARS-CoV-2,2-week count of sequences,total,463,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W19,SARS-CoV-2,2-week count of sequences,total,558,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W18,SARS-CoV-2,2-week count of sequences,total,640,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W17,SARS-CoV-2,2-week count of sequences,total,794,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W16,SARS-CoV-2,2-week count of sequences,total,678,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W15,SARS-CoV-2,2-week count of sequences,total,676,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W14,SARS-CoV-2,2-week count of sequences,total,647,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W13,SARS-CoV-2,2-week count of sequences,total,459,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W12,SARS-CoV-2,2-week count of sequences,total,536,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W11,SARS-CoV-2,2-week count of sequences,total,656,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W10,SARS-CoV-2,2-week count of sequences,total,616,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W09,SARS-CoV-2,2-week count of sequences,total,588,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W08,SARS-CoV-2,2-week count of sequences,total,623,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W07,SARS-CoV-2,2-week count of sequences,total,744,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W06,SARS-CoV-2,2-week count of sequences,total,819,≤1%
SARS-CoV-2 variant,GISAID,Czechia,2021-W05,SARS-CoV-2,2-week count of sequences,total,522,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W04,SARS-CoV-2,2-week count of sequences,total,279,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W03,SARS-CoV-2,2-week count of sequences,total,240,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W02,SARS-CoV-2,2-week count of sequences,total,416,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2021-W01,SARS-CoV-2,2-week count of sequences,total,376,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W53,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2020-W52,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W51,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W50,SARS-CoV-2,2-week count of sequences,total,196,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W49,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W48,SARS-CoV-2,2-week count of sequences,total,121,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W47,SARS-CoV-2,2-week count of sequences,total,193,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W46,SARS-CoV-2,2-week count of sequences,total,298,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W45,SARS-CoV-2,2-week count of sequences,total,418,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W44,SARS-CoV-2,2-week count of sequences,total,412,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W43,SARS-CoV-2,2-week count of sequences,total,277,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W42,SARS-CoV-2,2-week count of sequences,total,182,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Czechia,2020-W41,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Czechia,2020-W40,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W39,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W38,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W37,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W36,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W35,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W34,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W33,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W32,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W31,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W30,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W29,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W28,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W27,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W26,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Czechia,2020-W25,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Denmark,2025-W04,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Denmark,2025-W03,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Denmark,2025-W02,SARS-CoV-2,2-week count of sequences,total,137,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2025-W01,SARS-CoV-2,2-week count of sequences,total,177,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W52,SARS-CoV-2,2-week count of sequences,total,212,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W51,SARS-CoV-2,2-week count of sequences,total,225,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W50,SARS-CoV-2,2-week count of sequences,total,246,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W49,SARS-CoV-2,2-week count of sequences,total,273,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W48,SARS-CoV-2,2-week count of sequences,total,227,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W47,SARS-CoV-2,2-week count of sequences,total,215,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W46,SARS-CoV-2,2-week count of sequences,total,253,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W45,SARS-CoV-2,2-week count of sequences,total,327,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W44,SARS-CoV-2,2-week count of sequences,total,363,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W43,SARS-CoV-2,2-week count of sequences,total,369,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W42,SARS-CoV-2,2-week count of sequences,total,449,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W41,SARS-CoV-2,2-week count of sequences,total,453,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W40,SARS-CoV-2,2-week count of sequences,total,346,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W39,SARS-CoV-2,2-week count of sequences,total,292,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W38,SARS-CoV-2,2-week count of sequences,total,343,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W37,SARS-CoV-2,2-week count of sequences,total,513,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W36,SARS-CoV-2,2-week count of sequences,total,546,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W35,SARS-CoV-2,2-week count of sequences,total,439,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W34,SARS-CoV-2,2-week count of sequences,total,401,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W33,SARS-CoV-2,2-week count of sequences,total,372,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W32,SARS-CoV-2,2-week count of sequences,total,340,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W31,SARS-CoV-2,2-week count of sequences,total,378,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W30,SARS-CoV-2,2-week count of sequences,total,444,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W29,SARS-CoV-2,2-week count of sequences,total,421,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W28,SARS-CoV-2,2-week count of sequences,total,361,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W27,SARS-CoV-2,2-week count of sequences,total,253,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W26,SARS-CoV-2,2-week count of sequences,total,144,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W25,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2024-W24,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W23,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W22,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W21,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W20,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W19,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W18,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W17,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W16,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W15,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W14,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W13,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W12,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W11,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W10,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W09,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W08,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Denmark,2024-W07,SARS-CoV-2,2-week count of sequences,total,64,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2024-W06,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2024-W05,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2024-W04,SARS-CoV-2,2-week count of sequences,total,143,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W03,SARS-CoV-2,2-week count of sequences,total,237,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W02,SARS-CoV-2,2-week count of sequences,total,444,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2024-W01,SARS-CoV-2,2-week count of sequences,total,773,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W52,SARS-CoV-2,2-week count of sequences,total,1292,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W51,SARS-CoV-2,2-week count of sequences,total,1917,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W50,SARS-CoV-2,2-week count of sequences,total,2540,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W49,SARS-CoV-2,2-week count of sequences,total,2579,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W48,SARS-CoV-2,2-week count of sequences,total,1902,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W47,SARS-CoV-2,2-week count of sequences,total,1261,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W46,SARS-CoV-2,2-week count of sequences,total,1035,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W45,SARS-CoV-2,2-week count of sequences,total,1109,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W44,SARS-CoV-2,2-week count of sequences,total,1108,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W43,SARS-CoV-2,2-week count of sequences,total,933,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W42,SARS-CoV-2,2-week count of sequences,total,688,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W41,SARS-CoV-2,2-week count of sequences,total,572,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W40,SARS-CoV-2,2-week count of sequences,total,511,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W39,SARS-CoV-2,2-week count of sequences,total,425,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W38,SARS-CoV-2,2-week count of sequences,total,449,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W37,SARS-CoV-2,2-week count of sequences,total,512,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W36,SARS-CoV-2,2-week count of sequences,total,452,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W35,SARS-CoV-2,2-week count of sequences,total,424,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W34,SARS-CoV-2,2-week count of sequences,total,444,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W33,SARS-CoV-2,2-week count of sequences,total,346,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W32,SARS-CoV-2,2-week count of sequences,total,223,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W31,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W30,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2023-W29,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2023-W28,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2023-W27,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2023-W26,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2023-W25,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2023-W24,SARS-CoV-2,2-week count of sequences,total,118,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W23,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W22,SARS-CoV-2,2-week count of sequences,total,231,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W21,SARS-CoV-2,2-week count of sequences,total,301,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W20,SARS-CoV-2,2-week count of sequences,total,427,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W19,SARS-CoV-2,2-week count of sequences,total,532,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W18,SARS-CoV-2,2-week count of sequences,total,519,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W17,SARS-CoV-2,2-week count of sequences,total,600,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2023-W16,SARS-CoV-2,2-week count of sequences,total,703,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W15,SARS-CoV-2,2-week count of sequences,total,735,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W14,SARS-CoV-2,2-week count of sequences,total,1157,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W13,SARS-CoV-2,2-week count of sequences,total,1762,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W12,SARS-CoV-2,2-week count of sequences,total,1815,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W11,SARS-CoV-2,2-week count of sequences,total,1406,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W10,SARS-CoV-2,2-week count of sequences,total,1130,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W09,SARS-CoV-2,2-week count of sequences,total,985,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W08,SARS-CoV-2,2-week count of sequences,total,1056,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W07,SARS-CoV-2,2-week count of sequences,total,1339,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W06,SARS-CoV-2,2-week count of sequences,total,1444,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W05,SARS-CoV-2,2-week count of sequences,total,1442,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W04,SARS-CoV-2,2-week count of sequences,total,1571,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W03,SARS-CoV-2,2-week count of sequences,total,2260,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W02,SARS-CoV-2,2-week count of sequences,total,3972,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2023-W01,SARS-CoV-2,2-week count of sequences,total,6337,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W52,SARS-CoV-2,2-week count of sequences,total,7572,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W51,SARS-CoV-2,2-week count of sequences,total,7608,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W50,SARS-CoV-2,2-week count of sequences,total,7781,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W49,SARS-CoV-2,2-week count of sequences,total,7659,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W48,SARS-CoV-2,2-week count of sequences,total,6799,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W47,SARS-CoV-2,2-week count of sequences,total,5807,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W46,SARS-CoV-2,2-week count of sequences,total,5793,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W45,SARS-CoV-2,2-week count of sequences,total,6094,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W44,SARS-CoV-2,2-week count of sequences,total,6554,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W43,SARS-CoV-2,2-week count of sequences,total,7533,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W42,SARS-CoV-2,2-week count of sequences,total,7982,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W41,SARS-CoV-2,2-week count of sequences,total,8312,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W40,SARS-CoV-2,2-week count of sequences,total,8181,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W39,SARS-CoV-2,2-week count of sequences,total,7891,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W38,SARS-CoV-2,2-week count of sequences,total,7666,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W37,SARS-CoV-2,2-week count of sequences,total,7284,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W36,SARS-CoV-2,2-week count of sequences,total,6823,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W35,SARS-CoV-2,2-week count of sequences,total,5939,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W34,SARS-CoV-2,2-week count of sequences,total,5505,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W33,SARS-CoV-2,2-week count of sequences,total,6701,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W32,SARS-CoV-2,2-week count of sequences,total,7372,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W31,SARS-CoV-2,2-week count of sequences,total,7586,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W30,SARS-CoV-2,2-week count of sequences,total,8811,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W29,SARS-CoV-2,2-week count of sequences,total,8992,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W28,SARS-CoV-2,2-week count of sequences,total,8511,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W27,SARS-CoV-2,2-week count of sequences,total,8493,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W26,SARS-CoV-2,2-week count of sequences,total,9068,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W25,SARS-CoV-2,2-week count of sequences,total,10652,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W24,SARS-CoV-2,2-week count of sequences,total,9698,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W23,SARS-CoV-2,2-week count of sequences,total,6241,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W22,SARS-CoV-2,2-week count of sequences,total,4781,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W21,SARS-CoV-2,2-week count of sequences,total,5349,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W20,SARS-CoV-2,2-week count of sequences,total,6596,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W19,SARS-CoV-2,2-week count of sequences,total,7869,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W18,SARS-CoV-2,2-week count of sequences,total,9229,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W17,SARS-CoV-2,2-week count of sequences,total,12923,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W16,SARS-CoV-2,2-week count of sequences,total,17151,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W15,SARS-CoV-2,2-week count of sequences,total,21461,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W14,SARS-CoV-2,2-week count of sequences,total,25443,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W13,SARS-CoV-2,2-week count of sequences,total,26222,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W12,SARS-CoV-2,2-week count of sequences,total,26934,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W11,SARS-CoV-2,2-week count of sequences,total,28043,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W10,SARS-CoV-2,2-week count of sequences,total,28052,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W09,SARS-CoV-2,2-week count of sequences,total,28941,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W08,SARS-CoV-2,2-week count of sequences,total,30641,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W07,SARS-CoV-2,2-week count of sequences,total,29867,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W06,SARS-CoV-2,2-week count of sequences,total,26745,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W05,SARS-CoV-2,2-week count of sequences,total,27192,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W04,SARS-CoV-2,2-week count of sequences,total,31523,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W03,SARS-CoV-2,2-week count of sequences,total,30667,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W02,SARS-CoV-2,2-week count of sequences,total,23674,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2022-W01,SARS-CoV-2,2-week count of sequences,total,20946,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W52,SARS-CoV-2,2-week count of sequences,total,16502,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W51,SARS-CoV-2,2-week count of sequences,total,12909,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W50,SARS-CoV-2,2-week count of sequences,total,21521,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W49,SARS-CoV-2,2-week count of sequences,total,31906,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W48,SARS-CoV-2,2-week count of sequences,total,30633,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W47,SARS-CoV-2,2-week count of sequences,total,24366,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W46,SARS-CoV-2,2-week count of sequences,total,23256,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W45,SARS-CoV-2,2-week count of sequences,total,22799,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W44,SARS-CoV-2,2-week count of sequences,total,19643,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W43,SARS-CoV-2,2-week count of sequences,total,15814,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W42,SARS-CoV-2,2-week count of sequences,total,11716,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W41,SARS-CoV-2,2-week count of sequences,total,7815,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W40,SARS-CoV-2,2-week count of sequences,total,6191,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W39,SARS-CoV-2,2-week count of sequences,total,4975,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W38,SARS-CoV-2,2-week count of sequences,total,4235,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W37,SARS-CoV-2,2-week count of sequences,total,4718,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W36,SARS-CoV-2,2-week count of sequences,total,6355,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W35,SARS-CoV-2,2-week count of sequences,total,8915,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W34,SARS-CoV-2,2-week count of sequences,total,10856,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W33,SARS-CoV-2,2-week count of sequences,total,11455,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W32,SARS-CoV-2,2-week count of sequences,total,11444,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W31,SARS-CoV-2,2-week count of sequences,total,11121,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W30,SARS-CoV-2,2-week count of sequences,total,10410,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W29,SARS-CoV-2,2-week count of sequences,total,10956,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W28,SARS-CoV-2,2-week count of sequences,total,9146,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W27,SARS-CoV-2,2-week count of sequences,total,5174,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W26,SARS-CoV-2,2-week count of sequences,total,3153,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W25,SARS-CoV-2,2-week count of sequences,total,2105,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W24,SARS-CoV-2,2-week count of sequences,total,3144,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W23,SARS-CoV-2,2-week count of sequences,total,5963,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W22,SARS-CoV-2,2-week count of sequences,total,8723,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W21,SARS-CoV-2,2-week count of sequences,total,9577,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W20,SARS-CoV-2,2-week count of sequences,total,9745,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W19,SARS-CoV-2,2-week count of sequences,total,9925,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W18,SARS-CoV-2,2-week count of sequences,total,9102,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W17,SARS-CoV-2,2-week count of sequences,total,7779,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W16,SARS-CoV-2,2-week count of sequences,total,7370,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W15,SARS-CoV-2,2-week count of sequences,total,7182,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W14,SARS-CoV-2,2-week count of sequences,total,6964,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W13,SARS-CoV-2,2-week count of sequences,total,7297,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W12,SARS-CoV-2,2-week count of sequences,total,7210,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W11,SARS-CoV-2,2-week count of sequences,total,6428,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W10,SARS-CoV-2,2-week count of sequences,total,5719,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W09,SARS-CoV-2,2-week count of sequences,total,5399,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W08,SARS-CoV-2,2-week count of sequences,total,5122,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W07,SARS-CoV-2,2-week count of sequences,total,4419,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W06,SARS-CoV-2,2-week count of sequences,total,4257,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W05,SARS-CoV-2,2-week count of sequences,total,4919,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W04,SARS-CoV-2,2-week count of sequences,total,6457,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W03,SARS-CoV-2,2-week count of sequences,total,8270,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W02,SARS-CoV-2,2-week count of sequences,total,8661,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2021-W01,SARS-CoV-2,2-week count of sequences,total,8217,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W53,SARS-CoV-2,2-week count of sequences,total,7720,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W52,SARS-CoV-2,2-week count of sequences,total,8787,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W51,SARS-CoV-2,2-week count of sequences,total,9445,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W50,SARS-CoV-2,2-week count of sequences,total,7280,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W49,SARS-CoV-2,2-week count of sequences,total,5159,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W48,SARS-CoV-2,2-week count of sequences,total,4110,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W47,SARS-CoV-2,2-week count of sequences,total,3124,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W46,SARS-CoV-2,2-week count of sequences,total,2727,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W45,SARS-CoV-2,2-week count of sequences,total,2950,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W44,SARS-CoV-2,2-week count of sequences,total,1810,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W43,SARS-CoV-2,2-week count of sequences,total,1446,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W42,SARS-CoV-2,2-week count of sequences,total,1508,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W41,SARS-CoV-2,2-week count of sequences,total,821,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W40,SARS-CoV-2,2-week count of sequences,total,1267,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W39,SARS-CoV-2,2-week count of sequences,total,1606,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W38,SARS-CoV-2,2-week count of sequences,total,1048,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W37,SARS-CoV-2,2-week count of sequences,total,995,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W36,SARS-CoV-2,2-week count of sequences,total,987,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W35,SARS-CoV-2,2-week count of sequences,total,583,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2020-W34,SARS-CoV-2,2-week count of sequences,total,693,≤1%
SARS-CoV-2 variant,GISAID,Denmark,2020-W33,SARS-CoV-2,2-week count of sequences,total,423,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Denmark,2020-W32,SARS-CoV-2,2-week count of sequences,total,112,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2020-W31,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2020-W30,SARS-CoV-2,2-week count of sequences,total,142,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Denmark,2020-W29,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2020-W28,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Denmark,2020-W27,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2020-W26,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Denmark,2020-W25,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,NA,EU/EEA,2025-W04,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,NA,EU/EEA,2025-W03,SARS-CoV-2,2-week count of sequences,total,404,>1% to 2.5%
SARS-CoV-2 variant,NA,EU/EEA,2025-W02,SARS-CoV-2,2-week count of sequences,total,797,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2025-W01,SARS-CoV-2,2-week count of sequences,total,1036,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W52,SARS-CoV-2,2-week count of sequences,total,1432,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W51,SARS-CoV-2,2-week count of sequences,total,1786,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W50,SARS-CoV-2,2-week count of sequences,total,2017,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W49,SARS-CoV-2,2-week count of sequences,total,2347,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W48,SARS-CoV-2,2-week count of sequences,total,2594,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W47,SARS-CoV-2,2-week count of sequences,total,2745,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W46,SARS-CoV-2,2-week count of sequences,total,3006,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W45,SARS-CoV-2,2-week count of sequences,total,3244,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W44,SARS-CoV-2,2-week count of sequences,total,3682,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W43,SARS-CoV-2,2-week count of sequences,total,4559,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W42,SARS-CoV-2,2-week count of sequences,total,5347,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W41,SARS-CoV-2,2-week count of sequences,total,5572,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W40,SARS-CoV-2,2-week count of sequences,total,5340,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W39,SARS-CoV-2,2-week count of sequences,total,5350,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W38,SARS-CoV-2,2-week count of sequences,total,5049,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W37,SARS-CoV-2,2-week count of sequences,total,5076,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W36,SARS-CoV-2,2-week count of sequences,total,5350,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W35,SARS-CoV-2,2-week count of sequences,total,5119,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W34,SARS-CoV-2,2-week count of sequences,total,5046,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W33,SARS-CoV-2,2-week count of sequences,total,5298,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W32,SARS-CoV-2,2-week count of sequences,total,5730,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W31,SARS-CoV-2,2-week count of sequences,total,6282,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W30,SARS-CoV-2,2-week count of sequences,total,6778,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W29,SARS-CoV-2,2-week count of sequences,total,6898,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W28,SARS-CoV-2,2-week count of sequences,total,6930,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W27,SARS-CoV-2,2-week count of sequences,total,6968,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W26,SARS-CoV-2,2-week count of sequences,total,6779,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W25,SARS-CoV-2,2-week count of sequences,total,6068,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W24,SARS-CoV-2,2-week count of sequences,total,5173,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W23,SARS-CoV-2,2-week count of sequences,total,4519,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W22,SARS-CoV-2,2-week count of sequences,total,3861,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W21,SARS-CoV-2,2-week count of sequences,total,3018,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W20,SARS-CoV-2,2-week count of sequences,total,2218,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W19,SARS-CoV-2,2-week count of sequences,total,1687,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W18,SARS-CoV-2,2-week count of sequences,total,1301,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W17,SARS-CoV-2,2-week count of sequences,total,979,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W16,SARS-CoV-2,2-week count of sequences,total,844,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W15,SARS-CoV-2,2-week count of sequences,total,813,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W14,SARS-CoV-2,2-week count of sequences,total,813,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W13,SARS-CoV-2,2-week count of sequences,total,862,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W12,SARS-CoV-2,2-week count of sequences,total,945,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W11,SARS-CoV-2,2-week count of sequences,total,1034,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W10,SARS-CoV-2,2-week count of sequences,total,1222,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W09,SARS-CoV-2,2-week count of sequences,total,1523,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W08,SARS-CoV-2,2-week count of sequences,total,1985,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W07,SARS-CoV-2,2-week count of sequences,total,2448,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W06,SARS-CoV-2,2-week count of sequences,total,2987,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W05,SARS-CoV-2,2-week count of sequences,total,3712,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W04,SARS-CoV-2,2-week count of sequences,total,5204,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W03,SARS-CoV-2,2-week count of sequences,total,7126,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W02,SARS-CoV-2,2-week count of sequences,total,8827,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2024-W01,SARS-CoV-2,2-week count of sequences,total,10144,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W52,SARS-CoV-2,2-week count of sequences,total,11897,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W51,SARS-CoV-2,2-week count of sequences,total,16199,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W50,SARS-CoV-2,2-week count of sequences,total,18298,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W49,SARS-CoV-2,2-week count of sequences,total,16651,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W48,SARS-CoV-2,2-week count of sequences,total,15185,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W47,SARS-CoV-2,2-week count of sequences,total,14293,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W46,SARS-CoV-2,2-week count of sequences,total,13383,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W45,SARS-CoV-2,2-week count of sequences,total,12622,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W44,SARS-CoV-2,2-week count of sequences,total,12623,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W43,SARS-CoV-2,2-week count of sequences,total,12650,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W42,SARS-CoV-2,2-week count of sequences,total,12613,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W41,SARS-CoV-2,2-week count of sequences,total,12754,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W40,SARS-CoV-2,2-week count of sequences,total,12350,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W39,SARS-CoV-2,2-week count of sequences,total,12316,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W38,SARS-CoV-2,2-week count of sequences,total,12043,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W37,SARS-CoV-2,2-week count of sequences,total,11765,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W36,SARS-CoV-2,2-week count of sequences,total,11214,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W35,SARS-CoV-2,2-week count of sequences,total,9759,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W34,SARS-CoV-2,2-week count of sequences,total,7923,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W33,SARS-CoV-2,2-week count of sequences,total,6303,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W32,SARS-CoV-2,2-week count of sequences,total,5554,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W31,SARS-CoV-2,2-week count of sequences,total,4271,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W30,SARS-CoV-2,2-week count of sequences,total,3202,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W29,SARS-CoV-2,2-week count of sequences,total,2982,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W28,SARS-CoV-2,2-week count of sequences,total,2764,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W27,SARS-CoV-2,2-week count of sequences,total,2559,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W26,SARS-CoV-2,2-week count of sequences,total,2998,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W25,SARS-CoV-2,2-week count of sequences,total,3807,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W24,SARS-CoV-2,2-week count of sequences,total,5105,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W23,SARS-CoV-2,2-week count of sequences,total,6141,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W22,SARS-CoV-2,2-week count of sequences,total,7485,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W21,SARS-CoV-2,2-week count of sequences,total,8318,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W20,SARS-CoV-2,2-week count of sequences,total,8629,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W19,SARS-CoV-2,2-week count of sequences,total,9714,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W18,SARS-CoV-2,2-week count of sequences,total,11244,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W17,SARS-CoV-2,2-week count of sequences,total,13551,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W16,SARS-CoV-2,2-week count of sequences,total,15026,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W15,SARS-CoV-2,2-week count of sequences,total,15487,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W14,SARS-CoV-2,2-week count of sequences,total,17729,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W13,SARS-CoV-2,2-week count of sequences,total,22408,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W12,SARS-CoV-2,2-week count of sequences,total,26632,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W11,SARS-CoV-2,2-week count of sequences,total,29027,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W10,SARS-CoV-2,2-week count of sequences,total,30403,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W09,SARS-CoV-2,2-week count of sequences,total,30475,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W08,SARS-CoV-2,2-week count of sequences,total,29944,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W07,SARS-CoV-2,2-week count of sequences,total,29325,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W06,SARS-CoV-2,2-week count of sequences,total,28797,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W05,SARS-CoV-2,2-week count of sequences,total,27389,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W04,SARS-CoV-2,2-week count of sequences,total,26381,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W03,SARS-CoV-2,2-week count of sequences,total,30631,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W02,SARS-CoV-2,2-week count of sequences,total,36264,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2023-W01,SARS-CoV-2,2-week count of sequences,total,39443,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W52,SARS-CoV-2,2-week count of sequences,total,44023,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W51,SARS-CoV-2,2-week count of sequences,total,52877,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W50,SARS-CoV-2,2-week count of sequences,total,57233,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W49,SARS-CoV-2,2-week count of sequences,total,54270,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W48,SARS-CoV-2,2-week count of sequences,total,51433,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W47,SARS-CoV-2,2-week count of sequences,total,47161,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W46,SARS-CoV-2,2-week count of sequences,total,46712,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W45,SARS-CoV-2,2-week count of sequences,total,45602,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W44,SARS-CoV-2,2-week count of sequences,total,46516,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W43,SARS-CoV-2,2-week count of sequences,total,53651,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W42,SARS-CoV-2,2-week count of sequences,total,58162,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W41,SARS-CoV-2,2-week count of sequences,total,59345,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W40,SARS-CoV-2,2-week count of sequences,total,57097,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W39,SARS-CoV-2,2-week count of sequences,total,55776,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W38,SARS-CoV-2,2-week count of sequences,total,55530,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W37,SARS-CoV-2,2-week count of sequences,total,54227,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W36,SARS-CoV-2,2-week count of sequences,total,51758,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W35,SARS-CoV-2,2-week count of sequences,total,47894,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W34,SARS-CoV-2,2-week count of sequences,total,48828,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W33,SARS-CoV-2,2-week count of sequences,total,53680,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W32,SARS-CoV-2,2-week count of sequences,total,57033,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W31,SARS-CoV-2,2-week count of sequences,total,63752,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W30,SARS-CoV-2,2-week count of sequences,total,71307,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W29,SARS-CoV-2,2-week count of sequences,total,76472,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W28,SARS-CoV-2,2-week count of sequences,total,76943,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W27,SARS-CoV-2,2-week count of sequences,total,83395,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W26,SARS-CoV-2,2-week count of sequences,total,92544,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W25,SARS-CoV-2,2-week count of sequences,total,87496,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W24,SARS-CoV-2,2-week count of sequences,total,73802,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W23,SARS-CoV-2,2-week count of sequences,total,63323,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W22,SARS-CoV-2,2-week count of sequences,total,56800,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W21,SARS-CoV-2,2-week count of sequences,total,57346,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W20,SARS-CoV-2,2-week count of sequences,total,66127,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W19,SARS-CoV-2,2-week count of sequences,total,73612,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W18,SARS-CoV-2,2-week count of sequences,total,82665,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W17,SARS-CoV-2,2-week count of sequences,total,91757,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W16,SARS-CoV-2,2-week count of sequences,total,100002,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W15,SARS-CoV-2,2-week count of sequences,total,108515,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W14,SARS-CoV-2,2-week count of sequences,total,115381,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W13,SARS-CoV-2,2-week count of sequences,total,124872,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W12,SARS-CoV-2,2-week count of sequences,total,134878,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W11,SARS-CoV-2,2-week count of sequences,total,138858,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W10,SARS-CoV-2,2-week count of sequences,total,136448,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W09,SARS-CoV-2,2-week count of sequences,total,138124,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W08,SARS-CoV-2,2-week count of sequences,total,144907,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W07,SARS-CoV-2,2-week count of sequences,total,148721,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W06,SARS-CoV-2,2-week count of sequences,total,151112,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W05,SARS-CoV-2,2-week count of sequences,total,150748,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W04,SARS-CoV-2,2-week count of sequences,total,153220,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W03,SARS-CoV-2,2-week count of sequences,total,152214,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W02,SARS-CoV-2,2-week count of sequences,total,142511,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2022-W01,SARS-CoV-2,2-week count of sequences,total,136755,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W52,SARS-CoV-2,2-week count of sequences,total,119373,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W51,SARS-CoV-2,2-week count of sequences,total,110079,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W50,SARS-CoV-2,2-week count of sequences,total,120405,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W49,SARS-CoV-2,2-week count of sequences,total,127904,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W48,SARS-CoV-2,2-week count of sequences,total,117568,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W47,SARS-CoV-2,2-week count of sequences,total,104960,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W46,SARS-CoV-2,2-week count of sequences,total,103487,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W45,SARS-CoV-2,2-week count of sequences,total,96557,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W44,SARS-CoV-2,2-week count of sequences,total,92715,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W43,SARS-CoV-2,2-week count of sequences,total,86727,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W42,SARS-CoV-2,2-week count of sequences,total,73408,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W41,SARS-CoV-2,2-week count of sequences,total,62016,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W40,SARS-CoV-2,2-week count of sequences,total,57475,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W39,SARS-CoV-2,2-week count of sequences,total,56103,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W38,SARS-CoV-2,2-week count of sequences,total,57888,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W37,SARS-CoV-2,2-week count of sequences,total,64842,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W36,SARS-CoV-2,2-week count of sequences,total,71857,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W35,SARS-CoV-2,2-week count of sequences,total,77291,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W34,SARS-CoV-2,2-week count of sequences,total,78720,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W33,SARS-CoV-2,2-week count of sequences,total,76778,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W32,SARS-CoV-2,2-week count of sequences,total,72980,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W31,SARS-CoV-2,2-week count of sequences,total,70563,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W30,SARS-CoV-2,2-week count of sequences,total,77473,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W29,SARS-CoV-2,2-week count of sequences,total,77433,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W28,SARS-CoV-2,2-week count of sequences,total,58513,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W27,SARS-CoV-2,2-week count of sequences,total,39142,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W26,SARS-CoV-2,2-week count of sequences,total,28650,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W25,SARS-CoV-2,2-week count of sequences,total,25196,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W24,SARS-CoV-2,2-week count of sequences,total,31511,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W23,SARS-CoV-2,2-week count of sequences,total,38145,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W22,SARS-CoV-2,2-week count of sequences,total,43389,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W21,SARS-CoV-2,2-week count of sequences,total,52423,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W20,SARS-CoV-2,2-week count of sequences,total,61946,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W19,SARS-CoV-2,2-week count of sequences,total,71519,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W18,SARS-CoV-2,2-week count of sequences,total,76167,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W17,SARS-CoV-2,2-week count of sequences,total,77992,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W16,SARS-CoV-2,2-week count of sequences,total,81214,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W15,SARS-CoV-2,2-week count of sequences,total,75139,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W14,SARS-CoV-2,2-week count of sequences,total,69113,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W13,SARS-CoV-2,2-week count of sequences,total,75204,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W12,SARS-CoV-2,2-week count of sequences,total,80205,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W11,SARS-CoV-2,2-week count of sequences,total,76440,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W10,SARS-CoV-2,2-week count of sequences,total,68974,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W09,SARS-CoV-2,2-week count of sequences,total,60398,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W08,SARS-CoV-2,2-week count of sequences,total,52760,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W07,SARS-CoV-2,2-week count of sequences,total,47172,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W06,SARS-CoV-2,2-week count of sequences,total,43577,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W05,SARS-CoV-2,2-week count of sequences,total,41477,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W04,SARS-CoV-2,2-week count of sequences,total,35616,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W03,SARS-CoV-2,2-week count of sequences,total,28899,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W02,SARS-CoV-2,2-week count of sequences,total,23873,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2021-W01,SARS-CoV-2,2-week count of sequences,total,19470,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W53,SARS-CoV-2,2-week count of sequences,total,16422,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W52,SARS-CoV-2,2-week count of sequences,total,16507,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W51,SARS-CoV-2,2-week count of sequences,total,16795,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W50,SARS-CoV-2,2-week count of sequences,total,14277,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W49,SARS-CoV-2,2-week count of sequences,total,11804,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W48,SARS-CoV-2,2-week count of sequences,total,9210,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W47,SARS-CoV-2,2-week count of sequences,total,8566,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W46,SARS-CoV-2,2-week count of sequences,total,9240,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W45,SARS-CoV-2,2-week count of sequences,total,9446,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W44,SARS-CoV-2,2-week count of sequences,total,8197,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W43,SARS-CoV-2,2-week count of sequences,total,7153,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W42,SARS-CoV-2,2-week count of sequences,total,6761,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W41,SARS-CoV-2,2-week count of sequences,total,5299,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W40,SARS-CoV-2,2-week count of sequences,total,4858,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W39,SARS-CoV-2,2-week count of sequences,total,4891,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W38,SARS-CoV-2,2-week count of sequences,total,4018,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W37,SARS-CoV-2,2-week count of sequences,total,3453,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W36,SARS-CoV-2,2-week count of sequences,total,3205,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W35,SARS-CoV-2,2-week count of sequences,total,2463,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W34,SARS-CoV-2,2-week count of sequences,total,2579,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W33,SARS-CoV-2,2-week count of sequences,total,2331,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W32,SARS-CoV-2,2-week count of sequences,total,1605,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W31,SARS-CoV-2,2-week count of sequences,total,1250,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W30,SARS-CoV-2,2-week count of sequences,total,929,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W29,SARS-CoV-2,2-week count of sequences,total,897,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W28,SARS-CoV-2,2-week count of sequences,total,909,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W27,SARS-CoV-2,2-week count of sequences,total,1118,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W26,SARS-CoV-2,2-week count of sequences,total,2511,≤1%
SARS-CoV-2 variant,NA,EU/EEA,2020-W25,SARS-CoV-2,2-week count of sequences,total,1827,≤1%
SARS-CoV-2 variant,GISAID,Estonia,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W40,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W39,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W38,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W37,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W36,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W35,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W31,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W30,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W29,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W27,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W26,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W25,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W24,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W23,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W22,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W21,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2024-W17,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W16,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W15,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W14,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W13,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W12,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W11,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W10,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W09,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W08,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W07,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W06,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W05,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W04,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W03,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W02,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2024-W01,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W52,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W51,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W50,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W49,SARS-CoV-2,2-week count of sequences,total,142,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2023-W48,SARS-CoV-2,2-week count of sequences,total,157,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2023-W47,SARS-CoV-2,2-week count of sequences,total,143,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2023-W46,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W45,SARS-CoV-2,2-week count of sequences,total,116,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W44,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W43,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W42,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W41,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W40,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W39,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W38,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W37,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W36,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W35,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W34,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W33,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W32,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W31,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W30,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W29,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W28,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W27,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W26,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W25,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W24,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W23,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W22,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W21,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W20,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W19,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W18,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W17,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W16,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W15,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W14,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W13,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W12,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W11,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W10,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W09,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W08,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W07,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W06,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W05,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W04,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W03,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2023-W02,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Estonia,2023-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2022-W42,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2022-W41,SARS-CoV-2,2-week count of sequences,total,238,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W40,SARS-CoV-2,2-week count of sequences,total,373,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W39,SARS-CoV-2,2-week count of sequences,total,376,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W38,SARS-CoV-2,2-week count of sequences,total,376,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W37,SARS-CoV-2,2-week count of sequences,total,351,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W36,SARS-CoV-2,2-week count of sequences,total,243,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W35,SARS-CoV-2,2-week count of sequences,total,255,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W34,SARS-CoV-2,2-week count of sequences,total,326,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W33,SARS-CoV-2,2-week count of sequences,total,278,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W32,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W31,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2022-W30,SARS-CoV-2,2-week count of sequences,total,131,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W29,SARS-CoV-2,2-week count of sequences,total,172,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W28,SARS-CoV-2,2-week count of sequences,total,177,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W27,SARS-CoV-2,2-week count of sequences,total,165,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W26,SARS-CoV-2,2-week count of sequences,total,129,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W25,SARS-CoV-2,2-week count of sequences,total,171,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W24,SARS-CoV-2,2-week count of sequences,total,295,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W23,SARS-CoV-2,2-week count of sequences,total,355,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W22,SARS-CoV-2,2-week count of sequences,total,356,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W21,SARS-CoV-2,2-week count of sequences,total,338,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W20,SARS-CoV-2,2-week count of sequences,total,373,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W19,SARS-CoV-2,2-week count of sequences,total,378,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W18,SARS-CoV-2,2-week count of sequences,total,362,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W17,SARS-CoV-2,2-week count of sequences,total,376,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W16,SARS-CoV-2,2-week count of sequences,total,343,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W15,SARS-CoV-2,2-week count of sequences,total,351,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W14,SARS-CoV-2,2-week count of sequences,total,365,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W13,SARS-CoV-2,2-week count of sequences,total,331,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W12,SARS-CoV-2,2-week count of sequences,total,349,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W11,SARS-CoV-2,2-week count of sequences,total,365,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W10,SARS-CoV-2,2-week count of sequences,total,357,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W09,SARS-CoV-2,2-week count of sequences,total,369,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W08,SARS-CoV-2,2-week count of sequences,total,352,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W07,SARS-CoV-2,2-week count of sequences,total,269,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W06,SARS-CoV-2,2-week count of sequences,total,240,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W05,SARS-CoV-2,2-week count of sequences,total,312,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W04,SARS-CoV-2,2-week count of sequences,total,356,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W03,SARS-CoV-2,2-week count of sequences,total,347,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W02,SARS-CoV-2,2-week count of sequences,total,338,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2022-W01,SARS-CoV-2,2-week count of sequences,total,331,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W52,SARS-CoV-2,2-week count of sequences,total,340,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W51,SARS-CoV-2,2-week count of sequences,total,349,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W50,SARS-CoV-2,2-week count of sequences,total,346,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W49,SARS-CoV-2,2-week count of sequences,total,362,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W48,SARS-CoV-2,2-week count of sequences,total,332,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W47,SARS-CoV-2,2-week count of sequences,total,340,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W46,SARS-CoV-2,2-week count of sequences,total,325,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W45,SARS-CoV-2,2-week count of sequences,total,294,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W44,SARS-CoV-2,2-week count of sequences,total,302,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W43,SARS-CoV-2,2-week count of sequences,total,344,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W42,SARS-CoV-2,2-week count of sequences,total,362,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W41,SARS-CoV-2,2-week count of sequences,total,319,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W40,SARS-CoV-2,2-week count of sequences,total,332,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W39,SARS-CoV-2,2-week count of sequences,total,348,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W38,SARS-CoV-2,2-week count of sequences,total,347,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W37,SARS-CoV-2,2-week count of sequences,total,346,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W36,SARS-CoV-2,2-week count of sequences,total,366,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W35,SARS-CoV-2,2-week count of sequences,total,369,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W34,SARS-CoV-2,2-week count of sequences,total,362,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W33,SARS-CoV-2,2-week count of sequences,total,371,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W32,SARS-CoV-2,2-week count of sequences,total,360,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W31,SARS-CoV-2,2-week count of sequences,total,360,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W30,SARS-CoV-2,2-week count of sequences,total,368,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W29,SARS-CoV-2,2-week count of sequences,total,252,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W28,SARS-CoV-2,2-week count of sequences,total,160,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W27,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W26,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2021-W25,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2021-W24,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2021-W23,SARS-CoV-2,2-week count of sequences,total,137,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W22,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2021-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2021-W20,SARS-CoV-2,2-week count of sequences,total,167,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W19,SARS-CoV-2,2-week count of sequences,total,326,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W18,SARS-CoV-2,2-week count of sequences,total,327,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W17,SARS-CoV-2,2-week count of sequences,total,351,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W16,SARS-CoV-2,2-week count of sequences,total,356,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W15,SARS-CoV-2,2-week count of sequences,total,368,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W14,SARS-CoV-2,2-week count of sequences,total,795,≤1%
SARS-CoV-2 variant,GISAID,Estonia,2021-W13,SARS-CoV-2,2-week count of sequences,total,1127,≤1%
SARS-CoV-2 variant,GISAID,Estonia,2021-W12,SARS-CoV-2,2-week count of sequences,total,1034,≤1%
SARS-CoV-2 variant,GISAID,Estonia,2021-W11,SARS-CoV-2,2-week count of sequences,total,1027,≤1%
SARS-CoV-2 variant,GISAID,Estonia,2021-W10,SARS-CoV-2,2-week count of sequences,total,657,≤1%
SARS-CoV-2 variant,GISAID,Estonia,2021-W09,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W08,SARS-CoV-2,2-week count of sequences,total,442,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W07,SARS-CoV-2,2-week count of sequences,total,564,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W06,SARS-CoV-2,2-week count of sequences,total,164,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2021-W05,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2021-W04,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2021-W03,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Estonia,2021-W02,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Estonia,2021-W01,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W53,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W52,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W51,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W50,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W48,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W47,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W46,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W45,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W44,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W43,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W42,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W41,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2020-W40,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2020-W39,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Estonia,2020-W38,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Estonia,2020-W37,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Estonia,2020-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Estonia,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Finland,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Finland,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Finland,2025-W02,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Finland,2025-W01,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W52,SARS-CoV-2,2-week count of sequences,total,76,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W51,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W50,SARS-CoV-2,2-week count of sequences,total,71,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W49,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W48,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W47,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W46,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W45,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W44,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W43,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W42,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W41,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W40,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W39,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W38,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W37,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W36,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W35,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W34,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W33,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W32,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W31,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W30,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W29,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W28,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W27,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W26,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W25,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W24,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W23,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W22,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W21,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W20,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W19,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W18,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W17,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W16,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W15,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Finland,2024-W14,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W13,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W12,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W11,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W10,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W09,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W08,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W07,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2024-W06,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W05,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2024-W04,SARS-CoV-2,2-week count of sequences,total,126,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2024-W03,SARS-CoV-2,2-week count of sequences,total,155,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2024-W02,SARS-CoV-2,2-week count of sequences,total,158,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2024-W01,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W52,SARS-CoV-2,2-week count of sequences,total,192,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W51,SARS-CoV-2,2-week count of sequences,total,261,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W50,SARS-CoV-2,2-week count of sequences,total,271,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W49,SARS-CoV-2,2-week count of sequences,total,269,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W48,SARS-CoV-2,2-week count of sequences,total,303,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W47,SARS-CoV-2,2-week count of sequences,total,338,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W46,SARS-CoV-2,2-week count of sequences,total,355,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W45,SARS-CoV-2,2-week count of sequences,total,427,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W44,SARS-CoV-2,2-week count of sequences,total,416,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W43,SARS-CoV-2,2-week count of sequences,total,364,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W42,SARS-CoV-2,2-week count of sequences,total,375,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W41,SARS-CoV-2,2-week count of sequences,total,287,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W40,SARS-CoV-2,2-week count of sequences,total,229,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W39,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W38,SARS-CoV-2,2-week count of sequences,total,204,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W37,SARS-CoV-2,2-week count of sequences,total,188,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W36,SARS-CoV-2,2-week count of sequences,total,150,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W35,SARS-CoV-2,2-week count of sequences,total,82,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2023-W34,SARS-CoV-2,2-week count of sequences,total,72,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2023-W33,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2023-W32,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2023-W31,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2023-W30,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2023-W29,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2023-W28,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2023-W27,SARS-CoV-2,2-week count of sequences,total,103,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2023-W26,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2023-W25,SARS-CoV-2,2-week count of sequences,total,134,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W24,SARS-CoV-2,2-week count of sequences,total,187,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W23,SARS-CoV-2,2-week count of sequences,total,209,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W22,SARS-CoV-2,2-week count of sequences,total,195,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W21,SARS-CoV-2,2-week count of sequences,total,224,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W20,SARS-CoV-2,2-week count of sequences,total,337,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W19,SARS-CoV-2,2-week count of sequences,total,347,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W18,SARS-CoV-2,2-week count of sequences,total,324,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W17,SARS-CoV-2,2-week count of sequences,total,183,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W16,SARS-CoV-2,2-week count of sequences,total,220,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2023-W15,SARS-CoV-2,2-week count of sequences,total,360,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W14,SARS-CoV-2,2-week count of sequences,total,301,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W13,SARS-CoV-2,2-week count of sequences,total,312,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W12,SARS-CoV-2,2-week count of sequences,total,356,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W11,SARS-CoV-2,2-week count of sequences,total,445,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W10,SARS-CoV-2,2-week count of sequences,total,395,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W09,SARS-CoV-2,2-week count of sequences,total,301,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W08,SARS-CoV-2,2-week count of sequences,total,301,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W07,SARS-CoV-2,2-week count of sequences,total,306,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W06,SARS-CoV-2,2-week count of sequences,total,326,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W05,SARS-CoV-2,2-week count of sequences,total,313,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W04,SARS-CoV-2,2-week count of sequences,total,358,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W03,SARS-CoV-2,2-week count of sequences,total,377,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W02,SARS-CoV-2,2-week count of sequences,total,362,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2023-W01,SARS-CoV-2,2-week count of sequences,total,522,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W52,SARS-CoV-2,2-week count of sequences,total,533,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W51,SARS-CoV-2,2-week count of sequences,total,525,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W50,SARS-CoV-2,2-week count of sequences,total,603,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W49,SARS-CoV-2,2-week count of sequences,total,529,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W48,SARS-CoV-2,2-week count of sequences,total,514,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W47,SARS-CoV-2,2-week count of sequences,total,473,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W46,SARS-CoV-2,2-week count of sequences,total,467,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W45,SARS-CoV-2,2-week count of sequences,total,495,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W44,SARS-CoV-2,2-week count of sequences,total,414,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W43,SARS-CoV-2,2-week count of sequences,total,292,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W42,SARS-CoV-2,2-week count of sequences,total,250,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W41,SARS-CoV-2,2-week count of sequences,total,257,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W40,SARS-CoV-2,2-week count of sequences,total,271,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W39,SARS-CoV-2,2-week count of sequences,total,230,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2022-W38,SARS-CoV-2,2-week count of sequences,total,213,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2022-W37,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2022-W36,SARS-CoV-2,2-week count of sequences,total,225,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2022-W35,SARS-CoV-2,2-week count of sequences,total,271,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W34,SARS-CoV-2,2-week count of sequences,total,292,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W33,SARS-CoV-2,2-week count of sequences,total,507,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W32,SARS-CoV-2,2-week count of sequences,total,742,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W31,SARS-CoV-2,2-week count of sequences,total,762,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W30,SARS-CoV-2,2-week count of sequences,total,867,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W29,SARS-CoV-2,2-week count of sequences,total,850,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W28,SARS-CoV-2,2-week count of sequences,total,767,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W27,SARS-CoV-2,2-week count of sequences,total,779,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W26,SARS-CoV-2,2-week count of sequences,total,767,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W25,SARS-CoV-2,2-week count of sequences,total,774,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W24,SARS-CoV-2,2-week count of sequences,total,703,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W23,SARS-CoV-2,2-week count of sequences,total,672,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W22,SARS-CoV-2,2-week count of sequences,total,658,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W21,SARS-CoV-2,2-week count of sequences,total,737,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W20,SARS-CoV-2,2-week count of sequences,total,768,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W19,SARS-CoV-2,2-week count of sequences,total,754,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W18,SARS-CoV-2,2-week count of sequences,total,804,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W17,SARS-CoV-2,2-week count of sequences,total,937,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W16,SARS-CoV-2,2-week count of sequences,total,779,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W15,SARS-CoV-2,2-week count of sequences,total,592,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W14,SARS-CoV-2,2-week count of sequences,total,565,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2022-W13,SARS-CoV-2,2-week count of sequences,total,709,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W12,SARS-CoV-2,2-week count of sequences,total,1147,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W11,SARS-CoV-2,2-week count of sequences,total,1226,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W10,SARS-CoV-2,2-week count of sequences,total,1053,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W09,SARS-CoV-2,2-week count of sequences,total,841,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W08,SARS-CoV-2,2-week count of sequences,total,1064,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W07,SARS-CoV-2,2-week count of sequences,total,1141,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W06,SARS-CoV-2,2-week count of sequences,total,1069,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W05,SARS-CoV-2,2-week count of sequences,total,1203,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W04,SARS-CoV-2,2-week count of sequences,total,1375,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W03,SARS-CoV-2,2-week count of sequences,total,1501,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W02,SARS-CoV-2,2-week count of sequences,total,1482,≤1%
SARS-CoV-2 variant,GISAID,Finland,2022-W01,SARS-CoV-2,2-week count of sequences,total,1412,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W52,SARS-CoV-2,2-week count of sequences,total,1026,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W51,SARS-CoV-2,2-week count of sequences,total,1114,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W50,SARS-CoV-2,2-week count of sequences,total,1336,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W49,SARS-CoV-2,2-week count of sequences,total,1155,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W48,SARS-CoV-2,2-week count of sequences,total,943,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W47,SARS-CoV-2,2-week count of sequences,total,667,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W46,SARS-CoV-2,2-week count of sequences,total,505,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W45,SARS-CoV-2,2-week count of sequences,total,478,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W44,SARS-CoV-2,2-week count of sequences,total,503,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W43,SARS-CoV-2,2-week count of sequences,total,670,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W42,SARS-CoV-2,2-week count of sequences,total,804,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W41,SARS-CoV-2,2-week count of sequences,total,864,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W40,SARS-CoV-2,2-week count of sequences,total,964,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W39,SARS-CoV-2,2-week count of sequences,total,967,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W38,SARS-CoV-2,2-week count of sequences,total,878,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W37,SARS-CoV-2,2-week count of sequences,total,749,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W36,SARS-CoV-2,2-week count of sequences,total,895,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W35,SARS-CoV-2,2-week count of sequences,total,999,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W34,SARS-CoV-2,2-week count of sequences,total,932,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W33,SARS-CoV-2,2-week count of sequences,total,1027,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W32,SARS-CoV-2,2-week count of sequences,total,1234,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W31,SARS-CoV-2,2-week count of sequences,total,1655,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W30,SARS-CoV-2,2-week count of sequences,total,1777,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W29,SARS-CoV-2,2-week count of sequences,total,1491,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W28,SARS-CoV-2,2-week count of sequences,total,1160,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W27,SARS-CoV-2,2-week count of sequences,total,836,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W26,SARS-CoV-2,2-week count of sequences,total,945,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W25,SARS-CoV-2,2-week count of sequences,total,798,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W24,SARS-CoV-2,2-week count of sequences,total,323,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W23,SARS-CoV-2,2-week count of sequences,total,297,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W22,SARS-CoV-2,2-week count of sequences,total,423,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W21,SARS-CoV-2,2-week count of sequences,total,531,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W20,SARS-CoV-2,2-week count of sequences,total,584,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W19,SARS-CoV-2,2-week count of sequences,total,601,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W18,SARS-CoV-2,2-week count of sequences,total,549,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W17,SARS-CoV-2,2-week count of sequences,total,542,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W16,SARS-CoV-2,2-week count of sequences,total,633,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W15,SARS-CoV-2,2-week count of sequences,total,702,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W14,SARS-CoV-2,2-week count of sequences,total,842,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W13,SARS-CoV-2,2-week count of sequences,total,987,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W12,SARS-CoV-2,2-week count of sequences,total,1292,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W11,SARS-CoV-2,2-week count of sequences,total,1716,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W10,SARS-CoV-2,2-week count of sequences,total,1790,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W09,SARS-CoV-2,2-week count of sequences,total,1657,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W08,SARS-CoV-2,2-week count of sequences,total,1572,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W07,SARS-CoV-2,2-week count of sequences,total,1611,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W06,SARS-CoV-2,2-week count of sequences,total,1610,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W05,SARS-CoV-2,2-week count of sequences,total,1248,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W04,SARS-CoV-2,2-week count of sequences,total,926,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W03,SARS-CoV-2,2-week count of sequences,total,778,≤1%
SARS-CoV-2 variant,GISAID,Finland,2021-W02,SARS-CoV-2,2-week count of sequences,total,453,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2021-W01,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2020-W53,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2020-W52,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2020-W51,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2020-W50,SARS-CoV-2,2-week count of sequences,total,133,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2020-W49,SARS-CoV-2,2-week count of sequences,total,156,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2020-W48,SARS-CoV-2,2-week count of sequences,total,140,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2020-W47,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2020-W46,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W45,SARS-CoV-2,2-week count of sequences,total,51,>10% to 15%
SARS-CoV-2 variant,GISAID,Finland,2020-W44,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2020-W43,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2020-W42,SARS-CoV-2,2-week count of sequences,total,195,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2020-W41,SARS-CoV-2,2-week count of sequences,total,283,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Finland,2020-W40,SARS-CoV-2,2-week count of sequences,total,203,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Finland,2020-W39,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Finland,2020-W38,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W37,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W36,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W35,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W34,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W33,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W32,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Finland,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Finland,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Finland,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Finland,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Finland,2020-W26,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Finland,2020-W25,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,France,2025-W04,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,France,2025-W03,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,France,2025-W02,SARS-CoV-2,2-week count of sequences,total,151,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2025-W01,SARS-CoV-2,2-week count of sequences,total,231,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W52,SARS-CoV-2,2-week count of sequences,total,284,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W51,SARS-CoV-2,2-week count of sequences,total,377,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W50,SARS-CoV-2,2-week count of sequences,total,425,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W49,SARS-CoV-2,2-week count of sequences,total,451,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W48,SARS-CoV-2,2-week count of sequences,total,502,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W47,SARS-CoV-2,2-week count of sequences,total,483,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W46,SARS-CoV-2,2-week count of sequences,total,492,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W45,SARS-CoV-2,2-week count of sequences,total,534,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W44,SARS-CoV-2,2-week count of sequences,total,594,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W43,SARS-CoV-2,2-week count of sequences,total,753,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W42,SARS-CoV-2,2-week count of sequences,total,853,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W41,SARS-CoV-2,2-week count of sequences,total,856,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W40,SARS-CoV-2,2-week count of sequences,total,926,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W39,SARS-CoV-2,2-week count of sequences,total,1019,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W38,SARS-CoV-2,2-week count of sequences,total,889,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W37,SARS-CoV-2,2-week count of sequences,total,843,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W36,SARS-CoV-2,2-week count of sequences,total,892,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W35,SARS-CoV-2,2-week count of sequences,total,818,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W34,SARS-CoV-2,2-week count of sequences,total,805,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W33,SARS-CoV-2,2-week count of sequences,total,864,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W32,SARS-CoV-2,2-week count of sequences,total,891,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W31,SARS-CoV-2,2-week count of sequences,total,865,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W30,SARS-CoV-2,2-week count of sequences,total,983,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W29,SARS-CoV-2,2-week count of sequences,total,1012,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W28,SARS-CoV-2,2-week count of sequences,total,957,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W27,SARS-CoV-2,2-week count of sequences,total,1010,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W26,SARS-CoV-2,2-week count of sequences,total,1017,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W25,SARS-CoV-2,2-week count of sequences,total,851,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W24,SARS-CoV-2,2-week count of sequences,total,618,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W23,SARS-CoV-2,2-week count of sequences,total,576,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W22,SARS-CoV-2,2-week count of sequences,total,497,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W21,SARS-CoV-2,2-week count of sequences,total,350,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W20,SARS-CoV-2,2-week count of sequences,total,261,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W19,SARS-CoV-2,2-week count of sequences,total,213,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W18,SARS-CoV-2,2-week count of sequences,total,206,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W17,SARS-CoV-2,2-week count of sequences,total,169,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W16,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W15,SARS-CoV-2,2-week count of sequences,total,172,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W14,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W13,SARS-CoV-2,2-week count of sequences,total,172,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W12,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W11,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W10,SARS-CoV-2,2-week count of sequences,total,183,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2024-W09,SARS-CoV-2,2-week count of sequences,total,250,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W08,SARS-CoV-2,2-week count of sequences,total,300,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W07,SARS-CoV-2,2-week count of sequences,total,365,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W06,SARS-CoV-2,2-week count of sequences,total,476,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2024-W05,SARS-CoV-2,2-week count of sequences,total,611,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W04,SARS-CoV-2,2-week count of sequences,total,789,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W03,SARS-CoV-2,2-week count of sequences,total,960,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W02,SARS-CoV-2,2-week count of sequences,total,1252,≤1%
SARS-CoV-2 variant,GISAID,France,2024-W01,SARS-CoV-2,2-week count of sequences,total,1565,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W52,SARS-CoV-2,2-week count of sequences,total,2279,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W51,SARS-CoV-2,2-week count of sequences,total,3100,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W50,SARS-CoV-2,2-week count of sequences,total,3377,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W49,SARS-CoV-2,2-week count of sequences,total,3125,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W48,SARS-CoV-2,2-week count of sequences,total,2740,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W47,SARS-CoV-2,2-week count of sequences,total,2551,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W46,SARS-CoV-2,2-week count of sequences,total,2107,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W45,SARS-CoV-2,2-week count of sequences,total,1869,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W44,SARS-CoV-2,2-week count of sequences,total,2009,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W43,SARS-CoV-2,2-week count of sequences,total,2111,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W42,SARS-CoV-2,2-week count of sequences,total,2477,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W41,SARS-CoV-2,2-week count of sequences,total,2946,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W40,SARS-CoV-2,2-week count of sequences,total,3037,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W39,SARS-CoV-2,2-week count of sequences,total,3156,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W38,SARS-CoV-2,2-week count of sequences,total,3296,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W37,SARS-CoV-2,2-week count of sequences,total,3404,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W36,SARS-CoV-2,2-week count of sequences,total,3051,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W35,SARS-CoV-2,2-week count of sequences,total,2374,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W34,SARS-CoV-2,2-week count of sequences,total,1804,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W33,SARS-CoV-2,2-week count of sequences,total,1164,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W32,SARS-CoV-2,2-week count of sequences,total,760,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W31,SARS-CoV-2,2-week count of sequences,total,573,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2023-W30,SARS-CoV-2,2-week count of sequences,total,512,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2023-W29,SARS-CoV-2,2-week count of sequences,total,498,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2023-W28,SARS-CoV-2,2-week count of sequences,total,464,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2023-W27,SARS-CoV-2,2-week count of sequences,total,422,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2023-W26,SARS-CoV-2,2-week count of sequences,total,445,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2023-W25,SARS-CoV-2,2-week count of sequences,total,561,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2023-W24,SARS-CoV-2,2-week count of sequences,total,772,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W23,SARS-CoV-2,2-week count of sequences,total,1030,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W22,SARS-CoV-2,2-week count of sequences,total,1649,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W21,SARS-CoV-2,2-week count of sequences,total,1750,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W20,SARS-CoV-2,2-week count of sequences,total,1392,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W19,SARS-CoV-2,2-week count of sequences,total,1806,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W18,SARS-CoV-2,2-week count of sequences,total,2343,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W17,SARS-CoV-2,2-week count of sequences,total,2837,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W16,SARS-CoV-2,2-week count of sequences,total,3095,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W15,SARS-CoV-2,2-week count of sequences,total,2941,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W14,SARS-CoV-2,2-week count of sequences,total,3014,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W13,SARS-CoV-2,2-week count of sequences,total,2909,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W12,SARS-CoV-2,2-week count of sequences,total,2854,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W11,SARS-CoV-2,2-week count of sequences,total,2792,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W10,SARS-CoV-2,2-week count of sequences,total,2465,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W09,SARS-CoV-2,2-week count of sequences,total,2094,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W08,SARS-CoV-2,2-week count of sequences,total,1775,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W07,SARS-CoV-2,2-week count of sequences,total,1674,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W06,SARS-CoV-2,2-week count of sequences,total,1839,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W05,SARS-CoV-2,2-week count of sequences,total,1961,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W04,SARS-CoV-2,2-week count of sequences,total,2103,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W03,SARS-CoV-2,2-week count of sequences,total,2020,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W02,SARS-CoV-2,2-week count of sequences,total,2086,≤1%
SARS-CoV-2 variant,GISAID,France,2023-W01,SARS-CoV-2,2-week count of sequences,total,4150,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W52,SARS-CoV-2,2-week count of sequences,total,6718,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W51,SARS-CoV-2,2-week count of sequences,total,8281,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W50,SARS-CoV-2,2-week count of sequences,total,9964,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W49,SARS-CoV-2,2-week count of sequences,total,10424,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W48,SARS-CoV-2,2-week count of sequences,total,8754,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W47,SARS-CoV-2,2-week count of sequences,total,5377,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W46,SARS-CoV-2,2-week count of sequences,total,4022,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W45,SARS-CoV-2,2-week count of sequences,total,3610,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W44,SARS-CoV-2,2-week count of sequences,total,4094,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W43,SARS-CoV-2,2-week count of sequences,total,6393,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W42,SARS-CoV-2,2-week count of sequences,total,7698,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W41,SARS-CoV-2,2-week count of sequences,total,7679,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W40,SARS-CoV-2,2-week count of sequences,total,7227,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W39,SARS-CoV-2,2-week count of sequences,total,7515,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W38,SARS-CoV-2,2-week count of sequences,total,6690,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W37,SARS-CoV-2,2-week count of sequences,total,5486,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W36,SARS-CoV-2,2-week count of sequences,total,5066,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W35,SARS-CoV-2,2-week count of sequences,total,5097,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W34,SARS-CoV-2,2-week count of sequences,total,5156,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W33,SARS-CoV-2,2-week count of sequences,total,4965,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W32,SARS-CoV-2,2-week count of sequences,total,5871,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W31,SARS-CoV-2,2-week count of sequences,total,7745,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W30,SARS-CoV-2,2-week count of sequences,total,9881,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W29,SARS-CoV-2,2-week count of sequences,total,12123,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W28,SARS-CoV-2,2-week count of sequences,total,13158,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W27,SARS-CoV-2,2-week count of sequences,total,15379,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W26,SARS-CoV-2,2-week count of sequences,total,15236,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W25,SARS-CoV-2,2-week count of sequences,total,11229,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W24,SARS-CoV-2,2-week count of sequences,total,10841,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W23,SARS-CoV-2,2-week count of sequences,total,12440,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W22,SARS-CoV-2,2-week count of sequences,total,11565,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W21,SARS-CoV-2,2-week count of sequences,total,10594,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W20,SARS-CoV-2,2-week count of sequences,total,12581,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W19,SARS-CoV-2,2-week count of sequences,total,14429,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W18,SARS-CoV-2,2-week count of sequences,total,14632,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W17,SARS-CoV-2,2-week count of sequences,total,16235,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W16,SARS-CoV-2,2-week count of sequences,total,18922,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W15,SARS-CoV-2,2-week count of sequences,total,18830,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W14,SARS-CoV-2,2-week count of sequences,total,20133,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W13,SARS-CoV-2,2-week count of sequences,total,24116,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W12,SARS-CoV-2,2-week count of sequences,total,22515,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W11,SARS-CoV-2,2-week count of sequences,total,20485,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W10,SARS-CoV-2,2-week count of sequences,total,19601,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W09,SARS-CoV-2,2-week count of sequences,total,19174,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W08,SARS-CoV-2,2-week count of sequences,total,17217,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W07,SARS-CoV-2,2-week count of sequences,total,15152,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W06,SARS-CoV-2,2-week count of sequences,total,17974,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W05,SARS-CoV-2,2-week count of sequences,total,19087,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W04,SARS-CoV-2,2-week count of sequences,total,18345,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W03,SARS-CoV-2,2-week count of sequences,total,18596,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W02,SARS-CoV-2,2-week count of sequences,total,19779,≤1%
SARS-CoV-2 variant,GISAID,France,2022-W01,SARS-CoV-2,2-week count of sequences,total,25436,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W52,SARS-CoV-2,2-week count of sequences,total,25485,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W51,SARS-CoV-2,2-week count of sequences,total,21323,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W50,SARS-CoV-2,2-week count of sequences,total,20836,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W49,SARS-CoV-2,2-week count of sequences,total,20199,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W48,SARS-CoV-2,2-week count of sequences,total,18294,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W47,SARS-CoV-2,2-week count of sequences,total,17270,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W46,SARS-CoV-2,2-week count of sequences,total,16183,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W45,SARS-CoV-2,2-week count of sequences,total,14584,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W44,SARS-CoV-2,2-week count of sequences,total,16744,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W43,SARS-CoV-2,2-week count of sequences,total,13424,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W42,SARS-CoV-2,2-week count of sequences,total,6510,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W41,SARS-CoV-2,2-week count of sequences,total,3942,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W40,SARS-CoV-2,2-week count of sequences,total,3584,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W39,SARS-CoV-2,2-week count of sequences,total,3818,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W38,SARS-CoV-2,2-week count of sequences,total,4313,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W37,SARS-CoV-2,2-week count of sequences,total,5045,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W36,SARS-CoV-2,2-week count of sequences,total,6632,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W35,SARS-CoV-2,2-week count of sequences,total,8772,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W34,SARS-CoV-2,2-week count of sequences,total,10943,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W33,SARS-CoV-2,2-week count of sequences,total,12830,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W32,SARS-CoV-2,2-week count of sequences,total,13296,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W31,SARS-CoV-2,2-week count of sequences,total,15630,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W30,SARS-CoV-2,2-week count of sequences,total,25056,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W29,SARS-CoV-2,2-week count of sequences,total,26497,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W28,SARS-CoV-2,2-week count of sequences,total,13456,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W27,SARS-CoV-2,2-week count of sequences,total,4342,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W26,SARS-CoV-2,2-week count of sequences,total,2772,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W25,SARS-CoV-2,2-week count of sequences,total,1752,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W24,SARS-CoV-2,2-week count of sequences,total,1894,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W23,SARS-CoV-2,2-week count of sequences,total,2123,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W22,SARS-CoV-2,2-week count of sequences,total,2667,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W21,SARS-CoV-2,2-week count of sequences,total,3031,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W20,SARS-CoV-2,2-week count of sequences,total,3171,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W19,SARS-CoV-2,2-week count of sequences,total,3263,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W18,SARS-CoV-2,2-week count of sequences,total,3933,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W17,SARS-CoV-2,2-week count of sequences,total,4553,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W16,SARS-CoV-2,2-week count of sequences,total,5068,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W15,SARS-CoV-2,2-week count of sequences,total,5002,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W14,SARS-CoV-2,2-week count of sequences,total,5308,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W13,SARS-CoV-2,2-week count of sequences,total,6300,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W12,SARS-CoV-2,2-week count of sequences,total,7941,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W11,SARS-CoV-2,2-week count of sequences,total,8096,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W10,SARS-CoV-2,2-week count of sequences,total,7269,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W09,SARS-CoV-2,2-week count of sequences,total,5838,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W08,SARS-CoV-2,2-week count of sequences,total,3100,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W07,SARS-CoV-2,2-week count of sequences,total,2770,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W06,SARS-CoV-2,2-week count of sequences,total,2705,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W05,SARS-CoV-2,2-week count of sequences,total,3640,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W04,SARS-CoV-2,2-week count of sequences,total,2995,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W03,SARS-CoV-2,2-week count of sequences,total,1815,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W02,SARS-CoV-2,2-week count of sequences,total,1502,≤1%
SARS-CoV-2 variant,GISAID,France,2021-W01,SARS-CoV-2,2-week count of sequences,total,963,≤1%
SARS-CoV-2 variant,GISAID,France,2020-W53,SARS-CoV-2,2-week count of sequences,total,554,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W52,SARS-CoV-2,2-week count of sequences,total,513,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W51,SARS-CoV-2,2-week count of sequences,total,448,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W50,SARS-CoV-2,2-week count of sequences,total,377,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W49,SARS-CoV-2,2-week count of sequences,total,364,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W48,SARS-CoV-2,2-week count of sequences,total,474,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W47,SARS-CoV-2,2-week count of sequences,total,650,≤1%
SARS-CoV-2 variant,GISAID,France,2020-W46,SARS-CoV-2,2-week count of sequences,total,766,≤1%
SARS-CoV-2 variant,GISAID,France,2020-W45,SARS-CoV-2,2-week count of sequences,total,1077,≤1%
SARS-CoV-2 variant,GISAID,France,2020-W44,SARS-CoV-2,2-week count of sequences,total,1283,≤1%
SARS-CoV-2 variant,GISAID,France,2020-W43,SARS-CoV-2,2-week count of sequences,total,918,≤1%
SARS-CoV-2 variant,GISAID,France,2020-W42,SARS-CoV-2,2-week count of sequences,total,543,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W41,SARS-CoV-2,2-week count of sequences,total,469,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W40,SARS-CoV-2,2-week count of sequences,total,370,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W39,SARS-CoV-2,2-week count of sequences,total,505,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W38,SARS-CoV-2,2-week count of sequences,total,774,≤1%
SARS-CoV-2 variant,GISAID,France,2020-W37,SARS-CoV-2,2-week count of sequences,total,840,≤1%
SARS-CoV-2 variant,GISAID,France,2020-W36,SARS-CoV-2,2-week count of sequences,total,554,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W35,SARS-CoV-2,2-week count of sequences,total,277,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W34,SARS-CoV-2,2-week count of sequences,total,300,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W33,SARS-CoV-2,2-week count of sequences,total,261,>1% to 2.5%
SARS-CoV-2 variant,GISAID,France,2020-W32,SARS-CoV-2,2-week count of sequences,total,203,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2020-W31,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,France,2020-W30,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,France,2020-W29,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,France,2020-W28,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,France,2020-W27,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,France,2020-W26,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,France,2020-W25,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Germany,2025-W04,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Germany,2025-W03,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2025-W02,SARS-CoV-2,2-week count of sequences,total,135,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2025-W01,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W52,SARS-CoV-2,2-week count of sequences,total,182,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W51,SARS-CoV-2,2-week count of sequences,total,231,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W50,SARS-CoV-2,2-week count of sequences,total,263,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W49,SARS-CoV-2,2-week count of sequences,total,320,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W48,SARS-CoV-2,2-week count of sequences,total,374,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W47,SARS-CoV-2,2-week count of sequences,total,383,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W46,SARS-CoV-2,2-week count of sequences,total,401,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W45,SARS-CoV-2,2-week count of sequences,total,404,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W44,SARS-CoV-2,2-week count of sequences,total,448,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W43,SARS-CoV-2,2-week count of sequences,total,548,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W42,SARS-CoV-2,2-week count of sequences,total,591,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W41,SARS-CoV-2,2-week count of sequences,total,534,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W40,SARS-CoV-2,2-week count of sequences,total,482,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W39,SARS-CoV-2,2-week count of sequences,total,499,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W38,SARS-CoV-2,2-week count of sequences,total,419,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W37,SARS-CoV-2,2-week count of sequences,total,350,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W36,SARS-CoV-2,2-week count of sequences,total,355,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W35,SARS-CoV-2,2-week count of sequences,total,349,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W34,SARS-CoV-2,2-week count of sequences,total,341,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W33,SARS-CoV-2,2-week count of sequences,total,365,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W32,SARS-CoV-2,2-week count of sequences,total,372,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W31,SARS-CoV-2,2-week count of sequences,total,411,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W30,SARS-CoV-2,2-week count of sequences,total,407,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W29,SARS-CoV-2,2-week count of sequences,total,392,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W28,SARS-CoV-2,2-week count of sequences,total,384,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W27,SARS-CoV-2,2-week count of sequences,total,286,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W26,SARS-CoV-2,2-week count of sequences,total,262,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W25,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W24,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W23,SARS-CoV-2,2-week count of sequences,total,127,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W22,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W21,SARS-CoV-2,2-week count of sequences,total,115,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W20,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W19,SARS-CoV-2,2-week count of sequences,total,117,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W18,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W17,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W16,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W15,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W14,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W13,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2024-W12,SARS-CoV-2,2-week count of sequences,total,118,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W11,SARS-CoV-2,2-week count of sequences,total,129,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W10,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W09,SARS-CoV-2,2-week count of sequences,total,155,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W08,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W07,SARS-CoV-2,2-week count of sequences,total,218,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2024-W06,SARS-CoV-2,2-week count of sequences,total,285,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W05,SARS-CoV-2,2-week count of sequences,total,351,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W04,SARS-CoV-2,2-week count of sequences,total,421,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W03,SARS-CoV-2,2-week count of sequences,total,439,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W02,SARS-CoV-2,2-week count of sequences,total,451,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2024-W01,SARS-CoV-2,2-week count of sequences,total,426,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W52,SARS-CoV-2,2-week count of sequences,total,521,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W51,SARS-CoV-2,2-week count of sequences,total,723,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W50,SARS-CoV-2,2-week count of sequences,total,821,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W49,SARS-CoV-2,2-week count of sequences,total,829,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W48,SARS-CoV-2,2-week count of sequences,total,750,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W47,SARS-CoV-2,2-week count of sequences,total,749,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W46,SARS-CoV-2,2-week count of sequences,total,738,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W45,SARS-CoV-2,2-week count of sequences,total,638,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W44,SARS-CoV-2,2-week count of sequences,total,695,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W43,SARS-CoV-2,2-week count of sequences,total,718,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W42,SARS-CoV-2,2-week count of sequences,total,686,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W41,SARS-CoV-2,2-week count of sequences,total,668,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W40,SARS-CoV-2,2-week count of sequences,total,581,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W39,SARS-CoV-2,2-week count of sequences,total,557,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W38,SARS-CoV-2,2-week count of sequences,total,494,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W37,SARS-CoV-2,2-week count of sequences,total,437,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W36,SARS-CoV-2,2-week count of sequences,total,384,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W35,SARS-CoV-2,2-week count of sequences,total,292,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W34,SARS-CoV-2,2-week count of sequences,total,256,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W33,SARS-CoV-2,2-week count of sequences,total,226,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W32,SARS-CoV-2,2-week count of sequences,total,203,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W31,SARS-CoV-2,2-week count of sequences,total,203,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W30,SARS-CoV-2,2-week count of sequences,total,184,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W29,SARS-CoV-2,2-week count of sequences,total,137,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W28,SARS-CoV-2,2-week count of sequences,total,112,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2023-W27,SARS-CoV-2,2-week count of sequences,total,108,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2023-W26,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W25,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W24,SARS-CoV-2,2-week count of sequences,total,193,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W23,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W22,SARS-CoV-2,2-week count of sequences,total,206,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W21,SARS-CoV-2,2-week count of sequences,total,218,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W20,SARS-CoV-2,2-week count of sequences,total,216,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2023-W19,SARS-CoV-2,2-week count of sequences,total,246,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W18,SARS-CoV-2,2-week count of sequences,total,394,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2023-W17,SARS-CoV-2,2-week count of sequences,total,1041,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W16,SARS-CoV-2,2-week count of sequences,total,1551,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W15,SARS-CoV-2,2-week count of sequences,total,1775,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W14,SARS-CoV-2,2-week count of sequences,total,2657,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W13,SARS-CoV-2,2-week count of sequences,total,3702,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W12,SARS-CoV-2,2-week count of sequences,total,4573,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W11,SARS-CoV-2,2-week count of sequences,total,4988,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W10,SARS-CoV-2,2-week count of sequences,total,5569,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W09,SARS-CoV-2,2-week count of sequences,total,6793,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W08,SARS-CoV-2,2-week count of sequences,total,7401,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W07,SARS-CoV-2,2-week count of sequences,total,7378,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W06,SARS-CoV-2,2-week count of sequences,total,7179,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W05,SARS-CoV-2,2-week count of sequences,total,6802,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W04,SARS-CoV-2,2-week count of sequences,total,6267,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W03,SARS-CoV-2,2-week count of sequences,total,6523,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W02,SARS-CoV-2,2-week count of sequences,total,7010,≤1%
SARS-CoV-2 variant,GISAID,Germany,2023-W01,SARS-CoV-2,2-week count of sequences,total,6290,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W52,SARS-CoV-2,2-week count of sequences,total,6785,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W51,SARS-CoV-2,2-week count of sequences,total,9199,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W50,SARS-CoV-2,2-week count of sequences,total,10145,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W49,SARS-CoV-2,2-week count of sequences,total,8841,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W48,SARS-CoV-2,2-week count of sequences,total,8910,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W47,SARS-CoV-2,2-week count of sequences,total,9441,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W46,SARS-CoV-2,2-week count of sequences,total,8791,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W45,SARS-CoV-2,2-week count of sequences,total,8046,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W44,SARS-CoV-2,2-week count of sequences,total,8525,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W43,SARS-CoV-2,2-week count of sequences,total,10404,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W42,SARS-CoV-2,2-week count of sequences,total,11920,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W41,SARS-CoV-2,2-week count of sequences,total,12250,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W40,SARS-CoV-2,2-week count of sequences,total,10664,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W39,SARS-CoV-2,2-week count of sequences,total,9383,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W38,SARS-CoV-2,2-week count of sequences,total,10881,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W37,SARS-CoV-2,2-week count of sequences,total,12453,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W36,SARS-CoV-2,2-week count of sequences,total,10865,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W35,SARS-CoV-2,2-week count of sequences,total,9220,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W34,SARS-CoV-2,2-week count of sequences,total,9159,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W33,SARS-CoV-2,2-week count of sequences,total,9529,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W32,SARS-CoV-2,2-week count of sequences,total,10071,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W31,SARS-CoV-2,2-week count of sequences,total,11435,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W30,SARS-CoV-2,2-week count of sequences,total,14466,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W29,SARS-CoV-2,2-week count of sequences,total,16154,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W28,SARS-CoV-2,2-week count of sequences,total,16336,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W27,SARS-CoV-2,2-week count of sequences,total,20865,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W26,SARS-CoV-2,2-week count of sequences,total,27391,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W25,SARS-CoV-2,2-week count of sequences,total,26928,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W24,SARS-CoV-2,2-week count of sequences,total,20206,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W23,SARS-CoV-2,2-week count of sequences,total,15864,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W22,SARS-CoV-2,2-week count of sequences,total,14821,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W21,SARS-CoV-2,2-week count of sequences,total,15567,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W20,SARS-CoV-2,2-week count of sequences,total,18168,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W19,SARS-CoV-2,2-week count of sequences,total,20659,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W18,SARS-CoV-2,2-week count of sequences,total,23549,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W17,SARS-CoV-2,2-week count of sequences,total,25827,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W16,SARS-CoV-2,2-week count of sequences,total,28280,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W15,SARS-CoV-2,2-week count of sequences,total,29594,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W14,SARS-CoV-2,2-week count of sequences,total,29071,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W13,SARS-CoV-2,2-week count of sequences,total,30507,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W12,SARS-CoV-2,2-week count of sequences,total,37022,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W11,SARS-CoV-2,2-week count of sequences,total,42148,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W10,SARS-CoV-2,2-week count of sequences,total,42207,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W09,SARS-CoV-2,2-week count of sequences,total,39690,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W08,SARS-CoV-2,2-week count of sequences,total,40547,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W07,SARS-CoV-2,2-week count of sequences,total,41482,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W06,SARS-CoV-2,2-week count of sequences,total,39915,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W05,SARS-CoV-2,2-week count of sequences,total,37853,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W04,SARS-CoV-2,2-week count of sequences,total,34549,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W03,SARS-CoV-2,2-week count of sequences,total,30763,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W02,SARS-CoV-2,2-week count of sequences,total,27118,≤1%
SARS-CoV-2 variant,GISAID,Germany,2022-W01,SARS-CoV-2,2-week count of sequences,total,26164,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W52,SARS-CoV-2,2-week count of sequences,total,25091,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W51,SARS-CoV-2,2-week count of sequences,total,26008,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W50,SARS-CoV-2,2-week count of sequences,total,26852,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W49,SARS-CoV-2,2-week count of sequences,total,25549,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W48,SARS-CoV-2,2-week count of sequences,total,24087,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W47,SARS-CoV-2,2-week count of sequences,total,23891,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W46,SARS-CoV-2,2-week count of sequences,total,22118,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W45,SARS-CoV-2,2-week count of sequences,total,18453,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W44,SARS-CoV-2,2-week count of sequences,total,16306,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W43,SARS-CoV-2,2-week count of sequences,total,16025,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W42,SARS-CoV-2,2-week count of sequences,total,15233,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W41,SARS-CoV-2,2-week count of sequences,total,13833,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W40,SARS-CoV-2,2-week count of sequences,total,14171,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W39,SARS-CoV-2,2-week count of sequences,total,16046,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W38,SARS-CoV-2,2-week count of sequences,total,17931,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W37,SARS-CoV-2,2-week count of sequences,total,20122,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W36,SARS-CoV-2,2-week count of sequences,total,20792,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W35,SARS-CoV-2,2-week count of sequences,total,19501,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W34,SARS-CoV-2,2-week count of sequences,total,17369,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W33,SARS-CoV-2,2-week count of sequences,total,13350,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W32,SARS-CoV-2,2-week count of sequences,total,9027,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W31,SARS-CoV-2,2-week count of sequences,total,6293,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W30,SARS-CoV-2,2-week count of sequences,total,5639,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W29,SARS-CoV-2,2-week count of sequences,total,4614,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W28,SARS-CoV-2,2-week count of sequences,total,3161,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W27,SARS-CoV-2,2-week count of sequences,total,2658,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W26,SARS-CoV-2,2-week count of sequences,total,2412,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W25,SARS-CoV-2,2-week count of sequences,total,2654,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W24,SARS-CoV-2,2-week count of sequences,total,3839,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W23,SARS-CoV-2,2-week count of sequences,total,5471,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W22,SARS-CoV-2,2-week count of sequences,total,7550,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W21,SARS-CoV-2,2-week count of sequences,total,9860,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W20,SARS-CoV-2,2-week count of sequences,total,11942,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W19,SARS-CoV-2,2-week count of sequences,total,17470,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W18,SARS-CoV-2,2-week count of sequences,total,20928,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W17,SARS-CoV-2,2-week count of sequences,total,20497,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W16,SARS-CoV-2,2-week count of sequences,total,21918,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W15,SARS-CoV-2,2-week count of sequences,total,20033,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W14,SARS-CoV-2,2-week count of sequences,total,17292,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W13,SARS-CoV-2,2-week count of sequences,total,16941,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W12,SARS-CoV-2,2-week count of sequences,total,16339,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W11,SARS-CoV-2,2-week count of sequences,total,15081,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W10,SARS-CoV-2,2-week count of sequences,total,13418,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W09,SARS-CoV-2,2-week count of sequences,total,12142,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W08,SARS-CoV-2,2-week count of sequences,total,10976,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W07,SARS-CoV-2,2-week count of sequences,total,9403,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W06,SARS-CoV-2,2-week count of sequences,total,7662,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W05,SARS-CoV-2,2-week count of sequences,total,6515,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W04,SARS-CoV-2,2-week count of sequences,total,5226,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W03,SARS-CoV-2,2-week count of sequences,total,3223,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W02,SARS-CoV-2,2-week count of sequences,total,1605,≤1%
SARS-CoV-2 variant,GISAID,Germany,2021-W01,SARS-CoV-2,2-week count of sequences,total,853,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W53,SARS-CoV-2,2-week count of sequences,total,729,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W52,SARS-CoV-2,2-week count of sequences,total,879,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W51,SARS-CoV-2,2-week count of sequences,total,1048,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W50,SARS-CoV-2,2-week count of sequences,total,1020,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W49,SARS-CoV-2,2-week count of sequences,total,793,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W48,SARS-CoV-2,2-week count of sequences,total,672,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W47,SARS-CoV-2,2-week count of sequences,total,618,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W46,SARS-CoV-2,2-week count of sequences,total,553,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W45,SARS-CoV-2,2-week count of sequences,total,577,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W44,SARS-CoV-2,2-week count of sequences,total,532,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W43,SARS-CoV-2,2-week count of sequences,total,444,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W42,SARS-CoV-2,2-week count of sequences,total,441,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W41,SARS-CoV-2,2-week count of sequences,total,369,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W40,SARS-CoV-2,2-week count of sequences,total,361,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W39,SARS-CoV-2,2-week count of sequences,total,330,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W38,SARS-CoV-2,2-week count of sequences,total,224,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2020-W37,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2020-W36,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2020-W35,SARS-CoV-2,2-week count of sequences,total,180,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2020-W34,SARS-CoV-2,2-week count of sequences,total,235,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2020-W33,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Germany,2020-W32,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2020-W31,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Germany,2020-W30,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2020-W29,SARS-CoV-2,2-week count of sequences,total,116,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2020-W28,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Germany,2020-W27,SARS-CoV-2,2-week count of sequences,total,410,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Germany,2020-W26,SARS-CoV-2,2-week count of sequences,total,1914,≤1%
SARS-CoV-2 variant,GISAID,Germany,2020-W25,SARS-CoV-2,2-week count of sequences,total,1537,≤1%
SARS-CoV-2 variant,GISAID,Greece,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2024-W52,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W51,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W50,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W49,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2024-W47,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W46,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W45,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W44,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W43,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W42,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W41,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2024-W40,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2024-W39,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W38,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W37,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2024-W36,SARS-CoV-2,2-week count of sequences,total,155,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W35,SARS-CoV-2,2-week count of sequences,total,149,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W34,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2024-W33,SARS-CoV-2,2-week count of sequences,total,111,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2024-W32,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W31,SARS-CoV-2,2-week count of sequences,total,225,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W30,SARS-CoV-2,2-week count of sequences,total,247,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2024-W29,SARS-CoV-2,2-week count of sequences,total,231,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W28,SARS-CoV-2,2-week count of sequences,total,209,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W27,SARS-CoV-2,2-week count of sequences,total,210,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W26,SARS-CoV-2,2-week count of sequences,total,222,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W25,SARS-CoV-2,2-week count of sequences,total,210,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W24,SARS-CoV-2,2-week count of sequences,total,160,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W23,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2024-W22,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W21,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W20,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W19,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W18,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W17,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W16,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W15,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2024-W13,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W12,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W11,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W10,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Greece,2024-W09,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2024-W08,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2024-W07,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2024-W06,SARS-CoV-2,2-week count of sequences,total,76,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2024-W05,SARS-CoV-2,2-week count of sequences,total,147,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2024-W04,SARS-CoV-2,2-week count of sequences,total,243,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2024-W03,SARS-CoV-2,2-week count of sequences,total,366,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2024-W02,SARS-CoV-2,2-week count of sequences,total,427,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2024-W01,SARS-CoV-2,2-week count of sequences,total,352,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W52,SARS-CoV-2,2-week count of sequences,total,322,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W51,SARS-CoV-2,2-week count of sequences,total,473,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W50,SARS-CoV-2,2-week count of sequences,total,582,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W49,SARS-CoV-2,2-week count of sequences,total,529,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W48,SARS-CoV-2,2-week count of sequences,total,508,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W47,SARS-CoV-2,2-week count of sequences,total,519,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W46,SARS-CoV-2,2-week count of sequences,total,521,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W45,SARS-CoV-2,2-week count of sequences,total,617,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W44,SARS-CoV-2,2-week count of sequences,total,748,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W43,SARS-CoV-2,2-week count of sequences,total,846,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W42,SARS-CoV-2,2-week count of sequences,total,928,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W41,SARS-CoV-2,2-week count of sequences,total,917,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W40,SARS-CoV-2,2-week count of sequences,total,827,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W39,SARS-CoV-2,2-week count of sequences,total,746,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W38,SARS-CoV-2,2-week count of sequences,total,683,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W37,SARS-CoV-2,2-week count of sequences,total,623,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W36,SARS-CoV-2,2-week count of sequences,total,619,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W35,SARS-CoV-2,2-week count of sequences,total,575,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W34,SARS-CoV-2,2-week count of sequences,total,304,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W33,SARS-CoV-2,2-week count of sequences,total,113,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2023-W32,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2023-W31,SARS-CoV-2,2-week count of sequences,total,72,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2023-W30,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2023-W29,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2023-W28,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2023-W27,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2023-W26,SARS-CoV-2,2-week count of sequences,total,72,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2023-W25,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2023-W24,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2023-W23,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2023-W22,SARS-CoV-2,2-week count of sequences,total,156,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2023-W21,SARS-CoV-2,2-week count of sequences,total,264,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W20,SARS-CoV-2,2-week count of sequences,total,266,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W19,SARS-CoV-2,2-week count of sequences,total,229,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2023-W18,SARS-CoV-2,2-week count of sequences,total,237,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2023-W17,SARS-CoV-2,2-week count of sequences,total,285,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W16,SARS-CoV-2,2-week count of sequences,total,242,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W15,SARS-CoV-2,2-week count of sequences,total,214,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2023-W14,SARS-CoV-2,2-week count of sequences,total,266,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W13,SARS-CoV-2,2-week count of sequences,total,262,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W12,SARS-CoV-2,2-week count of sequences,total,274,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W11,SARS-CoV-2,2-week count of sequences,total,352,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W10,SARS-CoV-2,2-week count of sequences,total,462,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W09,SARS-CoV-2,2-week count of sequences,total,601,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W08,SARS-CoV-2,2-week count of sequences,total,543,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W07,SARS-CoV-2,2-week count of sequences,total,371,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W06,SARS-CoV-2,2-week count of sequences,total,412,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W05,SARS-CoV-2,2-week count of sequences,total,513,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W04,SARS-CoV-2,2-week count of sequences,total,598,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2023-W03,SARS-CoV-2,2-week count of sequences,total,718,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W02,SARS-CoV-2,2-week count of sequences,total,775,≤1%
SARS-CoV-2 variant,GISAID,Greece,2023-W01,SARS-CoV-2,2-week count of sequences,total,698,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W52,SARS-CoV-2,2-week count of sequences,total,610,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W51,SARS-CoV-2,2-week count of sequences,total,687,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W50,SARS-CoV-2,2-week count of sequences,total,927,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W49,SARS-CoV-2,2-week count of sequences,total,903,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W48,SARS-CoV-2,2-week count of sequences,total,774,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W47,SARS-CoV-2,2-week count of sequences,total,830,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W46,SARS-CoV-2,2-week count of sequences,total,867,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W45,SARS-CoV-2,2-week count of sequences,total,725,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W44,SARS-CoV-2,2-week count of sequences,total,580,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W43,SARS-CoV-2,2-week count of sequences,total,634,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W42,SARS-CoV-2,2-week count of sequences,total,711,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W41,SARS-CoV-2,2-week count of sequences,total,635,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W40,SARS-CoV-2,2-week count of sequences,total,561,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W39,SARS-CoV-2,2-week count of sequences,total,703,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W38,SARS-CoV-2,2-week count of sequences,total,528,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W37,SARS-CoV-2,2-week count of sequences,total,295,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W36,SARS-CoV-2,2-week count of sequences,total,328,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W35,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2022-W34,SARS-CoV-2,2-week count of sequences,total,131,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2022-W33,SARS-CoV-2,2-week count of sequences,total,434,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W32,SARS-CoV-2,2-week count of sequences,total,606,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W31,SARS-CoV-2,2-week count of sequences,total,602,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W30,SARS-CoV-2,2-week count of sequences,total,678,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W29,SARS-CoV-2,2-week count of sequences,total,749,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W28,SARS-CoV-2,2-week count of sequences,total,721,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W27,SARS-CoV-2,2-week count of sequences,total,678,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W26,SARS-CoV-2,2-week count of sequences,total,749,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W25,SARS-CoV-2,2-week count of sequences,total,747,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W24,SARS-CoV-2,2-week count of sequences,total,433,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W23,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2022-W22,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Greece,2022-W21,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Greece,2022-W20,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Greece,2022-W19,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2022-W18,SARS-CoV-2,2-week count of sequences,total,304,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W17,SARS-CoV-2,2-week count of sequences,total,465,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W16,SARS-CoV-2,2-week count of sequences,total,466,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W15,SARS-CoV-2,2-week count of sequences,total,588,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W14,SARS-CoV-2,2-week count of sequences,total,869,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W13,SARS-CoV-2,2-week count of sequences,total,844,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W12,SARS-CoV-2,2-week count of sequences,total,558,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W11,SARS-CoV-2,2-week count of sequences,total,250,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W10,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Greece,2022-W09,SARS-CoV-2,2-week count of sequences,total,565,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W08,SARS-CoV-2,2-week count of sequences,total,1474,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W07,SARS-CoV-2,2-week count of sequences,total,1536,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W06,SARS-CoV-2,2-week count of sequences,total,846,≤1%
SARS-CoV-2 variant,GISAID,Greece,2022-W05,SARS-CoV-2,2-week count of sequences,total,299,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W04,SARS-CoV-2,2-week count of sequences,total,340,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W03,SARS-CoV-2,2-week count of sequences,total,402,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2022-W02,SARS-CoV-2,2-week count of sequences,total,171,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2022-W01,SARS-CoV-2,2-week count of sequences,total,124,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W52,SARS-CoV-2,2-week count of sequences,total,267,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W51,SARS-CoV-2,2-week count of sequences,total,523,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W50,SARS-CoV-2,2-week count of sequences,total,586,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W49,SARS-CoV-2,2-week count of sequences,total,982,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W48,SARS-CoV-2,2-week count of sequences,total,972,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W47,SARS-CoV-2,2-week count of sequences,total,587,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W46,SARS-CoV-2,2-week count of sequences,total,661,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W45,SARS-CoV-2,2-week count of sequences,total,602,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W44,SARS-CoV-2,2-week count of sequences,total,426,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W43,SARS-CoV-2,2-week count of sequences,total,155,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W42,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Greece,2021-W41,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Greece,2021-W40,SARS-CoV-2,2-week count of sequences,total,123,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W39,SARS-CoV-2,2-week count of sequences,total,321,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W38,SARS-CoV-2,2-week count of sequences,total,448,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W37,SARS-CoV-2,2-week count of sequences,total,649,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W36,SARS-CoV-2,2-week count of sequences,total,757,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W35,SARS-CoV-2,2-week count of sequences,total,347,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W34,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Greece,2021-W33,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W32,SARS-CoV-2,2-week count of sequences,total,254,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W31,SARS-CoV-2,2-week count of sequences,total,349,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W30,SARS-CoV-2,2-week count of sequences,total,675,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W29,SARS-CoV-2,2-week count of sequences,total,408,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W28,SARS-CoV-2,2-week count of sequences,total,280,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W27,SARS-CoV-2,2-week count of sequences,total,297,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W26,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Greece,2021-W25,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2021-W24,SARS-CoV-2,2-week count of sequences,total,186,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W23,SARS-CoV-2,2-week count of sequences,total,184,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W22,SARS-CoV-2,2-week count of sequences,total,236,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W21,SARS-CoV-2,2-week count of sequences,total,562,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W20,SARS-CoV-2,2-week count of sequences,total,968,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W19,SARS-CoV-2,2-week count of sequences,total,1256,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W18,SARS-CoV-2,2-week count of sequences,total,1253,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W17,SARS-CoV-2,2-week count of sequences,total,1273,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W16,SARS-CoV-2,2-week count of sequences,total,919,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W15,SARS-CoV-2,2-week count of sequences,total,614,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W14,SARS-CoV-2,2-week count of sequences,total,596,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W13,SARS-CoV-2,2-week count of sequences,total,339,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W12,SARS-CoV-2,2-week count of sequences,total,600,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W11,SARS-CoV-2,2-week count of sequences,total,1041,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W10,SARS-CoV-2,2-week count of sequences,total,1263,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W09,SARS-CoV-2,2-week count of sequences,total,1123,≤1%
SARS-CoV-2 variant,GISAID,Greece,2021-W08,SARS-CoV-2,2-week count of sequences,total,543,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2021-W07,SARS-CoV-2,2-week count of sequences,total,151,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W06,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W05,SARS-CoV-2,2-week count of sequences,total,112,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2021-W04,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W03,SARS-CoV-2,2-week count of sequences,total,144,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2021-W02,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2021-W01,SARS-CoV-2,2-week count of sequences,total,167,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2020-W53,SARS-CoV-2,2-week count of sequences,total,201,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2020-W52,SARS-CoV-2,2-week count of sequences,total,235,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2020-W51,SARS-CoV-2,2-week count of sequences,total,268,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Greece,2020-W50,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2020-W49,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Greece,2020-W48,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2020-W47,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2020-W46,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2020-W45,SARS-CoV-2,2-week count of sequences,total,208,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2020-W44,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Greece,2020-W43,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W42,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2020-W41,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2020-W40,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W39,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2020-W38,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Greece,2020-W37,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W36,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W35,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W34,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W33,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W32,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W31,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W30,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Greece,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Greece,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W50,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W49,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W48,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W47,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W46,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W45,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W44,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W43,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W42,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Hungary,2024-W41,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W40,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W39,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Hungary,2024-W38,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W37,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W36,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W35,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W32,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W31,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W19,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W18,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W17,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W16,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W15,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W09,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W08,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2024-W07,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W06,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W05,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W04,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W03,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W02,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Hungary,2024-W01,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W52,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W51,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W50,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W49,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W48,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W47,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W46,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W45,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W44,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W43,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W42,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W41,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W40,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W39,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W38,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W37,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W19,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W18,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2023-W16,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W15,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W14,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W13,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W12,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W11,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W10,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W09,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W08,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W07,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W06,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W05,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W04,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W03,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W02,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Hungary,2023-W01,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W52,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W51,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W50,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W49,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W48,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W47,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W46,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W45,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W44,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W43,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W42,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W41,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W40,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W39,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W38,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W37,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W36,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W35,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W34,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W33,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W32,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W31,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W30,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W29,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W28,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W27,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W26,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W25,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W24,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W23,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W22,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W21,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W20,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2022-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2022-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2022-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2022-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2022-W14,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W13,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W12,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2022-W10,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W09,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W08,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W07,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W06,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W05,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W04,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W03,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W02,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Hungary,2022-W01,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W52,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W51,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W50,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W49,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W48,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W47,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W46,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W22,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W21,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2021-W09,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W08,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W07,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W06,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W05,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W04,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W03,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W02,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Hungary,2021-W01,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W53,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W51,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W50,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W45,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W44,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W43,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W42,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W41,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Hungary,2020-W40,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,GISAID,Hungary,2020-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W37,SARS-CoV-2,2-week count of sequences,total,71,>5% to 10%
SARS-CoV-2 variant,GISAID,Hungary,2020-W36,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Hungary,2020-W35,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Hungary,2020-W29,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W28,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W27,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W26,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Hungary,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2024-W32,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W31,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W30,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2024-W29,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2024-W28,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2024-W27,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2024-W26,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2024-W25,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2024-W24,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W23,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W22,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W21,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W20,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W19,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W18,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W17,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W16,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W15,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W14,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W13,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W12,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W11,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W10,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W09,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W08,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W07,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W06,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W05,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W04,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W03,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W02,SARS-CoV-2,2-week count of sequences,total,51,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2024-W01,SARS-CoV-2,2-week count of sequences,total,82,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W52,SARS-CoV-2,2-week count of sequences,total,128,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W51,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W50,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W49,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W48,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W47,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W46,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W45,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W44,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W43,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W42,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W41,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W40,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W39,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W38,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W37,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W36,SARS-CoV-2,2-week count of sequences,total,72,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W35,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W34,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W33,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W32,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W31,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W30,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W29,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W28,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W27,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W26,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W25,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W24,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W23,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W22,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W21,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W20,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W19,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W18,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W17,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W16,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W15,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W14,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W13,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W12,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2023-W11,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W10,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2023-W09,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W08,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W07,SARS-CoV-2,2-week count of sequences,total,144,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W06,SARS-CoV-2,2-week count of sequences,total,172,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W05,SARS-CoV-2,2-week count of sequences,total,182,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W04,SARS-CoV-2,2-week count of sequences,total,151,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W03,SARS-CoV-2,2-week count of sequences,total,160,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W02,SARS-CoV-2,2-week count of sequences,total,165,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2023-W01,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W52,SARS-CoV-2,2-week count of sequences,total,193,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W51,SARS-CoV-2,2-week count of sequences,total,188,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W50,SARS-CoV-2,2-week count of sequences,total,206,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W49,SARS-CoV-2,2-week count of sequences,total,265,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W48,SARS-CoV-2,2-week count of sequences,total,295,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W47,SARS-CoV-2,2-week count of sequences,total,300,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W46,SARS-CoV-2,2-week count of sequences,total,230,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W45,SARS-CoV-2,2-week count of sequences,total,150,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W44,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W43,SARS-CoV-2,2-week count of sequences,total,181,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W42,SARS-CoV-2,2-week count of sequences,total,156,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W41,SARS-CoV-2,2-week count of sequences,total,134,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W40,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W39,SARS-CoV-2,2-week count of sequences,total,131,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W38,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2022-W37,SARS-CoV-2,2-week count of sequences,total,166,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W36,SARS-CoV-2,2-week count of sequences,total,216,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W35,SARS-CoV-2,2-week count of sequences,total,147,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W34,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2022-W33,SARS-CoV-2,2-week count of sequences,total,166,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W32,SARS-CoV-2,2-week count of sequences,total,323,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W31,SARS-CoV-2,2-week count of sequences,total,303,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W30,SARS-CoV-2,2-week count of sequences,total,304,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W29,SARS-CoV-2,2-week count of sequences,total,267,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W28,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W27,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2022-W26,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W25,SARS-CoV-2,2-week count of sequences,total,196,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W24,SARS-CoV-2,2-week count of sequences,total,216,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W23,SARS-CoV-2,2-week count of sequences,total,105,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2022-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W18,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Iceland,2022-W17,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Iceland,2022-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W12,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Iceland,2022-W11,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Iceland,2022-W10,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Iceland,2022-W09,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2022-W08,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Iceland,2022-W07,SARS-CoV-2,2-week count of sequences,total,346,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W06,SARS-CoV-2,2-week count of sequences,total,1449,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2022-W05,SARS-CoV-2,2-week count of sequences,total,2015,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2022-W04,SARS-CoV-2,2-week count of sequences,total,1125,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2022-W03,SARS-CoV-2,2-week count of sequences,total,352,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2022-W02,SARS-CoV-2,2-week count of sequences,total,769,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2022-W01,SARS-CoV-2,2-week count of sequences,total,2802,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W52,SARS-CoV-2,2-week count of sequences,total,4003,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W51,SARS-CoV-2,2-week count of sequences,total,2054,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W50,SARS-CoV-2,2-week count of sequences,total,937,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W49,SARS-CoV-2,2-week count of sequences,total,1129,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W48,SARS-CoV-2,2-week count of sequences,total,430,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2021-W47,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W46,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W45,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W44,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W43,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W42,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W41,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2021-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2021-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2021-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2021-W36,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W35,SARS-CoV-2,2-week count of sequences,total,400,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2021-W34,SARS-CoV-2,2-week count of sequences,total,966,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W33,SARS-CoV-2,2-week count of sequences,total,1268,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W32,SARS-CoV-2,2-week count of sequences,total,1491,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W31,SARS-CoV-2,2-week count of sequences,total,1451,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W30,SARS-CoV-2,2-week count of sequences,total,1188,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W29,SARS-CoV-2,2-week count of sequences,total,623,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2021-W28,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2021-W27,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W26,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W25,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W24,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W23,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W22,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W21,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W20,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W19,SARS-CoV-2,2-week count of sequences,total,64,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W18,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W17,SARS-CoV-2,2-week count of sequences,total,158,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2021-W16,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2021-W15,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W14,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W13,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W12,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W11,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W10,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W09,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W08,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W07,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W06,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W05,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W04,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2021-W03,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2021-W02,SARS-CoV-2,2-week count of sequences,total,172,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2021-W01,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W53,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W52,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W51,SARS-CoV-2,2-week count of sequences,total,157,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W50,SARS-CoV-2,2-week count of sequences,total,160,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W49,SARS-CoV-2,2-week count of sequences,total,200,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W48,SARS-CoV-2,2-week count of sequences,total,180,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W47,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W46,SARS-CoV-2,2-week count of sequences,total,262,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W45,SARS-CoV-2,2-week count of sequences,total,541,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W44,SARS-CoV-2,2-week count of sequences,total,754,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2020-W43,SARS-CoV-2,2-week count of sequences,total,897,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2020-W42,SARS-CoV-2,2-week count of sequences,total,1095,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2020-W41,SARS-CoV-2,2-week count of sequences,total,879,≤1%
SARS-CoV-2 variant,GISAID,Iceland,2020-W40,SARS-CoV-2,2-week count of sequences,total,575,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W39,SARS-CoV-2,2-week count of sequences,total,473,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W38,SARS-CoV-2,2-week count of sequences,total,225,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Iceland,2020-W37,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Iceland,2020-W36,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2020-W35,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2020-W34,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2020-W33,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2020-W32,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2020-W31,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Iceland,2020-W30,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Iceland,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Iceland,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Ireland,2025-W04,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Ireland,2025-W03,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Ireland,2025-W02,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Ireland,2025-W01,SARS-CoV-2,2-week count of sequences,total,51,>10% to 15%
SARS-CoV-2 variant,GISAID,Ireland,2024-W52,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Ireland,2024-W51,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Ireland,2024-W50,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W49,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W48,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W47,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W46,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W45,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W44,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W43,SARS-CoV-2,2-week count of sequences,total,133,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W42,SARS-CoV-2,2-week count of sequences,total,190,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W41,SARS-CoV-2,2-week count of sequences,total,249,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W40,SARS-CoV-2,2-week count of sequences,total,245,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W39,SARS-CoV-2,2-week count of sequences,total,244,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W38,SARS-CoV-2,2-week count of sequences,total,251,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W37,SARS-CoV-2,2-week count of sequences,total,204,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W36,SARS-CoV-2,2-week count of sequences,total,257,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W35,SARS-CoV-2,2-week count of sequences,total,258,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W34,SARS-CoV-2,2-week count of sequences,total,194,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W33,SARS-CoV-2,2-week count of sequences,total,222,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W32,SARS-CoV-2,2-week count of sequences,total,260,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W31,SARS-CoV-2,2-week count of sequences,total,287,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W30,SARS-CoV-2,2-week count of sequences,total,355,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W29,SARS-CoV-2,2-week count of sequences,total,405,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W28,SARS-CoV-2,2-week count of sequences,total,395,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W27,SARS-CoV-2,2-week count of sequences,total,405,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W26,SARS-CoV-2,2-week count of sequences,total,461,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W25,SARS-CoV-2,2-week count of sequences,total,460,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W24,SARS-CoV-2,2-week count of sequences,total,341,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W23,SARS-CoV-2,2-week count of sequences,total,244,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W22,SARS-CoV-2,2-week count of sequences,total,215,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W21,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W20,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W19,SARS-CoV-2,2-week count of sequences,total,187,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W18,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W17,SARS-CoV-2,2-week count of sequences,total,133,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W16,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W15,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W14,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W13,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W12,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W11,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W10,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W09,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W08,SARS-CoV-2,2-week count of sequences,total,103,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2024-W07,SARS-CoV-2,2-week count of sequences,total,123,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W06,SARS-CoV-2,2-week count of sequences,total,166,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W05,SARS-CoV-2,2-week count of sequences,total,246,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W04,SARS-CoV-2,2-week count of sequences,total,287,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W03,SARS-CoV-2,2-week count of sequences,total,324,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W02,SARS-CoV-2,2-week count of sequences,total,329,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2024-W01,SARS-CoV-2,2-week count of sequences,total,333,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W52,SARS-CoV-2,2-week count of sequences,total,353,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W51,SARS-CoV-2,2-week count of sequences,total,307,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W50,SARS-CoV-2,2-week count of sequences,total,261,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W49,SARS-CoV-2,2-week count of sequences,total,217,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W48,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W47,SARS-CoV-2,2-week count of sequences,total,224,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W46,SARS-CoV-2,2-week count of sequences,total,266,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W45,SARS-CoV-2,2-week count of sequences,total,256,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W44,SARS-CoV-2,2-week count of sequences,total,236,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W43,SARS-CoV-2,2-week count of sequences,total,236,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W42,SARS-CoV-2,2-week count of sequences,total,257,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W41,SARS-CoV-2,2-week count of sequences,total,275,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W40,SARS-CoV-2,2-week count of sequences,total,303,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W39,SARS-CoV-2,2-week count of sequences,total,302,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W38,SARS-CoV-2,2-week count of sequences,total,260,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W37,SARS-CoV-2,2-week count of sequences,total,238,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W36,SARS-CoV-2,2-week count of sequences,total,260,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W35,SARS-CoV-2,2-week count of sequences,total,243,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W34,SARS-CoV-2,2-week count of sequences,total,289,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W33,SARS-CoV-2,2-week count of sequences,total,343,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W32,SARS-CoV-2,2-week count of sequences,total,351,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W31,SARS-CoV-2,2-week count of sequences,total,303,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W30,SARS-CoV-2,2-week count of sequences,total,207,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W29,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W28,SARS-CoV-2,2-week count of sequences,total,125,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W27,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2023-W26,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2023-W25,SARS-CoV-2,2-week count of sequences,total,97,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2023-W24,SARS-CoV-2,2-week count of sequences,total,113,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2023-W23,SARS-CoV-2,2-week count of sequences,total,121,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W22,SARS-CoV-2,2-week count of sequences,total,186,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W21,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W20,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W19,SARS-CoV-2,2-week count of sequences,total,169,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W18,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W17,SARS-CoV-2,2-week count of sequences,total,140,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W16,SARS-CoV-2,2-week count of sequences,total,145,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W15,SARS-CoV-2,2-week count of sequences,total,156,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W14,SARS-CoV-2,2-week count of sequences,total,415,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W13,SARS-CoV-2,2-week count of sequences,total,866,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2023-W12,SARS-CoV-2,2-week count of sequences,total,958,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2023-W11,SARS-CoV-2,2-week count of sequences,total,771,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2023-W10,SARS-CoV-2,2-week count of sequences,total,632,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2023-W09,SARS-CoV-2,2-week count of sequences,total,576,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W08,SARS-CoV-2,2-week count of sequences,total,546,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W07,SARS-CoV-2,2-week count of sequences,total,480,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W06,SARS-CoV-2,2-week count of sequences,total,457,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W05,SARS-CoV-2,2-week count of sequences,total,478,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W04,SARS-CoV-2,2-week count of sequences,total,498,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2023-W03,SARS-CoV-2,2-week count of sequences,total,648,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2023-W02,SARS-CoV-2,2-week count of sequences,total,1500,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2023-W01,SARS-CoV-2,2-week count of sequences,total,1813,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W52,SARS-CoV-2,2-week count of sequences,total,1012,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W51,SARS-CoV-2,2-week count of sequences,total,811,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W50,SARS-CoV-2,2-week count of sequences,total,876,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W49,SARS-CoV-2,2-week count of sequences,total,739,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W48,SARS-CoV-2,2-week count of sequences,total,1066,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W47,SARS-CoV-2,2-week count of sequences,total,1151,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W46,SARS-CoV-2,2-week count of sequences,total,1155,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W45,SARS-CoV-2,2-week count of sequences,total,1171,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W44,SARS-CoV-2,2-week count of sequences,total,1151,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W43,SARS-CoV-2,2-week count of sequences,total,1417,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W42,SARS-CoV-2,2-week count of sequences,total,1562,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W41,SARS-CoV-2,2-week count of sequences,total,1533,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W40,SARS-CoV-2,2-week count of sequences,total,1155,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W39,SARS-CoV-2,2-week count of sequences,total,1036,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W38,SARS-CoV-2,2-week count of sequences,total,1261,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W37,SARS-CoV-2,2-week count of sequences,total,1361,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W36,SARS-CoV-2,2-week count of sequences,total,1482,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W35,SARS-CoV-2,2-week count of sequences,total,1574,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W34,SARS-CoV-2,2-week count of sequences,total,1484,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W33,SARS-CoV-2,2-week count of sequences,total,1141,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W32,SARS-CoV-2,2-week count of sequences,total,869,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W31,SARS-CoV-2,2-week count of sequences,total,817,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W30,SARS-CoV-2,2-week count of sequences,total,959,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W29,SARS-CoV-2,2-week count of sequences,total,1545,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W28,SARS-CoV-2,2-week count of sequences,total,2279,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W27,SARS-CoV-2,2-week count of sequences,total,2616,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W26,SARS-CoV-2,2-week count of sequences,total,3474,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W25,SARS-CoV-2,2-week count of sequences,total,5326,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W24,SARS-CoV-2,2-week count of sequences,total,3354,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W23,SARS-CoV-2,2-week count of sequences,total,1188,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W22,SARS-CoV-2,2-week count of sequences,total,1501,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W21,SARS-CoV-2,2-week count of sequences,total,950,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W20,SARS-CoV-2,2-week count of sequences,total,1457,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W19,SARS-CoV-2,2-week count of sequences,total,2511,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W18,SARS-CoV-2,2-week count of sequences,total,2821,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W17,SARS-CoV-2,2-week count of sequences,total,2448,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W16,SARS-CoV-2,2-week count of sequences,total,1938,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W15,SARS-CoV-2,2-week count of sequences,total,2220,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W14,SARS-CoV-2,2-week count of sequences,total,2563,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W13,SARS-CoV-2,2-week count of sequences,total,3456,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W12,SARS-CoV-2,2-week count of sequences,total,3907,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W11,SARS-CoV-2,2-week count of sequences,total,1791,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W10,SARS-CoV-2,2-week count of sequences,total,305,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2022-W09,SARS-CoV-2,2-week count of sequences,total,665,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W08,SARS-CoV-2,2-week count of sequences,total,863,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W07,SARS-CoV-2,2-week count of sequences,total,734,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W06,SARS-CoV-2,2-week count of sequences,total,1044,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W05,SARS-CoV-2,2-week count of sequences,total,1697,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W04,SARS-CoV-2,2-week count of sequences,total,4532,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W03,SARS-CoV-2,2-week count of sequences,total,5874,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W02,SARS-CoV-2,2-week count of sequences,total,4497,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2022-W01,SARS-CoV-2,2-week count of sequences,total,3054,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W52,SARS-CoV-2,2-week count of sequences,total,1300,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W51,SARS-CoV-2,2-week count of sequences,total,3072,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W50,SARS-CoV-2,2-week count of sequences,total,3786,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W49,SARS-CoV-2,2-week count of sequences,total,2466,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W48,SARS-CoV-2,2-week count of sequences,total,1782,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W47,SARS-CoV-2,2-week count of sequences,total,537,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2021-W46,SARS-CoV-2,2-week count of sequences,total,399,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2021-W45,SARS-CoV-2,2-week count of sequences,total,999,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W44,SARS-CoV-2,2-week count of sequences,total,2884,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W43,SARS-CoV-2,2-week count of sequences,total,3436,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W42,SARS-CoV-2,2-week count of sequences,total,3009,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W41,SARS-CoV-2,2-week count of sequences,total,2993,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W40,SARS-CoV-2,2-week count of sequences,total,2384,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W39,SARS-CoV-2,2-week count of sequences,total,1696,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W38,SARS-CoV-2,2-week count of sequences,total,1670,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W37,SARS-CoV-2,2-week count of sequences,total,2479,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W36,SARS-CoV-2,2-week count of sequences,total,2764,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W35,SARS-CoV-2,2-week count of sequences,total,2228,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W34,SARS-CoV-2,2-week count of sequences,total,2578,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W33,SARS-CoV-2,2-week count of sequences,total,2929,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W32,SARS-CoV-2,2-week count of sequences,total,2743,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W31,SARS-CoV-2,2-week count of sequences,total,3033,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W30,SARS-CoV-2,2-week count of sequences,total,3081,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W29,SARS-CoV-2,2-week count of sequences,total,2935,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W28,SARS-CoV-2,2-week count of sequences,total,2673,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W27,SARS-CoV-2,2-week count of sequences,total,1809,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W26,SARS-CoV-2,2-week count of sequences,total,1284,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W25,SARS-CoV-2,2-week count of sequences,total,1598,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W24,SARS-CoV-2,2-week count of sequences,total,1647,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W23,SARS-CoV-2,2-week count of sequences,total,1422,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W22,SARS-CoV-2,2-week count of sequences,total,1697,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W21,SARS-CoV-2,2-week count of sequences,total,2381,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W20,SARS-CoV-2,2-week count of sequences,total,2401,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W19,SARS-CoV-2,2-week count of sequences,total,2160,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W18,SARS-CoV-2,2-week count of sequences,total,2101,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W17,SARS-CoV-2,2-week count of sequences,total,1914,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W16,SARS-CoV-2,2-week count of sequences,total,1602,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W15,SARS-CoV-2,2-week count of sequences,total,1545,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W14,SARS-CoV-2,2-week count of sequences,total,1362,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W13,SARS-CoV-2,2-week count of sequences,total,1429,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W12,SARS-CoV-2,2-week count of sequences,total,1816,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W11,SARS-CoV-2,2-week count of sequences,total,1746,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W10,SARS-CoV-2,2-week count of sequences,total,1488,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W09,SARS-CoV-2,2-week count of sequences,total,1635,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W08,SARS-CoV-2,2-week count of sequences,total,1610,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W07,SARS-CoV-2,2-week count of sequences,total,1478,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W06,SARS-CoV-2,2-week count of sequences,total,1726,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W05,SARS-CoV-2,2-week count of sequences,total,1195,≤1%
SARS-CoV-2 variant,GISAID,Ireland,2021-W04,SARS-CoV-2,2-week count of sequences,total,560,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2021-W03,SARS-CoV-2,2-week count of sequences,total,506,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2021-W02,SARS-CoV-2,2-week count of sequences,total,390,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2021-W01,SARS-CoV-2,2-week count of sequences,total,277,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Ireland,2020-W53,SARS-CoV-2,2-week count of sequences,total,210,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2020-W52,SARS-CoV-2,2-week count of sequences,total,159,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2020-W51,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W50,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W49,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W48,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2020-W47,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W46,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W45,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W44,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W43,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W42,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2020-W41,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W40,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W39,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W38,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Ireland,2020-W37,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W36,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W35,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W34,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W33,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W32,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W31,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Ireland,2020-W30,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W29,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W28,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W27,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W26,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Ireland,2020-W25,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2025-W03,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Italy,2025-W02,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,TESSy,Italy,2025-W01,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,TESSy,Italy,2024-W52,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,TESSy,Italy,2024-W51,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,TESSy,Italy,2024-W50,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2024-W49,SARS-CoV-2,2-week count of sequences,total,165,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2024-W48,SARS-CoV-2,2-week count of sequences,total,264,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W47,SARS-CoV-2,2-week count of sequences,total,286,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W46,SARS-CoV-2,2-week count of sequences,total,296,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W45,SARS-CoV-2,2-week count of sequences,total,322,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W44,SARS-CoV-2,2-week count of sequences,total,378,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W43,SARS-CoV-2,2-week count of sequences,total,533,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W42,SARS-CoV-2,2-week count of sequences,total,661,≤1%
SARS-CoV-2 variant,TESSy,Italy,2024-W41,SARS-CoV-2,2-week count of sequences,total,675,≤1%
SARS-CoV-2 variant,TESSy,Italy,2024-W40,SARS-CoV-2,2-week count of sequences,total,634,≤1%
SARS-CoV-2 variant,TESSy,Italy,2024-W39,SARS-CoV-2,2-week count of sequences,total,551,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W38,SARS-CoV-2,2-week count of sequences,total,450,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W37,SARS-CoV-2,2-week count of sequences,total,411,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W36,SARS-CoV-2,2-week count of sequences,total,438,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W35,SARS-CoV-2,2-week count of sequences,total,545,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W34,SARS-CoV-2,2-week count of sequences,total,669,≤1%
SARS-CoV-2 variant,TESSy,Italy,2024-W33,SARS-CoV-2,2-week count of sequences,total,697,≤1%
SARS-CoV-2 variant,TESSy,Italy,2024-W32,SARS-CoV-2,2-week count of sequences,total,664,≤1%
SARS-CoV-2 variant,TESSy,Italy,2024-W31,SARS-CoV-2,2-week count of sequences,total,585,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W30,SARS-CoV-2,2-week count of sequences,total,553,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W29,SARS-CoV-2,2-week count of sequences,total,511,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W28,SARS-CoV-2,2-week count of sequences,total,432,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W27,SARS-CoV-2,2-week count of sequences,total,381,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W26,SARS-CoV-2,2-week count of sequences,total,311,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W25,SARS-CoV-2,2-week count of sequences,total,235,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2024-W24,SARS-CoV-2,2-week count of sequences,total,170,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2024-W23,SARS-CoV-2,2-week count of sequences,total,158,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2024-W22,SARS-CoV-2,2-week count of sequences,total,139,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2024-W21,SARS-CoV-2,2-week count of sequences,total,117,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2024-W20,SARS-CoV-2,2-week count of sequences,total,103,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2024-W19,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2024-W18,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,TESSy,Italy,2024-W17,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,TESSy,Italy,2024-W16,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,TESSy,Italy,2024-W15,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,TESSy,Italy,2024-W14,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,TESSy,Italy,2024-W13,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,TESSy,Italy,2024-W12,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,TESSy,Italy,2024-W11,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,TESSy,Italy,2024-W10,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2024-W09,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2024-W08,SARS-CoV-2,2-week count of sequences,total,211,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2024-W07,SARS-CoV-2,2-week count of sequences,total,274,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W06,SARS-CoV-2,2-week count of sequences,total,237,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2024-W05,SARS-CoV-2,2-week count of sequences,total,262,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W04,SARS-CoV-2,2-week count of sequences,total,611,≤1%
SARS-CoV-2 variant,TESSy,Italy,2024-W03,SARS-CoV-2,2-week count of sequences,total,747,≤1%
SARS-CoV-2 variant,TESSy,Italy,2024-W02,SARS-CoV-2,2-week count of sequences,total,595,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2024-W01,SARS-CoV-2,2-week count of sequences,total,626,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W52,SARS-CoV-2,2-week count of sequences,total,630,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W51,SARS-CoV-2,2-week count of sequences,total,1361,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W50,SARS-CoV-2,2-week count of sequences,total,1413,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W49,SARS-CoV-2,2-week count of sequences,total,896,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W48,SARS-CoV-2,2-week count of sequences,total,958,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W47,SARS-CoV-2,2-week count of sequences,total,1392,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W46,SARS-CoV-2,2-week count of sequences,total,1265,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W45,SARS-CoV-2,2-week count of sequences,total,694,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W44,SARS-CoV-2,2-week count of sequences,total,668,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W43,SARS-CoV-2,2-week count of sequences,total,1205,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W42,SARS-CoV-2,2-week count of sequences,total,1347,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W41,SARS-CoV-2,2-week count of sequences,total,954,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W40,SARS-CoV-2,2-week count of sequences,total,998,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W39,SARS-CoV-2,2-week count of sequences,total,1417,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W38,SARS-CoV-2,2-week count of sequences,total,1398,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W37,SARS-CoV-2,2-week count of sequences,total,968,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W36,SARS-CoV-2,2-week count of sequences,total,848,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W35,SARS-CoV-2,2-week count of sequences,total,997,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W34,SARS-CoV-2,2-week count of sequences,total,850,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W33,SARS-CoV-2,2-week count of sequences,total,374,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2023-W32,SARS-CoV-2,2-week count of sequences,total,328,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2023-W31,SARS-CoV-2,2-week count of sequences,total,289,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2023-W30,SARS-CoV-2,2-week count of sequences,total,242,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2023-W29,SARS-CoV-2,2-week count of sequences,total,326,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2023-W28,SARS-CoV-2,2-week count of sequences,total,323,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2023-W27,SARS-CoV-2,2-week count of sequences,total,210,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2023-W26,SARS-CoV-2,2-week count of sequences,total,233,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2023-W25,SARS-CoV-2,2-week count of sequences,total,280,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2023-W24,SARS-CoV-2,2-week count of sequences,total,596,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2023-W23,SARS-CoV-2,2-week count of sequences,total,727,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W22,SARS-CoV-2,2-week count of sequences,total,639,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W21,SARS-CoV-2,2-week count of sequences,total,693,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W20,SARS-CoV-2,2-week count of sequences,total,712,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W19,SARS-CoV-2,2-week count of sequences,total,812,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W18,SARS-CoV-2,2-week count of sequences,total,864,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W17,SARS-CoV-2,2-week count of sequences,total,954,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W16,SARS-CoV-2,2-week count of sequences,total,1108,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W15,SARS-CoV-2,2-week count of sequences,total,1320,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W14,SARS-CoV-2,2-week count of sequences,total,1240,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W13,SARS-CoV-2,2-week count of sequences,total,1101,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W12,SARS-CoV-2,2-week count of sequences,total,1231,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W11,SARS-CoV-2,2-week count of sequences,total,1616,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W10,SARS-CoV-2,2-week count of sequences,total,1555,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W09,SARS-CoV-2,2-week count of sequences,total,1249,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W08,SARS-CoV-2,2-week count of sequences,total,1458,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W07,SARS-CoV-2,2-week count of sequences,total,1918,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W06,SARS-CoV-2,2-week count of sequences,total,1818,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W05,SARS-CoV-2,2-week count of sequences,total,1470,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W04,SARS-CoV-2,2-week count of sequences,total,1681,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W03,SARS-CoV-2,2-week count of sequences,total,2529,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W02,SARS-CoV-2,2-week count of sequences,total,2706,≤1%
SARS-CoV-2 variant,TESSy,Italy,2023-W01,SARS-CoV-2,2-week count of sequences,total,1695,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W52,SARS-CoV-2,2-week count of sequences,total,1499,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W51,SARS-CoV-2,2-week count of sequences,total,3083,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W50,SARS-CoV-2,2-week count of sequences,total,2931,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W49,SARS-CoV-2,2-week count of sequences,total,1751,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W48,SARS-CoV-2,2-week count of sequences,total,1999,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W47,SARS-CoV-2,2-week count of sequences,total,1876,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W46,SARS-CoV-2,2-week count of sequences,total,2857,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W45,SARS-CoV-2,2-week count of sequences,total,2927,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W44,SARS-CoV-2,2-week count of sequences,total,1916,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W43,SARS-CoV-2,2-week count of sequences,total,932,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2022-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2022-W40,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W39,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2022-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2022-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2022-W35,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,TESSy,Italy,2022-W34,SARS-CoV-2,2-week count of sequences,total,125,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2022-W33,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2022-W32,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W31,SARS-CoV-2,2-week count of sequences,total,1214,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W30,SARS-CoV-2,2-week count of sequences,total,1209,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W29,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W28,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W27,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2022-W25,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W24,SARS-CoV-2,2-week count of sequences,total,550,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2022-W23,SARS-CoV-2,2-week count of sequences,total,547,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2022-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2022-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2022-W20,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W19,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W18,SARS-CoV-2,2-week count of sequences,total,1315,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W17,SARS-CoV-2,2-week count of sequences,total,1315,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W16,SARS-CoV-2,2-week count of sequences,total,122,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2022-W15,SARS-CoV-2,2-week count of sequences,total,122,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2022-W14,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W13,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W12,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W11,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W10,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W09,SARS-CoV-2,2-week count of sequences,total,1052,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W08,SARS-CoV-2,2-week count of sequences,total,1150,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W07,SARS-CoV-2,2-week count of sequences,total,1149,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W06,SARS-CoV-2,2-week count of sequences,total,1051,≤1%
SARS-CoV-2 variant,TESSy,Italy,2022-W05,SARS-CoV-2,2-week count of sequences,total,180,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2022-W04,SARS-CoV-2,2-week count of sequences,total,261,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2022-W03,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2022-W02,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2022-W01,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W50,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,TESSy,Italy,2021-W49,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,TESSy,Italy,2021-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W47,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2021-W46,SARS-CoV-2,2-week count of sequences,total,2429,≤1%
SARS-CoV-2 variant,TESSy,Italy,2021-W45,SARS-CoV-2,2-week count of sequences,total,2351,≤1%
SARS-CoV-2 variant,TESSy,Italy,2021-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W42,SARS-CoV-2,2-week count of sequences,total,1178,≤1%
SARS-CoV-2 variant,TESSy,Italy,2021-W41,SARS-CoV-2,2-week count of sequences,total,2187,≤1%
SARS-CoV-2 variant,TESSy,Italy,2021-W40,SARS-CoV-2,2-week count of sequences,total,1009,≤1%
SARS-CoV-2 variant,TESSy,Italy,2021-W39,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W38,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W37,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W36,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W35,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W34,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W33,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W32,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W31,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W30,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W29,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W28,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W27,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W26,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W24,SARS-CoV-2,2-week count of sequences,total,239,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2021-W23,SARS-CoV-2,2-week count of sequences,total,239,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2021-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W18,SARS-CoV-2,2-week count of sequences,total,151,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2021-W17,SARS-CoV-2,2-week count of sequences,total,151,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Italy,2021-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W14,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W13,SARS-CoV-2,2-week count of sequences,total,1147,≤1%
SARS-CoV-2 variant,TESSy,Italy,2021-W12,SARS-CoV-2,2-week count of sequences,total,1122,≤1%
SARS-CoV-2 variant,TESSy,Italy,2021-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W09,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W08,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2021-W07,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2021-W06,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W05,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Italy,2021-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2021-W01,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2020-W53,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2020-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2020-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2020-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2020-W49,SARS-CoV-2,2-week count of sequences,total,534,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2020-W48,SARS-CoV-2,2-week count of sequences,total,534,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2020-W47,SARS-CoV-2,2-week count of sequences,total,635,≤1%
SARS-CoV-2 variant,TESSy,Italy,2020-W46,SARS-CoV-2,2-week count of sequences,total,646,≤1%
SARS-CoV-2 variant,TESSy,Italy,2020-W45,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W44,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W43,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W42,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2020-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2020-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2020-W38,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W37,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W36,SARS-CoV-2,2-week count of sequences,total,274,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2020-W35,SARS-CoV-2,2-week count of sequences,total,273,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Italy,2020-W34,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2020-W33,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2020-W32,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W31,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W30,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W29,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,TESSy,Italy,2020-W28,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2020-W27,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,TESSy,Italy,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Italy,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W09,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W08,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W07,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W06,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W05,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2024-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W09,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W08,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W07,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W06,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W05,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2023-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2022-W52,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Latvia,2022-W51,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2022-W50,SARS-CoV-2,2-week count of sequences,total,142,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W49,SARS-CoV-2,2-week count of sequences,total,203,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W48,SARS-CoV-2,2-week count of sequences,total,144,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W47,SARS-CoV-2,2-week count of sequences,total,239,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W46,SARS-CoV-2,2-week count of sequences,total,603,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W45,SARS-CoV-2,2-week count of sequences,total,792,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W44,SARS-CoV-2,2-week count of sequences,total,698,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W43,SARS-CoV-2,2-week count of sequences,total,924,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W42,SARS-CoV-2,2-week count of sequences,total,1234,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W41,SARS-CoV-2,2-week count of sequences,total,1013,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W40,SARS-CoV-2,2-week count of sequences,total,1110,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W39,SARS-CoV-2,2-week count of sequences,total,1381,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W38,SARS-CoV-2,2-week count of sequences,total,1534,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W37,SARS-CoV-2,2-week count of sequences,total,1471,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W36,SARS-CoV-2,2-week count of sequences,total,1036,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W35,SARS-CoV-2,2-week count of sequences,total,767,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W34,SARS-CoV-2,2-week count of sequences,total,721,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W33,SARS-CoV-2,2-week count of sequences,total,939,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W32,SARS-CoV-2,2-week count of sequences,total,857,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W31,SARS-CoV-2,2-week count of sequences,total,624,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W30,SARS-CoV-2,2-week count of sequences,total,552,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W29,SARS-CoV-2,2-week count of sequences,total,314,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W28,SARS-CoV-2,2-week count of sequences,total,219,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W27,SARS-CoV-2,2-week count of sequences,total,183,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W26,SARS-CoV-2,2-week count of sequences,total,97,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2022-W25,SARS-CoV-2,2-week count of sequences,total,113,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2022-W24,SARS-CoV-2,2-week count of sequences,total,192,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W23,SARS-CoV-2,2-week count of sequences,total,279,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W22,SARS-CoV-2,2-week count of sequences,total,321,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W21,SARS-CoV-2,2-week count of sequences,total,166,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W20,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2022-W19,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2022-W18,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Latvia,2022-W17,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2022-W16,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2022-W15,SARS-CoV-2,2-week count of sequences,total,129,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W14,SARS-CoV-2,2-week count of sequences,total,199,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W13,SARS-CoV-2,2-week count of sequences,total,437,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W12,SARS-CoV-2,2-week count of sequences,total,602,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W11,SARS-CoV-2,2-week count of sequences,total,628,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W10,SARS-CoV-2,2-week count of sequences,total,737,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W09,SARS-CoV-2,2-week count of sequences,total,733,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W08,SARS-CoV-2,2-week count of sequences,total,844,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W07,SARS-CoV-2,2-week count of sequences,total,1038,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W06,SARS-CoV-2,2-week count of sequences,total,958,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W05,SARS-CoV-2,2-week count of sequences,total,1024,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W04,SARS-CoV-2,2-week count of sequences,total,901,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2022-W03,SARS-CoV-2,2-week count of sequences,total,529,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W02,SARS-CoV-2,2-week count of sequences,total,607,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2022-W01,SARS-CoV-2,2-week count of sequences,total,651,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W52,SARS-CoV-2,2-week count of sequences,total,572,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W51,SARS-CoV-2,2-week count of sequences,total,557,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W50,SARS-CoV-2,2-week count of sequences,total,582,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W49,SARS-CoV-2,2-week count of sequences,total,785,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W48,SARS-CoV-2,2-week count of sequences,total,624,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W47,SARS-CoV-2,2-week count of sequences,total,460,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W46,SARS-CoV-2,2-week count of sequences,total,798,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W45,SARS-CoV-2,2-week count of sequences,total,722,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W44,SARS-CoV-2,2-week count of sequences,total,528,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W43,SARS-CoV-2,2-week count of sequences,total,653,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W42,SARS-CoV-2,2-week count of sequences,total,602,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W41,SARS-CoV-2,2-week count of sequences,total,406,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W40,SARS-CoV-2,2-week count of sequences,total,295,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W39,SARS-CoV-2,2-week count of sequences,total,254,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W38,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W37,SARS-CoV-2,2-week count of sequences,total,103,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2021-W36,SARS-CoV-2,2-week count of sequences,total,239,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W35,SARS-CoV-2,2-week count of sequences,total,428,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W34,SARS-CoV-2,2-week count of sequences,total,297,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W33,SARS-CoV-2,2-week count of sequences,total,143,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W32,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W31,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W30,SARS-CoV-2,2-week count of sequences,total,187,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W29,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W28,SARS-CoV-2,2-week count of sequences,total,103,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2021-W27,SARS-CoV-2,2-week count of sequences,total,256,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W26,SARS-CoV-2,2-week count of sequences,total,229,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W25,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W24,SARS-CoV-2,2-week count of sequences,total,233,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W23,SARS-CoV-2,2-week count of sequences,total,324,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W22,SARS-CoV-2,2-week count of sequences,total,369,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W21,SARS-CoV-2,2-week count of sequences,total,557,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W20,SARS-CoV-2,2-week count of sequences,total,563,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W19,SARS-CoV-2,2-week count of sequences,total,531,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W18,SARS-CoV-2,2-week count of sequences,total,736,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W17,SARS-CoV-2,2-week count of sequences,total,810,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W16,SARS-CoV-2,2-week count of sequences,total,839,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W15,SARS-CoV-2,2-week count of sequences,total,780,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W14,SARS-CoV-2,2-week count of sequences,total,794,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W13,SARS-CoV-2,2-week count of sequences,total,984,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W12,SARS-CoV-2,2-week count of sequences,total,1276,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W11,SARS-CoV-2,2-week count of sequences,total,1245,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W10,SARS-CoV-2,2-week count of sequences,total,678,≤1%
SARS-CoV-2 variant,GISAID,Latvia,2021-W09,SARS-CoV-2,2-week count of sequences,total,472,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W08,SARS-CoV-2,2-week count of sequences,total,484,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W07,SARS-CoV-2,2-week count of sequences,total,430,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W06,SARS-CoV-2,2-week count of sequences,total,387,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W05,SARS-CoV-2,2-week count of sequences,total,249,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W04,SARS-CoV-2,2-week count of sequences,total,165,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Latvia,2021-W03,SARS-CoV-2,2-week count of sequences,total,82,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2021-W02,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Latvia,2021-W01,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W53,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W52,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W51,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W50,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2020-W48,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W47,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Latvia,2020-W45,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W44,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W43,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W42,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Latvia,2020-W41,SARS-CoV-2,2-week count of sequences,total,297,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2020-W40,SARS-CoV-2,2-week count of sequences,total,241,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Latvia,2020-W39,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W38,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W37,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W36,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W35,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W34,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W33,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W32,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W31,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W30,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W29,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W28,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W27,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W26,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Latvia,2020-W25,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W09,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W08,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W07,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W06,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W05,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2024-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W09,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W08,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W07,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W06,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W05,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2023-W01,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W52,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W51,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W50,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W49,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W48,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W47,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W46,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W45,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W44,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W43,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W42,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W41,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W40,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W39,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W38,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W37,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W36,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W35,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W34,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W33,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W32,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W31,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W30,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W29,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W28,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W27,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W26,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W25,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W24,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W23,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W22,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W21,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W20,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W19,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W18,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W17,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W16,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W15,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W14,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W13,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W12,SARS-CoV-2,2-week count of sequences,total,139,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W11,SARS-CoV-2,2-week count of sequences,total,150,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W10,SARS-CoV-2,2-week count of sequences,total,159,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W09,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W08,SARS-CoV-2,2-week count of sequences,total,157,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W07,SARS-CoV-2,2-week count of sequences,total,142,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W06,SARS-CoV-2,2-week count of sequences,total,164,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W05,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W04,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W03,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W02,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2022-W01,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W52,SARS-CoV-2,2-week count of sequences,total,116,>5% to 10%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W51,SARS-CoV-2,2-week count of sequences,total,116,>5% to 10%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W50,SARS-CoV-2,2-week count of sequences,total,133,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W49,SARS-CoV-2,2-week count of sequences,total,143,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W48,SARS-CoV-2,2-week count of sequences,total,123,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W47,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W46,SARS-CoV-2,2-week count of sequences,total,108,>5% to 10%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W45,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W44,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W43,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W42,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W41,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W40,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W39,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W38,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W37,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W36,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W35,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W34,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W33,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W32,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W31,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W30,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W29,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W28,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W27,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W25,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W24,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W23,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W21,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W20,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W19,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W18,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W17,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W16,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W15,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W14,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W13,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W09,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W08,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W07,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W06,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W05,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W04,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W03,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2021-W01,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W53,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W52,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W51,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W50,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W49,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W48,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W47,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W44,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W43,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Liechtenstein,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W52,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W51,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W46,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W45,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W16,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W15,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2024-W13,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W12,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W11,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W10,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W09,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W08,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W07,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W06,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W05,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W04,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W03,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W02,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Lithuania,2024-W01,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W52,SARS-CoV-2,2-week count of sequences,total,221,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W51,SARS-CoV-2,2-week count of sequences,total,332,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W50,SARS-CoV-2,2-week count of sequences,total,422,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W49,SARS-CoV-2,2-week count of sequences,total,463,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W48,SARS-CoV-2,2-week count of sequences,total,380,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W47,SARS-CoV-2,2-week count of sequences,total,270,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W46,SARS-CoV-2,2-week count of sequences,total,282,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W45,SARS-CoV-2,2-week count of sequences,total,341,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W44,SARS-CoV-2,2-week count of sequences,total,379,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W43,SARS-CoV-2,2-week count of sequences,total,349,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W42,SARS-CoV-2,2-week count of sequences,total,239,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W41,SARS-CoV-2,2-week count of sequences,total,194,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W40,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W39,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W38,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W37,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W36,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W35,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W34,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W33,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W32,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W31,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W30,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W29,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W28,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W27,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W26,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W25,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2023-W23,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W22,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W21,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W20,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W19,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W18,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W17,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W16,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W15,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W14,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W13,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W12,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W11,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W10,SARS-CoV-2,2-week count of sequences,total,137,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W09,SARS-CoV-2,2-week count of sequences,total,155,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W08,SARS-CoV-2,2-week count of sequences,total,149,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W07,SARS-CoV-2,2-week count of sequences,total,149,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W06,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W05,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W04,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W03,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W02,SARS-CoV-2,2-week count of sequences,total,126,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2023-W01,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W52,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W51,SARS-CoV-2,2-week count of sequences,total,184,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W50,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W49,SARS-CoV-2,2-week count of sequences,total,76,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W48,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W47,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W46,SARS-CoV-2,2-week count of sequences,total,172,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W45,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W44,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W43,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W42,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W41,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2022-W18,SARS-CoV-2,2-week count of sequences,total,349,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W17,SARS-CoV-2,2-week count of sequences,total,1020,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W16,SARS-CoV-2,2-week count of sequences,total,1113,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W15,SARS-CoV-2,2-week count of sequences,total,1060,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W14,SARS-CoV-2,2-week count of sequences,total,1000,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W13,SARS-CoV-2,2-week count of sequences,total,931,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W12,SARS-CoV-2,2-week count of sequences,total,1284,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W11,SARS-CoV-2,2-week count of sequences,total,1450,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W10,SARS-CoV-2,2-week count of sequences,total,1018,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W09,SARS-CoV-2,2-week count of sequences,total,951,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W08,SARS-CoV-2,2-week count of sequences,total,1403,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W07,SARS-CoV-2,2-week count of sequences,total,1478,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W06,SARS-CoV-2,2-week count of sequences,total,1329,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W05,SARS-CoV-2,2-week count of sequences,total,939,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W04,SARS-CoV-2,2-week count of sequences,total,611,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W03,SARS-CoV-2,2-week count of sequences,total,833,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W02,SARS-CoV-2,2-week count of sequences,total,1292,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2022-W01,SARS-CoV-2,2-week count of sequences,total,1544,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W52,SARS-CoV-2,2-week count of sequences,total,1688,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W51,SARS-CoV-2,2-week count of sequences,total,1698,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W50,SARS-CoV-2,2-week count of sequences,total,1823,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W49,SARS-CoV-2,2-week count of sequences,total,1879,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W48,SARS-CoV-2,2-week count of sequences,total,1558,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W47,SARS-CoV-2,2-week count of sequences,total,1208,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W46,SARS-CoV-2,2-week count of sequences,total,1104,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W45,SARS-CoV-2,2-week count of sequences,total,1220,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W44,SARS-CoV-2,2-week count of sequences,total,1230,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W43,SARS-CoV-2,2-week count of sequences,total,1045,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W42,SARS-CoV-2,2-week count of sequences,total,935,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W41,SARS-CoV-2,2-week count of sequences,total,964,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W40,SARS-CoV-2,2-week count of sequences,total,902,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W39,SARS-CoV-2,2-week count of sequences,total,827,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W38,SARS-CoV-2,2-week count of sequences,total,762,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W37,SARS-CoV-2,2-week count of sequences,total,965,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W36,SARS-CoV-2,2-week count of sequences,total,1225,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W35,SARS-CoV-2,2-week count of sequences,total,1345,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W34,SARS-CoV-2,2-week count of sequences,total,1450,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W33,SARS-CoV-2,2-week count of sequences,total,1496,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W32,SARS-CoV-2,2-week count of sequences,total,1572,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W31,SARS-CoV-2,2-week count of sequences,total,1518,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W30,SARS-CoV-2,2-week count of sequences,total,1395,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W29,SARS-CoV-2,2-week count of sequences,total,996,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W28,SARS-CoV-2,2-week count of sequences,total,479,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W27,SARS-CoV-2,2-week count of sequences,total,244,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W26,SARS-CoV-2,2-week count of sequences,total,215,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W25,SARS-CoV-2,2-week count of sequences,total,326,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W24,SARS-CoV-2,2-week count of sequences,total,761,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W23,SARS-CoV-2,2-week count of sequences,total,1258,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W22,SARS-CoV-2,2-week count of sequences,total,1422,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W21,SARS-CoV-2,2-week count of sequences,total,1518,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W20,SARS-CoV-2,2-week count of sequences,total,1535,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W19,SARS-CoV-2,2-week count of sequences,total,1462,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W18,SARS-CoV-2,2-week count of sequences,total,1602,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W17,SARS-CoV-2,2-week count of sequences,total,1744,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W16,SARS-CoV-2,2-week count of sequences,total,1772,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W15,SARS-CoV-2,2-week count of sequences,total,1734,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W14,SARS-CoV-2,2-week count of sequences,total,1815,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W13,SARS-CoV-2,2-week count of sequences,total,1735,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W12,SARS-CoV-2,2-week count of sequences,total,1963,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W11,SARS-CoV-2,2-week count of sequences,total,1421,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W10,SARS-CoV-2,2-week count of sequences,total,781,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W09,SARS-CoV-2,2-week count of sequences,total,1312,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W08,SARS-CoV-2,2-week count of sequences,total,1479,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W07,SARS-CoV-2,2-week count of sequences,total,977,≤1%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W06,SARS-CoV-2,2-week count of sequences,total,404,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W05,SARS-CoV-2,2-week count of sequences,total,184,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W04,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W03,SARS-CoV-2,2-week count of sequences,total,199,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W02,SARS-CoV-2,2-week count of sequences,total,246,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2021-W01,SARS-CoV-2,2-week count of sequences,total,225,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W53,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W52,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W51,SARS-CoV-2,2-week count of sequences,total,209,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W50,SARS-CoV-2,2-week count of sequences,total,312,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W49,SARS-CoV-2,2-week count of sequences,total,208,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W48,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W47,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W46,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W45,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W44,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W43,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W42,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W41,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W40,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W39,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W38,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W37,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W36,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W35,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W34,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W33,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W32,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W31,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W30,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Lithuania,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Lithuania,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Luxembourg,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Luxembourg,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Luxembourg,2025-W02,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2025-W01,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W52,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W51,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W49,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W48,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W47,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W46,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W45,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W44,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W43,SARS-CoV-2,2-week count of sequences,total,112,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W42,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W41,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W40,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W39,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W38,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W37,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W36,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W35,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W34,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W33,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W32,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W31,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W30,SARS-CoV-2,2-week count of sequences,total,76,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W29,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W28,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W27,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W26,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W25,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W24,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W23,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W22,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W21,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W20,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W19,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W18,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W17,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W16,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W15,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W14,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W13,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W12,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W11,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W10,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W09,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W08,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W07,SARS-CoV-2,2-week count of sequences,total,97,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W06,SARS-CoV-2,2-week count of sequences,total,126,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W05,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W04,SARS-CoV-2,2-week count of sequences,total,121,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W03,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W02,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2024-W01,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W52,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W51,SARS-CoV-2,2-week count of sequences,total,116,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W50,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W49,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W48,SARS-CoV-2,2-week count of sequences,total,166,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W47,SARS-CoV-2,2-week count of sequences,total,176,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W46,SARS-CoV-2,2-week count of sequences,total,198,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W45,SARS-CoV-2,2-week count of sequences,total,147,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W44,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W43,SARS-CoV-2,2-week count of sequences,total,131,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W42,SARS-CoV-2,2-week count of sequences,total,187,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W41,SARS-CoV-2,2-week count of sequences,total,223,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W40,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W39,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W38,SARS-CoV-2,2-week count of sequences,total,182,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W37,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W36,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W35,SARS-CoV-2,2-week count of sequences,total,247,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W34,SARS-CoV-2,2-week count of sequences,total,169,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W33,SARS-CoV-2,2-week count of sequences,total,133,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W32,SARS-CoV-2,2-week count of sequences,total,112,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W31,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W30,SARS-CoV-2,2-week count of sequences,total,82,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W29,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W28,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W27,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W26,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W25,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W24,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W23,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W22,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W21,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W20,SARS-CoV-2,2-week count of sequences,total,182,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W19,SARS-CoV-2,2-week count of sequences,total,255,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W18,SARS-CoV-2,2-week count of sequences,total,278,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W17,SARS-CoV-2,2-week count of sequences,total,288,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W16,SARS-CoV-2,2-week count of sequences,total,298,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W15,SARS-CoV-2,2-week count of sequences,total,297,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W14,SARS-CoV-2,2-week count of sequences,total,408,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W13,SARS-CoV-2,2-week count of sequences,total,467,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W12,SARS-CoV-2,2-week count of sequences,total,551,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W11,SARS-CoV-2,2-week count of sequences,total,672,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W10,SARS-CoV-2,2-week count of sequences,total,671,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W09,SARS-CoV-2,2-week count of sequences,total,575,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W08,SARS-CoV-2,2-week count of sequences,total,490,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W07,SARS-CoV-2,2-week count of sequences,total,489,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W06,SARS-CoV-2,2-week count of sequences,total,500,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W05,SARS-CoV-2,2-week count of sequences,total,493,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W04,SARS-CoV-2,2-week count of sequences,total,406,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W03,SARS-CoV-2,2-week count of sequences,total,380,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W02,SARS-CoV-2,2-week count of sequences,total,551,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2023-W01,SARS-CoV-2,2-week count of sequences,total,630,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W52,SARS-CoV-2,2-week count of sequences,total,641,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W51,SARS-CoV-2,2-week count of sequences,total,672,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W50,SARS-CoV-2,2-week count of sequences,total,638,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W49,SARS-CoV-2,2-week count of sequences,total,559,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W48,SARS-CoV-2,2-week count of sequences,total,487,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W47,SARS-CoV-2,2-week count of sequences,total,648,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W46,SARS-CoV-2,2-week count of sequences,total,920,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W45,SARS-CoV-2,2-week count of sequences,total,1011,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W44,SARS-CoV-2,2-week count of sequences,total,1053,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W43,SARS-CoV-2,2-week count of sequences,total,1176,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W42,SARS-CoV-2,2-week count of sequences,total,1191,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W41,SARS-CoV-2,2-week count of sequences,total,1139,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W40,SARS-CoV-2,2-week count of sequences,total,1076,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W39,SARS-CoV-2,2-week count of sequences,total,974,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W38,SARS-CoV-2,2-week count of sequences,total,863,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W37,SARS-CoV-2,2-week count of sequences,total,821,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W36,SARS-CoV-2,2-week count of sequences,total,921,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W35,SARS-CoV-2,2-week count of sequences,total,912,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W34,SARS-CoV-2,2-week count of sequences,total,1027,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W33,SARS-CoV-2,2-week count of sequences,total,1266,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W32,SARS-CoV-2,2-week count of sequences,total,1326,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W31,SARS-CoV-2,2-week count of sequences,total,1355,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W30,SARS-CoV-2,2-week count of sequences,total,1348,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W29,SARS-CoV-2,2-week count of sequences,total,1379,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W28,SARS-CoV-2,2-week count of sequences,total,1338,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W27,SARS-CoV-2,2-week count of sequences,total,1312,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W26,SARS-CoV-2,2-week count of sequences,total,1311,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W25,SARS-CoV-2,2-week count of sequences,total,1129,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W24,SARS-CoV-2,2-week count of sequences,total,1233,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W23,SARS-CoV-2,2-week count of sequences,total,1421,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W22,SARS-CoV-2,2-week count of sequences,total,1301,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W21,SARS-CoV-2,2-week count of sequences,total,1264,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W20,SARS-CoV-2,2-week count of sequences,total,1298,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W19,SARS-CoV-2,2-week count of sequences,total,1259,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W18,SARS-CoV-2,2-week count of sequences,total,1315,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W17,SARS-CoV-2,2-week count of sequences,total,1293,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W16,SARS-CoV-2,2-week count of sequences,total,1278,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W15,SARS-CoV-2,2-week count of sequences,total,1337,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W14,SARS-CoV-2,2-week count of sequences,total,1311,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W13,SARS-CoV-2,2-week count of sequences,total,1338,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W12,SARS-CoV-2,2-week count of sequences,total,1313,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W11,SARS-CoV-2,2-week count of sequences,total,1362,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W10,SARS-CoV-2,2-week count of sequences,total,1315,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W09,SARS-CoV-2,2-week count of sequences,total,1319,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W08,SARS-CoV-2,2-week count of sequences,total,1497,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W07,SARS-CoV-2,2-week count of sequences,total,1531,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W06,SARS-CoV-2,2-week count of sequences,total,1635,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W05,SARS-CoV-2,2-week count of sequences,total,1786,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W04,SARS-CoV-2,2-week count of sequences,total,1834,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W03,SARS-CoV-2,2-week count of sequences,total,1475,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W02,SARS-CoV-2,2-week count of sequences,total,1164,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2022-W01,SARS-CoV-2,2-week count of sequences,total,1155,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W52,SARS-CoV-2,2-week count of sequences,total,1158,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W51,SARS-CoV-2,2-week count of sequences,total,1358,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W50,SARS-CoV-2,2-week count of sequences,total,1259,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W49,SARS-CoV-2,2-week count of sequences,total,1154,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W48,SARS-CoV-2,2-week count of sequences,total,1237,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W47,SARS-CoV-2,2-week count of sequences,total,1047,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W46,SARS-CoV-2,2-week count of sequences,total,816,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W45,SARS-CoV-2,2-week count of sequences,total,769,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W44,SARS-CoV-2,2-week count of sequences,total,788,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W43,SARS-CoV-2,2-week count of sequences,total,798,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W42,SARS-CoV-2,2-week count of sequences,total,818,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W41,SARS-CoV-2,2-week count of sequences,total,764,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W40,SARS-CoV-2,2-week count of sequences,total,712,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W39,SARS-CoV-2,2-week count of sequences,total,705,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W38,SARS-CoV-2,2-week count of sequences,total,665,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W37,SARS-CoV-2,2-week count of sequences,total,600,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W36,SARS-CoV-2,2-week count of sequences,total,577,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W35,SARS-CoV-2,2-week count of sequences,total,549,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W34,SARS-CoV-2,2-week count of sequences,total,499,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W33,SARS-CoV-2,2-week count of sequences,total,413,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W32,SARS-CoV-2,2-week count of sequences,total,388,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W31,SARS-CoV-2,2-week count of sequences,total,460,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W30,SARS-CoV-2,2-week count of sequences,total,522,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W29,SARS-CoV-2,2-week count of sequences,total,700,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W28,SARS-CoV-2,2-week count of sequences,total,924,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W27,SARS-CoV-2,2-week count of sequences,total,945,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W26,SARS-CoV-2,2-week count of sequences,total,525,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W25,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W24,SARS-CoV-2,2-week count of sequences,total,164,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W23,SARS-CoV-2,2-week count of sequences,total,241,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W22,SARS-CoV-2,2-week count of sequences,total,313,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W21,SARS-CoV-2,2-week count of sequences,total,394,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W20,SARS-CoV-2,2-week count of sequences,total,553,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W19,SARS-CoV-2,2-week count of sequences,total,745,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W18,SARS-CoV-2,2-week count of sequences,total,892,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W17,SARS-CoV-2,2-week count of sequences,total,1073,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W16,SARS-CoV-2,2-week count of sequences,total,1107,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W15,SARS-CoV-2,2-week count of sequences,total,1043,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W14,SARS-CoV-2,2-week count of sequences,total,1045,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W13,SARS-CoV-2,2-week count of sequences,total,953,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W12,SARS-CoV-2,2-week count of sequences,total,828,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W11,SARS-CoV-2,2-week count of sequences,total,700,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W10,SARS-CoV-2,2-week count of sequences,total,731,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W09,SARS-CoV-2,2-week count of sequences,total,761,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W08,SARS-CoV-2,2-week count of sequences,total,494,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W07,SARS-CoV-2,2-week count of sequences,total,356,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W06,SARS-CoV-2,2-week count of sequences,total,630,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W05,SARS-CoV-2,2-week count of sequences,total,595,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W04,SARS-CoV-2,2-week count of sequences,total,323,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W03,SARS-CoV-2,2-week count of sequences,total,257,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W02,SARS-CoV-2,2-week count of sequences,total,211,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Luxembourg,2021-W01,SARS-CoV-2,2-week count of sequences,total,263,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W53,SARS-CoV-2,2-week count of sequences,total,269,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W52,SARS-CoV-2,2-week count of sequences,total,413,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W51,SARS-CoV-2,2-week count of sequences,total,677,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W50,SARS-CoV-2,2-week count of sequences,total,926,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W49,SARS-CoV-2,2-week count of sequences,total,770,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W48,SARS-CoV-2,2-week count of sequences,total,447,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W47,SARS-CoV-2,2-week count of sequences,total,444,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W46,SARS-CoV-2,2-week count of sequences,total,438,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W45,SARS-CoV-2,2-week count of sequences,total,535,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W44,SARS-CoV-2,2-week count of sequences,total,685,≤1%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W43,SARS-CoV-2,2-week count of sequences,total,394,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W42,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W41,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W40,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W39,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W38,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W37,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W36,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W35,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W34,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W33,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W32,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W31,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W30,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W29,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W28,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W27,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W26,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Luxembourg,2020-W25,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Malta,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W47,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W30,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W29,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2024-W28,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2024-W27,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2024-W26,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2024-W25,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2024-W24,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2024-W23,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2024-W22,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W21,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W20,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W19,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W18,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W17,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W16,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W14,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W13,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W12,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W11,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W10,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2024-W09,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W08,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W07,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W06,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W05,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W04,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W03,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W02,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,TESSy,Malta,2024-W01,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W52,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W51,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W50,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W49,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W48,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2023-W47,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W46,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W45,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W44,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W43,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W42,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W41,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W40,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W39,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W38,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W37,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W36,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W35,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W34,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W33,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W32,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W31,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W30,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W29,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W28,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W27,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W26,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W25,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W24,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W23,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W22,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W21,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W20,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W19,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W18,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W17,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W16,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W15,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W14,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W13,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W12,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W11,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W10,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W09,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W08,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W07,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W06,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W05,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W04,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W03,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W02,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,TESSy,Malta,2023-W01,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W52,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W51,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W50,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W49,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W48,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W47,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W46,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W45,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W44,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W43,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W42,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W41,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W40,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2022-W29,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W28,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2022-W27,SARS-CoV-2,2-week count of sequences,total,731,≤1%
SARS-CoV-2 variant,TESSy,Malta,2022-W26,SARS-CoV-2,2-week count of sequences,total,1091,≤1%
SARS-CoV-2 variant,TESSy,Malta,2022-W25,SARS-CoV-2,2-week count of sequences,total,933,≤1%
SARS-CoV-2 variant,TESSy,Malta,2022-W24,SARS-CoV-2,2-week count of sequences,total,625,≤1%
SARS-CoV-2 variant,TESSy,Malta,2022-W23,SARS-CoV-2,2-week count of sequences,total,200,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2022-W22,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2022-W21,SARS-CoV-2,2-week count of sequences,total,97,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2022-W20,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2022-W19,SARS-CoV-2,2-week count of sequences,total,118,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2022-W18,SARS-CoV-2,2-week count of sequences,total,217,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2022-W17,SARS-CoV-2,2-week count of sequences,total,351,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Malta,2022-W16,SARS-CoV-2,2-week count of sequences,total,250,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Malta,2022-W15,SARS-CoV-2,2-week count of sequences,total,450,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Malta,2022-W14,SARS-CoV-2,2-week count of sequences,total,424,>1% to 2.5%
SARS-CoV-2 variant,TESSy,Malta,2022-W13,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W12,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2022-W11,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2022-W10,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W09,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W08,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W07,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W06,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2022-W05,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,TESSy,Malta,2022-W04,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2022-W03,SARS-CoV-2,2-week count of sequences,total,219,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2022-W02,SARS-CoV-2,2-week count of sequences,total,227,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2022-W01,SARS-CoV-2,2-week count of sequences,total,172,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W52,SARS-CoV-2,2-week count of sequences,total,213,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W51,SARS-CoV-2,2-week count of sequences,total,151,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W50,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W49,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W48,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W47,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W46,SARS-CoV-2,2-week count of sequences,total,89,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W45,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2021-W44,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W43,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W42,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W41,SARS-CoV-2,2-week count of sequences,total,82,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W40,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W39,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W38,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W37,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W36,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W35,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W34,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W33,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W32,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W31,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W30,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W29,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W28,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W27,SARS-CoV-2,2-week count of sequences,total,196,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W26,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W25,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W24,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W23,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W22,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W21,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W20,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W19,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W18,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W17,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W16,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W15,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W14,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W13,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W12,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W11,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W10,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W09,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W08,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W07,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W06,SARS-CoV-2,2-week count of sequences,total,122,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W05,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,TESSy,Malta,2021-W04,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2021-W03,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2021-W02,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,TESSy,Malta,2021-W01,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,TESSy,Malta,2020-W53,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,TESSy,Malta,2020-W52,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,TESSy,Malta,2020-W51,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,TESSy,Malta,2020-W50,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2020-W49,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W48,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2020-W47,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,TESSy,Malta,2020-W46,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W45,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W44,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W43,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W41,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W35,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W34,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W33,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,TESSy,Malta,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Netherlands,2025-W04,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Netherlands,2025-W03,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Netherlands,2025-W02,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Netherlands,2025-W01,SARS-CoV-2,2-week count of sequences,total,72,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W52,SARS-CoV-2,2-week count of sequences,total,133,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W51,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W50,SARS-CoV-2,2-week count of sequences,total,202,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W49,SARS-CoV-2,2-week count of sequences,total,231,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W48,SARS-CoV-2,2-week count of sequences,total,266,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W47,SARS-CoV-2,2-week count of sequences,total,300,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W46,SARS-CoV-2,2-week count of sequences,total,302,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W45,SARS-CoV-2,2-week count of sequences,total,350,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W44,SARS-CoV-2,2-week count of sequences,total,403,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W43,SARS-CoV-2,2-week count of sequences,total,431,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W42,SARS-CoV-2,2-week count of sequences,total,475,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W41,SARS-CoV-2,2-week count of sequences,total,500,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W40,SARS-CoV-2,2-week count of sequences,total,539,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W39,SARS-CoV-2,2-week count of sequences,total,632,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W38,SARS-CoV-2,2-week count of sequences,total,563,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W37,SARS-CoV-2,2-week count of sequences,total,449,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W36,SARS-CoV-2,2-week count of sequences,total,429,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W35,SARS-CoV-2,2-week count of sequences,total,400,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W34,SARS-CoV-2,2-week count of sequences,total,372,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W33,SARS-CoV-2,2-week count of sequences,total,345,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W32,SARS-CoV-2,2-week count of sequences,total,415,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W31,SARS-CoV-2,2-week count of sequences,total,603,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W30,SARS-CoV-2,2-week count of sequences,total,771,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W29,SARS-CoV-2,2-week count of sequences,total,738,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W28,SARS-CoV-2,2-week count of sequences,total,616,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W27,SARS-CoV-2,2-week count of sequences,total,577,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W26,SARS-CoV-2,2-week count of sequences,total,566,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W25,SARS-CoV-2,2-week count of sequences,total,415,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W24,SARS-CoV-2,2-week count of sequences,total,230,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W23,SARS-CoV-2,2-week count of sequences,total,164,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W22,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W21,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W20,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W19,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W18,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W17,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W16,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W15,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W14,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W13,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W12,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W11,SARS-CoV-2,2-week count of sequences,total,71,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W10,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W09,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W08,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W07,SARS-CoV-2,2-week count of sequences,total,137,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W06,SARS-CoV-2,2-week count of sequences,total,202,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W05,SARS-CoV-2,2-week count of sequences,total,224,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W04,SARS-CoV-2,2-week count of sequences,total,227,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W03,SARS-CoV-2,2-week count of sequences,total,325,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W02,SARS-CoV-2,2-week count of sequences,total,473,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2024-W01,SARS-CoV-2,2-week count of sequences,total,700,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W52,SARS-CoV-2,2-week count of sequences,total,915,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W51,SARS-CoV-2,2-week count of sequences,total,1210,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W50,SARS-CoV-2,2-week count of sequences,total,1430,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W49,SARS-CoV-2,2-week count of sequences,total,1268,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W48,SARS-CoV-2,2-week count of sequences,total,1109,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W47,SARS-CoV-2,2-week count of sequences,total,1018,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W46,SARS-CoV-2,2-week count of sequences,total,924,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W45,SARS-CoV-2,2-week count of sequences,total,941,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W44,SARS-CoV-2,2-week count of sequences,total,954,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W43,SARS-CoV-2,2-week count of sequences,total,795,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W42,SARS-CoV-2,2-week count of sequences,total,646,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W41,SARS-CoV-2,2-week count of sequences,total,645,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W40,SARS-CoV-2,2-week count of sequences,total,638,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W39,SARS-CoV-2,2-week count of sequences,total,565,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W38,SARS-CoV-2,2-week count of sequences,total,483,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W37,SARS-CoV-2,2-week count of sequences,total,492,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W36,SARS-CoV-2,2-week count of sequences,total,436,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W35,SARS-CoV-2,2-week count of sequences,total,319,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W34,SARS-CoV-2,2-week count of sequences,total,219,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W33,SARS-CoV-2,2-week count of sequences,total,186,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W32,SARS-CoV-2,2-week count of sequences,total,176,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W31,SARS-CoV-2,2-week count of sequences,total,111,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W30,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W29,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W28,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W27,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W26,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W25,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W24,SARS-CoV-2,2-week count of sequences,total,115,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W23,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W22,SARS-CoV-2,2-week count of sequences,total,153,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W21,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W20,SARS-CoV-2,2-week count of sequences,total,242,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W19,SARS-CoV-2,2-week count of sequences,total,335,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W18,SARS-CoV-2,2-week count of sequences,total,350,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W17,SARS-CoV-2,2-week count of sequences,total,372,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W16,SARS-CoV-2,2-week count of sequences,total,471,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W15,SARS-CoV-2,2-week count of sequences,total,561,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W14,SARS-CoV-2,2-week count of sequences,total,665,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W13,SARS-CoV-2,2-week count of sequences,total,787,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W12,SARS-CoV-2,2-week count of sequences,total,959,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W11,SARS-CoV-2,2-week count of sequences,total,1115,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W10,SARS-CoV-2,2-week count of sequences,total,1210,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W09,SARS-CoV-2,2-week count of sequences,total,1452,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W08,SARS-CoV-2,2-week count of sequences,total,1520,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W07,SARS-CoV-2,2-week count of sequences,total,1351,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W06,SARS-CoV-2,2-week count of sequences,total,1302,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W05,SARS-CoV-2,2-week count of sequences,total,1231,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W04,SARS-CoV-2,2-week count of sequences,total,1094,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W03,SARS-CoV-2,2-week count of sequences,total,1239,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W02,SARS-CoV-2,2-week count of sequences,total,1591,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2023-W01,SARS-CoV-2,2-week count of sequences,total,1779,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W52,SARS-CoV-2,2-week count of sequences,total,1720,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W51,SARS-CoV-2,2-week count of sequences,total,1839,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W50,SARS-CoV-2,2-week count of sequences,total,1931,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W49,SARS-CoV-2,2-week count of sequences,total,1799,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W48,SARS-CoV-2,2-week count of sequences,total,1706,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W47,SARS-CoV-2,2-week count of sequences,total,1721,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W46,SARS-CoV-2,2-week count of sequences,total,1924,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W45,SARS-CoV-2,2-week count of sequences,total,2111,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W44,SARS-CoV-2,2-week count of sequences,total,2213,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W43,SARS-CoV-2,2-week count of sequences,total,2285,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W42,SARS-CoV-2,2-week count of sequences,total,2431,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W41,SARS-CoV-2,2-week count of sequences,total,2470,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W40,SARS-CoV-2,2-week count of sequences,total,2345,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W39,SARS-CoV-2,2-week count of sequences,total,2187,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W38,SARS-CoV-2,2-week count of sequences,total,2001,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W37,SARS-CoV-2,2-week count of sequences,total,1893,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W36,SARS-CoV-2,2-week count of sequences,total,1920,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W35,SARS-CoV-2,2-week count of sequences,total,1922,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W34,SARS-CoV-2,2-week count of sequences,total,1912,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W33,SARS-CoV-2,2-week count of sequences,total,2029,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W32,SARS-CoV-2,2-week count of sequences,total,2240,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W31,SARS-CoV-2,2-week count of sequences,total,2338,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W30,SARS-CoV-2,2-week count of sequences,total,2243,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W29,SARS-CoV-2,2-week count of sequences,total,2329,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W28,SARS-CoV-2,2-week count of sequences,total,2364,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W27,SARS-CoV-2,2-week count of sequences,total,2360,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W26,SARS-CoV-2,2-week count of sequences,total,2410,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W25,SARS-CoV-2,2-week count of sequences,total,2230,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W24,SARS-CoV-2,2-week count of sequences,total,2103,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W23,SARS-CoV-2,2-week count of sequences,total,1853,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W22,SARS-CoV-2,2-week count of sequences,total,1603,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W21,SARS-CoV-2,2-week count of sequences,total,1708,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W20,SARS-CoV-2,2-week count of sequences,total,1863,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W19,SARS-CoV-2,2-week count of sequences,total,2009,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W18,SARS-CoV-2,2-week count of sequences,total,2130,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W17,SARS-CoV-2,2-week count of sequences,total,2151,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W16,SARS-CoV-2,2-week count of sequences,total,2411,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W15,SARS-CoV-2,2-week count of sequences,total,2837,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W14,SARS-CoV-2,2-week count of sequences,total,2909,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W13,SARS-CoV-2,2-week count of sequences,total,3082,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W12,SARS-CoV-2,2-week count of sequences,total,3248,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W11,SARS-CoV-2,2-week count of sequences,total,3353,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W10,SARS-CoV-2,2-week count of sequences,total,3491,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W09,SARS-CoV-2,2-week count of sequences,total,3320,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W08,SARS-CoV-2,2-week count of sequences,total,3355,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W07,SARS-CoV-2,2-week count of sequences,total,3522,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W06,SARS-CoV-2,2-week count of sequences,total,3817,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W05,SARS-CoV-2,2-week count of sequences,total,3682,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W04,SARS-CoV-2,2-week count of sequences,total,3823,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W03,SARS-CoV-2,2-week count of sequences,total,4280,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W02,SARS-CoV-2,2-week count of sequences,total,4241,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2022-W01,SARS-CoV-2,2-week count of sequences,total,3993,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W52,SARS-CoV-2,2-week count of sequences,total,3638,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W51,SARS-CoV-2,2-week count of sequences,total,4084,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W50,SARS-CoV-2,2-week count of sequences,total,4422,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W49,SARS-CoV-2,2-week count of sequences,total,4215,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W48,SARS-CoV-2,2-week count of sequences,total,4060,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W47,SARS-CoV-2,2-week count of sequences,total,3970,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W46,SARS-CoV-2,2-week count of sequences,total,3838,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W45,SARS-CoV-2,2-week count of sequences,total,3777,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W44,SARS-CoV-2,2-week count of sequences,total,3805,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W43,SARS-CoV-2,2-week count of sequences,total,3287,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W42,SARS-CoV-2,2-week count of sequences,total,3002,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W41,SARS-CoV-2,2-week count of sequences,total,2868,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W40,SARS-CoV-2,2-week count of sequences,total,2344,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W39,SARS-CoV-2,2-week count of sequences,total,2374,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W38,SARS-CoV-2,2-week count of sequences,total,2707,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W37,SARS-CoV-2,2-week count of sequences,total,2773,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W36,SARS-CoV-2,2-week count of sequences,total,2872,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W35,SARS-CoV-2,2-week count of sequences,total,3478,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W34,SARS-CoV-2,2-week count of sequences,total,3767,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W33,SARS-CoV-2,2-week count of sequences,total,3224,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W32,SARS-CoV-2,2-week count of sequences,total,2897,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W31,SARS-CoV-2,2-week count of sequences,total,3188,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W30,SARS-CoV-2,2-week count of sequences,total,3887,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W29,SARS-CoV-2,2-week count of sequences,total,4888,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W28,SARS-CoV-2,2-week count of sequences,total,5331,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W27,SARS-CoV-2,2-week count of sequences,total,3632,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W26,SARS-CoV-2,2-week count of sequences,total,1801,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W25,SARS-CoV-2,2-week count of sequences,total,1935,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W24,SARS-CoV-2,2-week count of sequences,total,2538,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W23,SARS-CoV-2,2-week count of sequences,total,2641,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W22,SARS-CoV-2,2-week count of sequences,total,2694,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W21,SARS-CoV-2,2-week count of sequences,total,2977,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W20,SARS-CoV-2,2-week count of sequences,total,3293,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W19,SARS-CoV-2,2-week count of sequences,total,3501,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W18,SARS-CoV-2,2-week count of sequences,total,3912,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W17,SARS-CoV-2,2-week count of sequences,total,3948,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W16,SARS-CoV-2,2-week count of sequences,total,3667,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W15,SARS-CoV-2,2-week count of sequences,total,3626,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W14,SARS-CoV-2,2-week count of sequences,total,3764,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W13,SARS-CoV-2,2-week count of sequences,total,3927,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W12,SARS-CoV-2,2-week count of sequences,total,3697,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W11,SARS-CoV-2,2-week count of sequences,total,4067,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W10,SARS-CoV-2,2-week count of sequences,total,4251,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W09,SARS-CoV-2,2-week count of sequences,total,3446,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W08,SARS-CoV-2,2-week count of sequences,total,2834,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W07,SARS-CoV-2,2-week count of sequences,total,2533,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W06,SARS-CoV-2,2-week count of sequences,total,2360,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W05,SARS-CoV-2,2-week count of sequences,total,2290,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W04,SARS-CoV-2,2-week count of sequences,total,2016,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W03,SARS-CoV-2,2-week count of sequences,total,1779,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W02,SARS-CoV-2,2-week count of sequences,total,1706,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2021-W01,SARS-CoV-2,2-week count of sequences,total,1411,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W53,SARS-CoV-2,2-week count of sequences,total,1154,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W52,SARS-CoV-2,2-week count of sequences,total,1019,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W51,SARS-CoV-2,2-week count of sequences,total,846,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W50,SARS-CoV-2,2-week count of sequences,total,776,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W49,SARS-CoV-2,2-week count of sequences,total,673,≤1%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W48,SARS-CoV-2,2-week count of sequences,total,505,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W47,SARS-CoV-2,2-week count of sequences,total,456,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W46,SARS-CoV-2,2-week count of sequences,total,448,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W45,SARS-CoV-2,2-week count of sequences,total,434,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W44,SARS-CoV-2,2-week count of sequences,total,435,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W43,SARS-CoV-2,2-week count of sequences,total,441,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W42,SARS-CoV-2,2-week count of sequences,total,381,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W41,SARS-CoV-2,2-week count of sequences,total,290,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W40,SARS-CoV-2,2-week count of sequences,total,254,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W39,SARS-CoV-2,2-week count of sequences,total,260,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W38,SARS-CoV-2,2-week count of sequences,total,206,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W37,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W36,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W35,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W34,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W33,SARS-CoV-2,2-week count of sequences,total,108,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W32,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W31,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W30,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W29,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W28,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W27,SARS-CoV-2,2-week count of sequences,total,76,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W26,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Netherlands,2020-W25,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Norway,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Norway,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Norway,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Norway,2025-W01,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W52,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W51,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W50,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W49,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W48,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W47,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W46,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2024-W45,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W44,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W43,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W42,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2024-W41,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2024-W40,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W39,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W38,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W37,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W36,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W35,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W34,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2024-W33,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2024-W32,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W31,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W30,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2024-W29,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W28,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W27,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W26,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W25,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W24,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W23,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W22,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W21,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W20,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W19,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W18,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W17,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W16,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W15,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W14,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W13,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W12,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W11,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W10,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W09,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W08,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W07,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Norway,2024-W06,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2024-W05,SARS-CoV-2,2-week count of sequences,total,67,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2024-W04,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2024-W03,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2024-W02,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2024-W01,SARS-CoV-2,2-week count of sequences,total,71,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W52,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W51,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W50,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W49,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W48,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W47,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W46,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W45,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W44,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W43,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W42,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W41,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W40,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W39,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W38,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W37,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W36,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W35,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W34,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W33,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W32,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W31,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W30,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Norway,2023-W29,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Norway,2023-W28,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Norway,2023-W27,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Norway,2023-W26,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Norway,2023-W25,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Norway,2023-W24,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Norway,2023-W23,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2023-W22,SARS-CoV-2,2-week count of sequences,total,64,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W21,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W20,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2023-W19,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W18,SARS-CoV-2,2-week count of sequences,total,199,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W17,SARS-CoV-2,2-week count of sequences,total,180,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W16,SARS-CoV-2,2-week count of sequences,total,192,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W15,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W14,SARS-CoV-2,2-week count of sequences,total,122,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W13,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W12,SARS-CoV-2,2-week count of sequences,total,251,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2023-W11,SARS-CoV-2,2-week count of sequences,total,295,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2023-W10,SARS-CoV-2,2-week count of sequences,total,267,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2023-W09,SARS-CoV-2,2-week count of sequences,total,236,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W08,SARS-CoV-2,2-week count of sequences,total,204,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W07,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W06,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W05,SARS-CoV-2,2-week count of sequences,total,197,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W04,SARS-CoV-2,2-week count of sequences,total,204,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2023-W03,SARS-CoV-2,2-week count of sequences,total,274,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2023-W02,SARS-CoV-2,2-week count of sequences,total,463,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2023-W01,SARS-CoV-2,2-week count of sequences,total,570,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W52,SARS-CoV-2,2-week count of sequences,total,512,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W51,SARS-CoV-2,2-week count of sequences,total,428,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W50,SARS-CoV-2,2-week count of sequences,total,496,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W49,SARS-CoV-2,2-week count of sequences,total,569,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W48,SARS-CoV-2,2-week count of sequences,total,476,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W47,SARS-CoV-2,2-week count of sequences,total,416,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W46,SARS-CoV-2,2-week count of sequences,total,490,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W45,SARS-CoV-2,2-week count of sequences,total,550,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W44,SARS-CoV-2,2-week count of sequences,total,452,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W43,SARS-CoV-2,2-week count of sequences,total,332,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W42,SARS-CoV-2,2-week count of sequences,total,314,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W41,SARS-CoV-2,2-week count of sequences,total,356,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W40,SARS-CoV-2,2-week count of sequences,total,382,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W39,SARS-CoV-2,2-week count of sequences,total,352,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W38,SARS-CoV-2,2-week count of sequences,total,369,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W37,SARS-CoV-2,2-week count of sequences,total,399,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W36,SARS-CoV-2,2-week count of sequences,total,377,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W35,SARS-CoV-2,2-week count of sequences,total,398,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W34,SARS-CoV-2,2-week count of sequences,total,534,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W33,SARS-CoV-2,2-week count of sequences,total,660,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W32,SARS-CoV-2,2-week count of sequences,total,679,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W31,SARS-CoV-2,2-week count of sequences,total,715,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W30,SARS-CoV-2,2-week count of sequences,total,766,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W29,SARS-CoV-2,2-week count of sequences,total,663,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W28,SARS-CoV-2,2-week count of sequences,total,480,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W27,SARS-CoV-2,2-week count of sequences,total,580,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2022-W26,SARS-CoV-2,2-week count of sequences,total,1062,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W25,SARS-CoV-2,2-week count of sequences,total,1258,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W24,SARS-CoV-2,2-week count of sequences,total,867,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W23,SARS-CoV-2,2-week count of sequences,total,724,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W22,SARS-CoV-2,2-week count of sequences,total,701,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W21,SARS-CoV-2,2-week count of sequences,total,627,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W20,SARS-CoV-2,2-week count of sequences,total,750,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W19,SARS-CoV-2,2-week count of sequences,total,901,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W18,SARS-CoV-2,2-week count of sequences,total,956,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W17,SARS-CoV-2,2-week count of sequences,total,1165,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W16,SARS-CoV-2,2-week count of sequences,total,1386,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W15,SARS-CoV-2,2-week count of sequences,total,1426,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W14,SARS-CoV-2,2-week count of sequences,total,1907,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W13,SARS-CoV-2,2-week count of sequences,total,2281,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W12,SARS-CoV-2,2-week count of sequences,total,2403,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W11,SARS-CoV-2,2-week count of sequences,total,2848,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W10,SARS-CoV-2,2-week count of sequences,total,3165,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W09,SARS-CoV-2,2-week count of sequences,total,3054,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W08,SARS-CoV-2,2-week count of sequences,total,3005,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W07,SARS-CoV-2,2-week count of sequences,total,2758,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W06,SARS-CoV-2,2-week count of sequences,total,2608,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W05,SARS-CoV-2,2-week count of sequences,total,2535,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W04,SARS-CoV-2,2-week count of sequences,total,2505,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W03,SARS-CoV-2,2-week count of sequences,total,2878,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W02,SARS-CoV-2,2-week count of sequences,total,2862,≤1%
SARS-CoV-2 variant,GISAID,Norway,2022-W01,SARS-CoV-2,2-week count of sequences,total,2735,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W52,SARS-CoV-2,2-week count of sequences,total,2329,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W51,SARS-CoV-2,2-week count of sequences,total,2205,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W50,SARS-CoV-2,2-week count of sequences,total,2675,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W49,SARS-CoV-2,2-week count of sequences,total,2607,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W48,SARS-CoV-2,2-week count of sequences,total,2254,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W47,SARS-CoV-2,2-week count of sequences,total,2343,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W46,SARS-CoV-2,2-week count of sequences,total,2346,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W45,SARS-CoV-2,2-week count of sequences,total,2188,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W44,SARS-CoV-2,2-week count of sequences,total,2397,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W43,SARS-CoV-2,2-week count of sequences,total,2262,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W42,SARS-CoV-2,2-week count of sequences,total,1818,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W41,SARS-CoV-2,2-week count of sequences,total,1672,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W40,SARS-CoV-2,2-week count of sequences,total,1805,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W39,SARS-CoV-2,2-week count of sequences,total,1879,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W38,SARS-CoV-2,2-week count of sequences,total,2035,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W37,SARS-CoV-2,2-week count of sequences,total,2318,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W36,SARS-CoV-2,2-week count of sequences,total,2317,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W35,SARS-CoV-2,2-week count of sequences,total,2023,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W34,SARS-CoV-2,2-week count of sequences,total,1889,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W33,SARS-CoV-2,2-week count of sequences,total,1789,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W32,SARS-CoV-2,2-week count of sequences,total,1532,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W31,SARS-CoV-2,2-week count of sequences,total,1334,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W30,SARS-CoV-2,2-week count of sequences,total,1078,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W29,SARS-CoV-2,2-week count of sequences,total,911,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W28,SARS-CoV-2,2-week count of sequences,total,923,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W27,SARS-CoV-2,2-week count of sequences,total,911,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W26,SARS-CoV-2,2-week count of sequences,total,835,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W25,SARS-CoV-2,2-week count of sequences,total,844,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W24,SARS-CoV-2,2-week count of sequences,total,950,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W23,SARS-CoV-2,2-week count of sequences,total,1144,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W22,SARS-CoV-2,2-week count of sequences,total,1243,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W21,SARS-CoV-2,2-week count of sequences,total,1435,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W20,SARS-CoV-2,2-week count of sequences,total,1732,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W19,SARS-CoV-2,2-week count of sequences,total,1865,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W18,SARS-CoV-2,2-week count of sequences,total,1797,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W17,SARS-CoV-2,2-week count of sequences,total,1730,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W16,SARS-CoV-2,2-week count of sequences,total,1820,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W15,SARS-CoV-2,2-week count of sequences,total,1970,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W14,SARS-CoV-2,2-week count of sequences,total,1667,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W13,SARS-CoV-2,2-week count of sequences,total,1501,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W12,SARS-CoV-2,2-week count of sequences,total,1873,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W11,SARS-CoV-2,2-week count of sequences,total,1829,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W10,SARS-CoV-2,2-week count of sequences,total,1725,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W09,SARS-CoV-2,2-week count of sequences,total,1609,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W08,SARS-CoV-2,2-week count of sequences,total,1527,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W07,SARS-CoV-2,2-week count of sequences,total,1479,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W06,SARS-CoV-2,2-week count of sequences,total,1333,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W05,SARS-CoV-2,2-week count of sequences,total,1418,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W04,SARS-CoV-2,2-week count of sequences,total,1241,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W03,SARS-CoV-2,2-week count of sequences,total,762,≤1%
SARS-CoV-2 variant,GISAID,Norway,2021-W02,SARS-CoV-2,2-week count of sequences,total,549,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2021-W01,SARS-CoV-2,2-week count of sequences,total,432,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2020-W53,SARS-CoV-2,2-week count of sequences,total,294,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2020-W52,SARS-CoV-2,2-week count of sequences,total,291,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2020-W51,SARS-CoV-2,2-week count of sequences,total,279,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2020-W50,SARS-CoV-2,2-week count of sequences,total,231,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W49,SARS-CoV-2,2-week count of sequences,total,188,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W48,SARS-CoV-2,2-week count of sequences,total,164,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W47,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W46,SARS-CoV-2,2-week count of sequences,total,188,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W45,SARS-CoV-2,2-week count of sequences,total,265,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2020-W44,SARS-CoV-2,2-week count of sequences,total,287,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Norway,2020-W43,SARS-CoV-2,2-week count of sequences,total,206,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W42,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W41,SARS-CoV-2,2-week count of sequences,total,157,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W40,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W39,SARS-CoV-2,2-week count of sequences,total,117,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2020-W38,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2020-W37,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2020-W36,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2020-W35,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2020-W34,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2020-W33,SARS-CoV-2,2-week count of sequences,total,164,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W32,SARS-CoV-2,2-week count of sequences,total,186,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Norway,2020-W31,SARS-CoV-2,2-week count of sequences,total,85,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2020-W30,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2020-W29,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Norway,2020-W28,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2020-W27,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Norway,2020-W26,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Norway,2020-W25,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Poland,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2025-W03,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Poland,2025-W02,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Poland,2025-W01,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W52,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W51,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W50,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W49,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W48,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W47,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W46,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2024-W45,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W44,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W43,SARS-CoV-2,2-week count of sequences,total,82,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W42,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W41,SARS-CoV-2,2-week count of sequences,total,160,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2024-W40,SARS-CoV-2,2-week count of sequences,total,171,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2024-W39,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2024-W38,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2024-W37,SARS-CoV-2,2-week count of sequences,total,195,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2024-W36,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2024-W35,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W34,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W33,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W32,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2024-W31,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2024-W30,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W29,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W28,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W27,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W26,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W25,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W24,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W23,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W22,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W21,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W20,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W19,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2024-W17,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W16,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W15,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W14,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W13,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W12,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W11,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Poland,2024-W10,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2024-W09,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W08,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2024-W07,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2024-W06,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2024-W05,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W04,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W03,SARS-CoV-2,2-week count of sequences,total,94,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2024-W02,SARS-CoV-2,2-week count of sequences,total,229,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2024-W01,SARS-CoV-2,2-week count of sequences,total,206,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W52,SARS-CoV-2,2-week count of sequences,total,184,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W51,SARS-CoV-2,2-week count of sequences,total,387,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W50,SARS-CoV-2,2-week count of sequences,total,507,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W49,SARS-CoV-2,2-week count of sequences,total,523,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W48,SARS-CoV-2,2-week count of sequences,total,481,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W47,SARS-CoV-2,2-week count of sequences,total,353,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W46,SARS-CoV-2,2-week count of sequences,total,324,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W45,SARS-CoV-2,2-week count of sequences,total,287,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W44,SARS-CoV-2,2-week count of sequences,total,238,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W43,SARS-CoV-2,2-week count of sequences,total,225,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W42,SARS-CoV-2,2-week count of sequences,total,124,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W41,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2023-W40,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2023-W39,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2023-W38,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2023-W37,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2023-W36,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W35,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W34,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W33,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W32,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W31,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2023-W29,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W28,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W27,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W26,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W25,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W24,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W23,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W22,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Poland,2023-W21,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2023-W20,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2023-W19,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2023-W18,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2023-W17,SARS-CoV-2,2-week count of sequences,total,114,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2023-W16,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W15,SARS-CoV-2,2-week count of sequences,total,251,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W14,SARS-CoV-2,2-week count of sequences,total,386,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W13,SARS-CoV-2,2-week count of sequences,total,528,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W12,SARS-CoV-2,2-week count of sequences,total,755,≤1%
SARS-CoV-2 variant,GISAID,Poland,2023-W11,SARS-CoV-2,2-week count of sequences,total,955,≤1%
SARS-CoV-2 variant,GISAID,Poland,2023-W10,SARS-CoV-2,2-week count of sequences,total,881,≤1%
SARS-CoV-2 variant,GISAID,Poland,2023-W09,SARS-CoV-2,2-week count of sequences,total,711,≤1%
SARS-CoV-2 variant,GISAID,Poland,2023-W08,SARS-CoV-2,2-week count of sequences,total,496,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W07,SARS-CoV-2,2-week count of sequences,total,334,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W06,SARS-CoV-2,2-week count of sequences,total,282,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W05,SARS-CoV-2,2-week count of sequences,total,260,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2023-W04,SARS-CoV-2,2-week count of sequences,total,213,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W03,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W02,SARS-CoV-2,2-week count of sequences,total,167,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2023-W01,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W52,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W51,SARS-CoV-2,2-week count of sequences,total,215,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W50,SARS-CoV-2,2-week count of sequences,total,214,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W49,SARS-CoV-2,2-week count of sequences,total,165,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W48,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W47,SARS-CoV-2,2-week count of sequences,total,112,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2022-W46,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W45,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W44,SARS-CoV-2,2-week count of sequences,total,258,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W43,SARS-CoV-2,2-week count of sequences,total,314,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W42,SARS-CoV-2,2-week count of sequences,total,303,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W41,SARS-CoV-2,2-week count of sequences,total,515,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W40,SARS-CoV-2,2-week count of sequences,total,665,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W39,SARS-CoV-2,2-week count of sequences,total,598,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W38,SARS-CoV-2,2-week count of sequences,total,580,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W37,SARS-CoV-2,2-week count of sequences,total,571,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W36,SARS-CoV-2,2-week count of sequences,total,511,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W35,SARS-CoV-2,2-week count of sequences,total,615,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W34,SARS-CoV-2,2-week count of sequences,total,736,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W33,SARS-CoV-2,2-week count of sequences,total,820,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W32,SARS-CoV-2,2-week count of sequences,total,907,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W31,SARS-CoV-2,2-week count of sequences,total,784,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W30,SARS-CoV-2,2-week count of sequences,total,610,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W29,SARS-CoV-2,2-week count of sequences,total,460,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W28,SARS-CoV-2,2-week count of sequences,total,307,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W27,SARS-CoV-2,2-week count of sequences,total,221,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W26,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W25,SARS-CoV-2,2-week count of sequences,total,135,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W24,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W23,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W22,SARS-CoV-2,2-week count of sequences,total,118,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W21,SARS-CoV-2,2-week count of sequences,total,169,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W20,SARS-CoV-2,2-week count of sequences,total,189,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W19,SARS-CoV-2,2-week count of sequences,total,192,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2022-W18,SARS-CoV-2,2-week count of sequences,total,243,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W17,SARS-CoV-2,2-week count of sequences,total,242,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W16,SARS-CoV-2,2-week count of sequences,total,337,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W15,SARS-CoV-2,2-week count of sequences,total,586,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2022-W14,SARS-CoV-2,2-week count of sequences,total,958,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W13,SARS-CoV-2,2-week count of sequences,total,1167,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W12,SARS-CoV-2,2-week count of sequences,total,1399,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W11,SARS-CoV-2,2-week count of sequences,total,1846,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W10,SARS-CoV-2,2-week count of sequences,total,2177,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W09,SARS-CoV-2,2-week count of sequences,total,2607,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W08,SARS-CoV-2,2-week count of sequences,total,3763,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W07,SARS-CoV-2,2-week count of sequences,total,6147,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W06,SARS-CoV-2,2-week count of sequences,total,9416,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W05,SARS-CoV-2,2-week count of sequences,total,11174,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W04,SARS-CoV-2,2-week count of sequences,total,11000,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W03,SARS-CoV-2,2-week count of sequences,total,10186,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W02,SARS-CoV-2,2-week count of sequences,total,8897,≤1%
SARS-CoV-2 variant,GISAID,Poland,2022-W01,SARS-CoV-2,2-week count of sequences,total,6662,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W52,SARS-CoV-2,2-week count of sequences,total,4315,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W51,SARS-CoV-2,2-week count of sequences,total,3501,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W50,SARS-CoV-2,2-week count of sequences,total,3628,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W49,SARS-CoV-2,2-week count of sequences,total,3618,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W48,SARS-CoV-2,2-week count of sequences,total,2930,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W47,SARS-CoV-2,2-week count of sequences,total,2306,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W46,SARS-CoV-2,2-week count of sequences,total,3005,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W45,SARS-CoV-2,2-week count of sequences,total,4163,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W44,SARS-CoV-2,2-week count of sequences,total,3641,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W43,SARS-CoV-2,2-week count of sequences,total,2792,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W42,SARS-CoV-2,2-week count of sequences,total,2472,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W41,SARS-CoV-2,2-week count of sequences,total,2289,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W40,SARS-CoV-2,2-week count of sequences,total,2089,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W39,SARS-CoV-2,2-week count of sequences,total,1735,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W38,SARS-CoV-2,2-week count of sequences,total,1666,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W37,SARS-CoV-2,2-week count of sequences,total,1432,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W36,SARS-CoV-2,2-week count of sequences,total,1156,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W35,SARS-CoV-2,2-week count of sequences,total,937,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W34,SARS-CoV-2,2-week count of sequences,total,1000,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W33,SARS-CoV-2,2-week count of sequences,total,765,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W32,SARS-CoV-2,2-week count of sequences,total,334,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W31,SARS-CoV-2,2-week count of sequences,total,355,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W30,SARS-CoV-2,2-week count of sequences,total,323,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W29,SARS-CoV-2,2-week count of sequences,total,252,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W28,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2021-W27,SARS-CoV-2,2-week count of sequences,total,187,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2021-W26,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2021-W25,SARS-CoV-2,2-week count of sequences,total,150,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2021-W24,SARS-CoV-2,2-week count of sequences,total,391,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W23,SARS-CoV-2,2-week count of sequences,total,630,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W22,SARS-CoV-2,2-week count of sequences,total,1006,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W21,SARS-CoV-2,2-week count of sequences,total,1648,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W20,SARS-CoV-2,2-week count of sequences,total,2255,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W19,SARS-CoV-2,2-week count of sequences,total,2624,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W18,SARS-CoV-2,2-week count of sequences,total,2650,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W17,SARS-CoV-2,2-week count of sequences,total,2691,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W16,SARS-CoV-2,2-week count of sequences,total,3121,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W15,SARS-CoV-2,2-week count of sequences,total,2817,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W14,SARS-CoV-2,2-week count of sequences,total,2133,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W13,SARS-CoV-2,2-week count of sequences,total,1852,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W12,SARS-CoV-2,2-week count of sequences,total,1740,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W11,SARS-CoV-2,2-week count of sequences,total,2194,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W10,SARS-CoV-2,2-week count of sequences,total,2054,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W09,SARS-CoV-2,2-week count of sequences,total,1531,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W08,SARS-CoV-2,2-week count of sequences,total,1226,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W07,SARS-CoV-2,2-week count of sequences,total,764,≤1%
SARS-CoV-2 variant,GISAID,Poland,2021-W06,SARS-CoV-2,2-week count of sequences,total,467,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W05,SARS-CoV-2,2-week count of sequences,total,396,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W04,SARS-CoV-2,2-week count of sequences,total,348,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W03,SARS-CoV-2,2-week count of sequences,total,272,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Poland,2021-W02,SARS-CoV-2,2-week count of sequences,total,199,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2021-W01,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2020-W53,SARS-CoV-2,2-week count of sequences,total,135,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2020-W52,SARS-CoV-2,2-week count of sequences,total,156,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Poland,2020-W51,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Poland,2020-W50,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2020-W49,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Poland,2020-W48,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W47,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W46,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W45,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W44,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W43,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W42,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W41,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W40,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W39,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W38,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W37,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W36,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W35,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W34,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W33,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W32,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2020-W31,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2020-W29,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2020-W28,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2020-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Poland,2020-W26,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Poland,2020-W25,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Portugal,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Portugal,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Portugal,2025-W02,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Portugal,2025-W01,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W52,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W51,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W50,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W49,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W48,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W47,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W46,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W45,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W44,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W43,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W42,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W41,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W40,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W39,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W38,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W37,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W36,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W35,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W34,SARS-CoV-2,2-week count of sequences,total,100,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W33,SARS-CoV-2,2-week count of sequences,total,90,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W32,SARS-CoV-2,2-week count of sequences,total,115,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W31,SARS-CoV-2,2-week count of sequences,total,117,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W30,SARS-CoV-2,2-week count of sequences,total,112,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W29,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W28,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W27,SARS-CoV-2,2-week count of sequences,total,128,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W26,SARS-CoV-2,2-week count of sequences,total,166,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W25,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W24,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W23,SARS-CoV-2,2-week count of sequences,total,125,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W22,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W21,SARS-CoV-2,2-week count of sequences,total,164,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2024-W20,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W19,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W18,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W17,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W16,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W15,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W14,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W13,SARS-CoV-2,2-week count of sequences,total,14,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W12,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W11,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W10,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W09,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W08,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W07,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W06,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W05,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W04,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2024-W03,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W02,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Portugal,2024-W01,SARS-CoV-2,2-week count of sequences,total,143,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W52,SARS-CoV-2,2-week count of sequences,total,182,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W51,SARS-CoV-2,2-week count of sequences,total,64,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W50,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W49,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W48,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W47,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W46,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W45,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W44,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W43,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W42,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W41,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W40,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W39,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W38,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W37,SARS-CoV-2,2-week count of sequences,total,193,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W36,SARS-CoV-2,2-week count of sequences,total,261,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W35,SARS-CoV-2,2-week count of sequences,total,125,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W34,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W33,SARS-CoV-2,2-week count of sequences,total,312,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W32,SARS-CoV-2,2-week count of sequences,total,392,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W31,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W30,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W29,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W28,SARS-CoV-2,2-week count of sequences,total,128,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W27,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W26,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Portugal,2023-W25,SARS-CoV-2,2-week count of sequences,total,113,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2023-W24,SARS-CoV-2,2-week count of sequences,total,185,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W23,SARS-CoV-2,2-week count of sequences,total,147,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W22,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W21,SARS-CoV-2,2-week count of sequences,total,238,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W20,SARS-CoV-2,2-week count of sequences,total,218,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W19,SARS-CoV-2,2-week count of sequences,total,222,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W18,SARS-CoV-2,2-week count of sequences,total,239,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W17,SARS-CoV-2,2-week count of sequences,total,251,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W16,SARS-CoV-2,2-week count of sequences,total,245,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W15,SARS-CoV-2,2-week count of sequences,total,238,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W14,SARS-CoV-2,2-week count of sequences,total,242,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W13,SARS-CoV-2,2-week count of sequences,total,258,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W12,SARS-CoV-2,2-week count of sequences,total,249,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W11,SARS-CoV-2,2-week count of sequences,total,251,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W10,SARS-CoV-2,2-week count of sequences,total,250,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W09,SARS-CoV-2,2-week count of sequences,total,233,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W08,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W07,SARS-CoV-2,2-week count of sequences,total,206,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W06,SARS-CoV-2,2-week count of sequences,total,199,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W05,SARS-CoV-2,2-week count of sequences,total,198,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W04,SARS-CoV-2,2-week count of sequences,total,198,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W03,SARS-CoV-2,2-week count of sequences,total,278,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W02,SARS-CoV-2,2-week count of sequences,total,309,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2023-W01,SARS-CoV-2,2-week count of sequences,total,278,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W52,SARS-CoV-2,2-week count of sequences,total,264,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W51,SARS-CoV-2,2-week count of sequences,total,270,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W50,SARS-CoV-2,2-week count of sequences,total,336,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W49,SARS-CoV-2,2-week count of sequences,total,371,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W48,SARS-CoV-2,2-week count of sequences,total,414,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W47,SARS-CoV-2,2-week count of sequences,total,414,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W46,SARS-CoV-2,2-week count of sequences,total,291,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W45,SARS-CoV-2,2-week count of sequences,total,263,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W44,SARS-CoV-2,2-week count of sequences,total,245,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W43,SARS-CoV-2,2-week count of sequences,total,251,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W42,SARS-CoV-2,2-week count of sequences,total,244,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W41,SARS-CoV-2,2-week count of sequences,total,353,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W40,SARS-CoV-2,2-week count of sequences,total,538,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W39,SARS-CoV-2,2-week count of sequences,total,549,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W38,SARS-CoV-2,2-week count of sequences,total,561,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W37,SARS-CoV-2,2-week count of sequences,total,564,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W36,SARS-CoV-2,2-week count of sequences,total,540,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W35,SARS-CoV-2,2-week count of sequences,total,533,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W34,SARS-CoV-2,2-week count of sequences,total,506,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W33,SARS-CoV-2,2-week count of sequences,total,493,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W32,SARS-CoV-2,2-week count of sequences,total,482,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W31,SARS-CoV-2,2-week count of sequences,total,507,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W30,SARS-CoV-2,2-week count of sequences,total,545,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W29,SARS-CoV-2,2-week count of sequences,total,606,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2022-W28,SARS-CoV-2,2-week count of sequences,total,749,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W27,SARS-CoV-2,2-week count of sequences,total,1097,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W26,SARS-CoV-2,2-week count of sequences,total,1225,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W25,SARS-CoV-2,2-week count of sequences,total,905,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W24,SARS-CoV-2,2-week count of sequences,total,746,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W23,SARS-CoV-2,2-week count of sequences,total,765,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W22,SARS-CoV-2,2-week count of sequences,total,968,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W21,SARS-CoV-2,2-week count of sequences,total,1104,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W20,SARS-CoV-2,2-week count of sequences,total,1132,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W19,SARS-CoV-2,2-week count of sequences,total,1168,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W18,SARS-CoV-2,2-week count of sequences,total,1111,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W17,SARS-CoV-2,2-week count of sequences,total,1077,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W16,SARS-CoV-2,2-week count of sequences,total,1086,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W15,SARS-CoV-2,2-week count of sequences,total,1096,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W14,SARS-CoV-2,2-week count of sequences,total,1146,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W13,SARS-CoV-2,2-week count of sequences,total,1148,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W12,SARS-CoV-2,2-week count of sequences,total,1124,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W11,SARS-CoV-2,2-week count of sequences,total,1062,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W10,SARS-CoV-2,2-week count of sequences,total,979,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W09,SARS-CoV-2,2-week count of sequences,total,938,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W08,SARS-CoV-2,2-week count of sequences,total,925,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W07,SARS-CoV-2,2-week count of sequences,total,1029,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W06,SARS-CoV-2,2-week count of sequences,total,1055,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W05,SARS-CoV-2,2-week count of sequences,total,1033,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W04,SARS-CoV-2,2-week count of sequences,total,1044,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W03,SARS-CoV-2,2-week count of sequences,total,1053,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W02,SARS-CoV-2,2-week count of sequences,total,1102,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2022-W01,SARS-CoV-2,2-week count of sequences,total,1029,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W52,SARS-CoV-2,2-week count of sequences,total,868,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W51,SARS-CoV-2,2-week count of sequences,total,924,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W50,SARS-CoV-2,2-week count of sequences,total,916,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W49,SARS-CoV-2,2-week count of sequences,total,927,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W48,SARS-CoV-2,2-week count of sequences,total,1207,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W47,SARS-CoV-2,2-week count of sequences,total,1291,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W46,SARS-CoV-2,2-week count of sequences,total,1110,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W45,SARS-CoV-2,2-week count of sequences,total,961,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W44,SARS-CoV-2,2-week count of sequences,total,1033,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W43,SARS-CoV-2,2-week count of sequences,total,1080,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W42,SARS-CoV-2,2-week count of sequences,total,924,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W41,SARS-CoV-2,2-week count of sequences,total,893,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W40,SARS-CoV-2,2-week count of sequences,total,972,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W39,SARS-CoV-2,2-week count of sequences,total,1042,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W38,SARS-CoV-2,2-week count of sequences,total,1101,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W37,SARS-CoV-2,2-week count of sequences,total,1100,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W36,SARS-CoV-2,2-week count of sequences,total,1123,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W35,SARS-CoV-2,2-week count of sequences,total,1114,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W34,SARS-CoV-2,2-week count of sequences,total,1043,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W33,SARS-CoV-2,2-week count of sequences,total,1025,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W32,SARS-CoV-2,2-week count of sequences,total,1022,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W31,SARS-CoV-2,2-week count of sequences,total,975,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W30,SARS-CoV-2,2-week count of sequences,total,972,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W29,SARS-CoV-2,2-week count of sequences,total,1268,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W28,SARS-CoV-2,2-week count of sequences,total,1365,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W27,SARS-CoV-2,2-week count of sequences,total,1152,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W26,SARS-CoV-2,2-week count of sequences,total,1318,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W25,SARS-CoV-2,2-week count of sequences,total,1172,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W24,SARS-CoV-2,2-week count of sequences,total,1109,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W23,SARS-CoV-2,2-week count of sequences,total,1253,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W22,SARS-CoV-2,2-week count of sequences,total,614,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W21,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2021-W20,SARS-CoV-2,2-week count of sequences,total,361,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2021-W19,SARS-CoV-2,2-week count of sequences,total,1066,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W18,SARS-CoV-2,2-week count of sequences,total,811,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W17,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2021-W16,SARS-CoV-2,2-week count of sequences,total,482,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2021-W15,SARS-CoV-2,2-week count of sequences,total,1588,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W14,SARS-CoV-2,2-week count of sequences,total,1213,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W13,SARS-CoV-2,2-week count of sequences,total,72,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2021-W12,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2021-W11,SARS-CoV-2,2-week count of sequences,total,444,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2021-W10,SARS-CoV-2,2-week count of sequences,total,1095,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W09,SARS-CoV-2,2-week count of sequences,total,740,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W08,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2021-W07,SARS-CoV-2,2-week count of sequences,total,910,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W06,SARS-CoV-2,2-week count of sequences,total,938,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W05,SARS-CoV-2,2-week count of sequences,total,209,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2021-W04,SARS-CoV-2,2-week count of sequences,total,209,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Portugal,2021-W03,SARS-CoV-2,2-week count of sequences,total,768,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W02,SARS-CoV-2,2-week count of sequences,total,929,≤1%
SARS-CoV-2 variant,GISAID,Portugal,2021-W01,SARS-CoV-2,2-week count of sequences,total,330,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2020-W53,SARS-CoV-2,2-week count of sequences,total,322,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2020-W52,SARS-CoV-2,2-week count of sequences,total,267,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2020-W51,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W50,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W49,SARS-CoV-2,2-week count of sequences,total,34,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W48,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2020-W47,SARS-CoV-2,2-week count of sequences,total,377,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2020-W46,SARS-CoV-2,2-week count of sequences,total,383,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Portugal,2020-W45,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W44,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W43,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W42,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Portugal,2020-W41,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W40,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W39,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W38,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W37,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W36,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2020-W35,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2020-W34,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W33,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W32,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W31,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Portugal,2020-W29,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W28,SARS-CoV-2,2-week count of sequences,total,63,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2020-W27,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Portugal,2020-W26,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Portugal,2020-W25,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Romania,2025-W04,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Romania,2025-W03,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Romania,2025-W02,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2025-W01,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Romania,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Romania,2024-W50,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Romania,2024-W49,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W48,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W47,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W46,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W45,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W44,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W43,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W42,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W41,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W40,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W39,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Romania,2024-W38,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Romania,2024-W37,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Romania,2024-W36,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W35,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W34,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W33,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W32,SARS-CoV-2,2-week count of sequences,total,31,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W31,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W30,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W29,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W28,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W27,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W26,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W25,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W24,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W23,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W22,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W21,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W20,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W19,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Romania,2024-W17,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W16,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W15,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W14,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W13,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W12,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W11,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W10,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W09,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W08,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W07,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W06,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W05,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W04,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W03,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W02,SARS-CoV-2,2-week count of sequences,total,26,>15%
SARS-CoV-2 variant,GISAID,Romania,2024-W01,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W52,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W51,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W50,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W49,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W48,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W47,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W46,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W45,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W44,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W43,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W42,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W41,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W40,SARS-CoV-2,2-week count of sequences,total,192,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W39,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W38,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W37,SARS-CoV-2,2-week count of sequences,total,105,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W36,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W35,SARS-CoV-2,2-week count of sequences,total,105,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W34,SARS-CoV-2,2-week count of sequences,total,71,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W33,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W32,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W31,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W30,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W29,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W28,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W27,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W26,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W25,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W24,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W23,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Romania,2023-W22,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Romania,2023-W21,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W20,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W19,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2023-W18,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W17,SARS-CoV-2,2-week count of sequences,total,150,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W16,SARS-CoV-2,2-week count of sequences,total,145,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W15,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W14,SARS-CoV-2,2-week count of sequences,total,160,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W13,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W12,SARS-CoV-2,2-week count of sequences,total,149,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W11,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W10,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W09,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W08,SARS-CoV-2,2-week count of sequences,total,169,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W07,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W06,SARS-CoV-2,2-week count of sequences,total,139,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W05,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W04,SARS-CoV-2,2-week count of sequences,total,134,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W03,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W02,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2023-W01,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W52,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W51,SARS-CoV-2,2-week count of sequences,total,115,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W50,SARS-CoV-2,2-week count of sequences,total,131,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W49,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W48,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W47,SARS-CoV-2,2-week count of sequences,total,117,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W46,SARS-CoV-2,2-week count of sequences,total,126,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W45,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W44,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W43,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W42,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W41,SARS-CoV-2,2-week count of sequences,total,156,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W40,SARS-CoV-2,2-week count of sequences,total,146,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W39,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W38,SARS-CoV-2,2-week count of sequences,total,186,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W37,SARS-CoV-2,2-week count of sequences,total,249,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W36,SARS-CoV-2,2-week count of sequences,total,320,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W35,SARS-CoV-2,2-week count of sequences,total,363,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W34,SARS-CoV-2,2-week count of sequences,total,402,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W33,SARS-CoV-2,2-week count of sequences,total,506,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W32,SARS-CoV-2,2-week count of sequences,total,593,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W31,SARS-CoV-2,2-week count of sequences,total,720,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W30,SARS-CoV-2,2-week count of sequences,total,660,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W29,SARS-CoV-2,2-week count of sequences,total,531,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W28,SARS-CoV-2,2-week count of sequences,total,441,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W27,SARS-CoV-2,2-week count of sequences,total,224,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W26,SARS-CoV-2,2-week count of sequences,total,147,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W25,SARS-CoV-2,2-week count of sequences,total,165,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W24,SARS-CoV-2,2-week count of sequences,total,134,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W23,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2022-W22,SARS-CoV-2,2-week count of sequences,total,118,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W21,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W20,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W19,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W18,SARS-CoV-2,2-week count of sequences,total,142,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W17,SARS-CoV-2,2-week count of sequences,total,158,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2022-W16,SARS-CoV-2,2-week count of sequences,total,252,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W15,SARS-CoV-2,2-week count of sequences,total,389,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W14,SARS-CoV-2,2-week count of sequences,total,490,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W13,SARS-CoV-2,2-week count of sequences,total,625,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W12,SARS-CoV-2,2-week count of sequences,total,630,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W11,SARS-CoV-2,2-week count of sequences,total,598,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2022-W10,SARS-CoV-2,2-week count of sequences,total,681,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W09,SARS-CoV-2,2-week count of sequences,total,837,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W08,SARS-CoV-2,2-week count of sequences,total,1048,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W07,SARS-CoV-2,2-week count of sequences,total,1074,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W06,SARS-CoV-2,2-week count of sequences,total,973,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W05,SARS-CoV-2,2-week count of sequences,total,984,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W04,SARS-CoV-2,2-week count of sequences,total,912,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W03,SARS-CoV-2,2-week count of sequences,total,837,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W02,SARS-CoV-2,2-week count of sequences,total,815,≤1%
SARS-CoV-2 variant,GISAID,Romania,2022-W01,SARS-CoV-2,2-week count of sequences,total,588,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W52,SARS-CoV-2,2-week count of sequences,total,350,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W51,SARS-CoV-2,2-week count of sequences,total,306,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W50,SARS-CoV-2,2-week count of sequences,total,252,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W49,SARS-CoV-2,2-week count of sequences,total,153,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W48,SARS-CoV-2,2-week count of sequences,total,145,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W47,SARS-CoV-2,2-week count of sequences,total,225,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W46,SARS-CoV-2,2-week count of sequences,total,271,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W45,SARS-CoV-2,2-week count of sequences,total,282,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W44,SARS-CoV-2,2-week count of sequences,total,434,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W43,SARS-CoV-2,2-week count of sequences,total,643,≤1%
SARS-CoV-2 variant,GISAID,Romania,2021-W42,SARS-CoV-2,2-week count of sequences,total,685,≤1%
SARS-CoV-2 variant,GISAID,Romania,2021-W41,SARS-CoV-2,2-week count of sequences,total,900,≤1%
SARS-CoV-2 variant,GISAID,Romania,2021-W40,SARS-CoV-2,2-week count of sequences,total,1080,≤1%
SARS-CoV-2 variant,GISAID,Romania,2021-W39,SARS-CoV-2,2-week count of sequences,total,989,≤1%
SARS-CoV-2 variant,GISAID,Romania,2021-W38,SARS-CoV-2,2-week count of sequences,total,1054,≤1%
SARS-CoV-2 variant,GISAID,Romania,2021-W37,SARS-CoV-2,2-week count of sequences,total,1062,≤1%
SARS-CoV-2 variant,GISAID,Romania,2021-W36,SARS-CoV-2,2-week count of sequences,total,866,≤1%
SARS-CoV-2 variant,GISAID,Romania,2021-W35,SARS-CoV-2,2-week count of sequences,total,592,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W34,SARS-CoV-2,2-week count of sequences,total,368,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W33,SARS-CoV-2,2-week count of sequences,total,281,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W32,SARS-CoV-2,2-week count of sequences,total,300,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W31,SARS-CoV-2,2-week count of sequences,total,262,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W30,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W29,SARS-CoV-2,2-week count of sequences,total,97,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2021-W28,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Romania,2021-W27,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2021-W26,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2021-W25,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2021-W24,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2021-W23,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W22,SARS-CoV-2,2-week count of sequences,total,143,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W21,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W20,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W19,SARS-CoV-2,2-week count of sequences,total,167,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W18,SARS-CoV-2,2-week count of sequences,total,156,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W17,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W16,SARS-CoV-2,2-week count of sequences,total,175,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W15,SARS-CoV-2,2-week count of sequences,total,204,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W14,SARS-CoV-2,2-week count of sequences,total,316,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W13,SARS-CoV-2,2-week count of sequences,total,320,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W12,SARS-CoV-2,2-week count of sequences,total,223,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W11,SARS-CoV-2,2-week count of sequences,total,279,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W10,SARS-CoV-2,2-week count of sequences,total,320,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W09,SARS-CoV-2,2-week count of sequences,total,274,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W08,SARS-CoV-2,2-week count of sequences,total,243,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Romania,2021-W07,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W06,SARS-CoV-2,2-week count of sequences,total,167,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W05,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W04,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2021-W03,SARS-CoV-2,2-week count of sequences,total,105,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2021-W02,SARS-CoV-2,2-week count of sequences,total,116,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2021-W01,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2020-W53,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W52,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W51,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W50,SARS-CoV-2,2-week count of sequences,total,137,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2020-W49,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2020-W48,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2020-W47,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2020-W46,SARS-CoV-2,2-week count of sequences,total,136,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Romania,2020-W45,SARS-CoV-2,2-week count of sequences,total,86,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W44,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W43,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Romania,2020-W42,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Romania,2020-W41,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Romania,2020-W40,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Romania,2020-W39,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W38,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W37,SARS-CoV-2,2-week count of sequences,total,51,>10% to 15%
SARS-CoV-2 variant,GISAID,Romania,2020-W36,SARS-CoV-2,2-week count of sequences,total,79,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W35,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W34,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Romania,2020-W33,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Romania,2020-W32,SARS-CoV-2,2-week count of sequences,total,47,>10% to 15%
SARS-CoV-2 variant,GISAID,Romania,2020-W31,SARS-CoV-2,2-week count of sequences,total,83,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W30,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Romania,2020-W29,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Romania,2020-W28,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Romania,2020-W27,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Romania,2020-W26,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Romania,2020-W25,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2025-W03,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2025-W02,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2025-W01,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W52,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W51,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W50,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W49,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W48,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W47,SARS-CoV-2,2-week count of sequences,total,22,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W46,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W45,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W44,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W43,SARS-CoV-2,2-week count of sequences,total,42,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W42,SARS-CoV-2,2-week count of sequences,total,60,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W41,SARS-CoV-2,2-week count of sequences,total,73,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W40,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W39,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W38,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W37,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W36,SARS-CoV-2,2-week count of sequences,total,24,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W35,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W34,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W33,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W32,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W31,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W29,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W28,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W27,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W24,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W23,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W22,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W21,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W20,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W19,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W18,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W17,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W16,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W15,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W14,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W13,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2024-W12,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W11,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W10,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W09,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W08,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W07,SARS-CoV-2,2-week count of sequences,total,20,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W06,SARS-CoV-2,2-week count of sequences,total,27,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W05,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W04,SARS-CoV-2,2-week count of sequences,total,51,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W03,SARS-CoV-2,2-week count of sequences,total,62,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W02,SARS-CoV-2,2-week count of sequences,total,92,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2024-W01,SARS-CoV-2,2-week count of sequences,total,123,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W52,SARS-CoV-2,2-week count of sequences,total,137,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W51,SARS-CoV-2,2-week count of sequences,total,201,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W50,SARS-CoV-2,2-week count of sequences,total,246,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W49,SARS-CoV-2,2-week count of sequences,total,214,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W48,SARS-CoV-2,2-week count of sequences,total,170,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W47,SARS-CoV-2,2-week count of sequences,total,155,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W46,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W45,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W44,SARS-CoV-2,2-week count of sequences,total,161,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W43,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W42,SARS-CoV-2,2-week count of sequences,total,109,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W41,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W40,SARS-CoV-2,2-week count of sequences,total,116,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W39,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W38,SARS-CoV-2,2-week count of sequences,total,80,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W37,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W36,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W35,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W34,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W33,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W32,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W31,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W30,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W29,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W28,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W27,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W26,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W25,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W24,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W23,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W22,SARS-CoV-2,2-week count of sequences,total,16,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W21,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W20,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W19,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W18,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W17,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W16,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W15,SARS-CoV-2,2-week count of sequences,total,183,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W14,SARS-CoV-2,2-week count of sequences,total,177,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W13,SARS-CoV-2,2-week count of sequences,total,208,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W12,SARS-CoV-2,2-week count of sequences,total,261,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W11,SARS-CoV-2,2-week count of sequences,total,325,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W10,SARS-CoV-2,2-week count of sequences,total,411,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W09,SARS-CoV-2,2-week count of sequences,total,335,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W08,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W07,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W06,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W05,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W04,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W03,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W02,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2023-W01,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W52,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W51,SARS-CoV-2,2-week count of sequences,total,87,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W50,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W49,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W48,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W47,SARS-CoV-2,2-week count of sequences,total,105,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W46,SARS-CoV-2,2-week count of sequences,total,169,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W45,SARS-CoV-2,2-week count of sequences,total,247,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W44,SARS-CoV-2,2-week count of sequences,total,273,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W43,SARS-CoV-2,2-week count of sequences,total,284,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W42,SARS-CoV-2,2-week count of sequences,total,324,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W41,SARS-CoV-2,2-week count of sequences,total,380,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W40,SARS-CoV-2,2-week count of sequences,total,473,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W39,SARS-CoV-2,2-week count of sequences,total,514,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W38,SARS-CoV-2,2-week count of sequences,total,492,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W37,SARS-CoV-2,2-week count of sequences,total,491,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W36,SARS-CoV-2,2-week count of sequences,total,441,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W35,SARS-CoV-2,2-week count of sequences,total,521,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W34,SARS-CoV-2,2-week count of sequences,total,799,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W33,SARS-CoV-2,2-week count of sequences,total,985,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W32,SARS-CoV-2,2-week count of sequences,total,1033,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W31,SARS-CoV-2,2-week count of sequences,total,1378,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W30,SARS-CoV-2,2-week count of sequences,total,1510,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W29,SARS-CoV-2,2-week count of sequences,total,1335,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W28,SARS-CoV-2,2-week count of sequences,total,1016,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W27,SARS-CoV-2,2-week count of sequences,total,705,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W26,SARS-CoV-2,2-week count of sequences,total,652,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W25,SARS-CoV-2,2-week count of sequences,total,396,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W24,SARS-CoV-2,2-week count of sequences,total,264,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W23,SARS-CoV-2,2-week count of sequences,total,278,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W22,SARS-CoV-2,2-week count of sequences,total,267,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W21,SARS-CoV-2,2-week count of sequences,total,334,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W20,SARS-CoV-2,2-week count of sequences,total,491,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W19,SARS-CoV-2,2-week count of sequences,total,692,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W18,SARS-CoV-2,2-week count of sequences,total,1065,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W17,SARS-CoV-2,2-week count of sequences,total,1368,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W16,SARS-CoV-2,2-week count of sequences,total,1393,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W15,SARS-CoV-2,2-week count of sequences,total,1597,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W14,SARS-CoV-2,2-week count of sequences,total,2161,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W13,SARS-CoV-2,2-week count of sequences,total,2517,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W12,SARS-CoV-2,2-week count of sequences,total,2558,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W11,SARS-CoV-2,2-week count of sequences,total,2340,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W10,SARS-CoV-2,2-week count of sequences,total,1946,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W09,SARS-CoV-2,2-week count of sequences,total,2118,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W08,SARS-CoV-2,2-week count of sequences,total,2856,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W07,SARS-CoV-2,2-week count of sequences,total,2627,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W06,SARS-CoV-2,2-week count of sequences,total,2038,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W05,SARS-CoV-2,2-week count of sequences,total,2703,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W04,SARS-CoV-2,2-week count of sequences,total,2725,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W03,SARS-CoV-2,2-week count of sequences,total,1739,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W02,SARS-CoV-2,2-week count of sequences,total,1260,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2022-W01,SARS-CoV-2,2-week count of sequences,total,967,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W52,SARS-CoV-2,2-week count of sequences,total,603,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W51,SARS-CoV-2,2-week count of sequences,total,396,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W50,SARS-CoV-2,2-week count of sequences,total,759,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W49,SARS-CoV-2,2-week count of sequences,total,1528,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W48,SARS-CoV-2,2-week count of sequences,total,1540,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W47,SARS-CoV-2,2-week count of sequences,total,1257,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W46,SARS-CoV-2,2-week count of sequences,total,1748,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W45,SARS-CoV-2,2-week count of sequences,total,2293,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W44,SARS-CoV-2,2-week count of sequences,total,2221,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W43,SARS-CoV-2,2-week count of sequences,total,1737,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W42,SARS-CoV-2,2-week count of sequences,total,1559,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W41,SARS-CoV-2,2-week count of sequences,total,1711,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W40,SARS-CoV-2,2-week count of sequences,total,1381,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W39,SARS-CoV-2,2-week count of sequences,total,845,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W38,SARS-CoV-2,2-week count of sequences,total,984,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W37,SARS-CoV-2,2-week count of sequences,total,1208,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W36,SARS-CoV-2,2-week count of sequences,total,962,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W35,SARS-CoV-2,2-week count of sequences,total,782,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W34,SARS-CoV-2,2-week count of sequences,total,680,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W33,SARS-CoV-2,2-week count of sequences,total,619,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W32,SARS-CoV-2,2-week count of sequences,total,480,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W31,SARS-CoV-2,2-week count of sequences,total,372,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W30,SARS-CoV-2,2-week count of sequences,total,365,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W29,SARS-CoV-2,2-week count of sequences,total,271,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W28,SARS-CoV-2,2-week count of sequences,total,281,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W27,SARS-CoV-2,2-week count of sequences,total,242,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W26,SARS-CoV-2,2-week count of sequences,total,194,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W25,SARS-CoV-2,2-week count of sequences,total,251,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W24,SARS-CoV-2,2-week count of sequences,total,439,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W23,SARS-CoV-2,2-week count of sequences,total,596,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W22,SARS-CoV-2,2-week count of sequences,total,590,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W21,SARS-CoV-2,2-week count of sequences,total,691,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W20,SARS-CoV-2,2-week count of sequences,total,567,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W19,SARS-CoV-2,2-week count of sequences,total,338,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W18,SARS-CoV-2,2-week count of sequences,total,316,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W17,SARS-CoV-2,2-week count of sequences,total,337,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W16,SARS-CoV-2,2-week count of sequences,total,430,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W15,SARS-CoV-2,2-week count of sequences,total,616,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W14,SARS-CoV-2,2-week count of sequences,total,720,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W13,SARS-CoV-2,2-week count of sequences,total,660,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W12,SARS-CoV-2,2-week count of sequences,total,653,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W11,SARS-CoV-2,2-week count of sequences,total,584,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W10,SARS-CoV-2,2-week count of sequences,total,622,≤1%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W09,SARS-CoV-2,2-week count of sequences,total,438,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W08,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W07,SARS-CoV-2,2-week count of sequences,total,104,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W06,SARS-CoV-2,2-week count of sequences,total,150,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W05,SARS-CoV-2,2-week count of sequences,total,119,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W04,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W03,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W02,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2021-W01,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W53,SARS-CoV-2,2-week count of sequences,total,115,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W52,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W51,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W50,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W49,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W48,SARS-CoV-2,2-week count of sequences,total,17,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W47,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W46,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W45,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W44,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W43,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W42,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W41,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W40,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2020-W39,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W38,SARS-CoV-2,2-week count of sequences,total,10,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W37,SARS-CoV-2,2-week count of sequences,total,4,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W36,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2020-W35,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W34,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W33,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W32,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W31,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W30,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2020-W29,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W28,SARS-CoV-2,2-week count of sequences,total,3,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W27,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Slovakia,2020-W26,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovakia,2020-W25,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Slovenia,2025-W04,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2025-W03,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2025-W02,SARS-CoV-2,2-week count of sequences,total,64,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2025-W01,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W52,SARS-CoV-2,2-week count of sequences,total,36,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W51,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W50,SARS-CoV-2,2-week count of sequences,total,33,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W49,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W48,SARS-CoV-2,2-week count of sequences,total,69,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W47,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W46,SARS-CoV-2,2-week count of sequences,total,84,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W45,SARS-CoV-2,2-week count of sequences,total,81,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W44,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W43,SARS-CoV-2,2-week count of sequences,total,149,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W42,SARS-CoV-2,2-week count of sequences,total,193,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W41,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W40,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W39,SARS-CoV-2,2-week count of sequences,total,115,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W38,SARS-CoV-2,2-week count of sequences,total,152,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W37,SARS-CoV-2,2-week count of sequences,total,142,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W36,SARS-CoV-2,2-week count of sequences,total,82,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W35,SARS-CoV-2,2-week count of sequences,total,95,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W34,SARS-CoV-2,2-week count of sequences,total,98,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W33,SARS-CoV-2,2-week count of sequences,total,56,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W32,SARS-CoV-2,2-week count of sequences,total,93,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W31,SARS-CoV-2,2-week count of sequences,total,101,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W30,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W29,SARS-CoV-2,2-week count of sequences,total,46,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W28,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W27,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W26,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W25,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W24,SARS-CoV-2,2-week count of sequences,total,30,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W23,SARS-CoV-2,2-week count of sequences,total,28,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W22,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W21,SARS-CoV-2,2-week count of sequences,total,13,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W20,SARS-CoV-2,2-week count of sequences,total,11,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W19,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W18,SARS-CoV-2,2-week count of sequences,total,6,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W17,SARS-CoV-2,2-week count of sequences,total,2,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W16,SARS-CoV-2,2-week count of sequences,total,5,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W15,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W14,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W13,SARS-CoV-2,2-week count of sequences,total,9,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W12,SARS-CoV-2,2-week count of sequences,total,12,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W11,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W10,SARS-CoV-2,2-week count of sequences,total,21,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W09,SARS-CoV-2,2-week count of sequences,total,23,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W08,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W07,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W06,SARS-CoV-2,2-week count of sequences,total,65,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W05,SARS-CoV-2,2-week count of sequences,total,49,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W04,SARS-CoV-2,2-week count of sequences,total,78,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W03,SARS-CoV-2,2-week count of sequences,total,127,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W02,SARS-CoV-2,2-week count of sequences,total,181,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2024-W01,SARS-CoV-2,2-week count of sequences,total,179,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W52,SARS-CoV-2,2-week count of sequences,total,210,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W51,SARS-CoV-2,2-week count of sequences,total,297,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W50,SARS-CoV-2,2-week count of sequences,total,281,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W49,SARS-CoV-2,2-week count of sequences,total,257,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W48,SARS-CoV-2,2-week count of sequences,total,242,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W47,SARS-CoV-2,2-week count of sequences,total,254,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W46,SARS-CoV-2,2-week count of sequences,total,211,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W45,SARS-CoV-2,2-week count of sequences,total,139,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W44,SARS-CoV-2,2-week count of sequences,total,168,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W43,SARS-CoV-2,2-week count of sequences,total,158,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W42,SARS-CoV-2,2-week count of sequences,total,200,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W41,SARS-CoV-2,2-week count of sequences,total,236,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W40,SARS-CoV-2,2-week count of sequences,total,188,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W39,SARS-CoV-2,2-week count of sequences,total,177,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W38,SARS-CoV-2,2-week count of sequences,total,162,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W37,SARS-CoV-2,2-week count of sequences,total,132,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W36,SARS-CoV-2,2-week count of sequences,total,88,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W35,SARS-CoV-2,2-week count of sequences,total,75,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W34,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W33,SARS-CoV-2,2-week count of sequences,total,51,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W32,SARS-CoV-2,2-week count of sequences,total,32,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W31,SARS-CoV-2,2-week count of sequences,total,19,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W30,SARS-CoV-2,2-week count of sequences,total,18,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W29,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W28,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W27,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W26,SARS-CoV-2,2-week count of sequences,total,37,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W25,SARS-CoV-2,2-week count of sequences,total,55,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W24,SARS-CoV-2,2-week count of sequences,total,70,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W23,SARS-CoV-2,2-week count of sequences,total,96,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W22,SARS-CoV-2,2-week count of sequences,total,127,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W21,SARS-CoV-2,2-week count of sequences,total,143,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W20,SARS-CoV-2,2-week count of sequences,total,144,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W19,SARS-CoV-2,2-week count of sequences,total,134,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W18,SARS-CoV-2,2-week count of sequences,total,165,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W17,SARS-CoV-2,2-week count of sequences,total,234,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W16,SARS-CoV-2,2-week count of sequences,total,256,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W15,SARS-CoV-2,2-week count of sequences,total,253,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W14,SARS-CoV-2,2-week count of sequences,total,298,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W13,SARS-CoV-2,2-week count of sequences,total,361,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W12,SARS-CoV-2,2-week count of sequences,total,366,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W11,SARS-CoV-2,2-week count of sequences,total,330,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W10,SARS-CoV-2,2-week count of sequences,total,272,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W09,SARS-CoV-2,2-week count of sequences,total,245,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W08,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W07,SARS-CoV-2,2-week count of sequences,total,224,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W06,SARS-CoV-2,2-week count of sequences,total,264,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W05,SARS-CoV-2,2-week count of sequences,total,243,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W04,SARS-CoV-2,2-week count of sequences,total,220,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W03,SARS-CoV-2,2-week count of sequences,total,341,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W02,SARS-CoV-2,2-week count of sequences,total,546,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2023-W01,SARS-CoV-2,2-week count of sequences,total,687,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W52,SARS-CoV-2,2-week count of sequences,total,891,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W51,SARS-CoV-2,2-week count of sequences,total,1214,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W50,SARS-CoV-2,2-week count of sequences,total,1190,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W49,SARS-CoV-2,2-week count of sequences,total,902,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W48,SARS-CoV-2,2-week count of sequences,total,739,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W47,SARS-CoV-2,2-week count of sequences,total,631,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W46,SARS-CoV-2,2-week count of sequences,total,528,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W45,SARS-CoV-2,2-week count of sequences,total,496,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W44,SARS-CoV-2,2-week count of sequences,total,604,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W43,SARS-CoV-2,2-week count of sequences,total,820,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W42,SARS-CoV-2,2-week count of sequences,total,1051,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W41,SARS-CoV-2,2-week count of sequences,total,1218,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W40,SARS-CoV-2,2-week count of sequences,total,1168,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W39,SARS-CoV-2,2-week count of sequences,total,965,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W38,SARS-CoV-2,2-week count of sequences,total,1022,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W37,SARS-CoV-2,2-week count of sequences,total,1061,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W36,SARS-CoV-2,2-week count of sequences,total,731,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W35,SARS-CoV-2,2-week count of sequences,total,540,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W34,SARS-CoV-2,2-week count of sequences,total,665,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W33,SARS-CoV-2,2-week count of sequences,total,735,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W32,SARS-CoV-2,2-week count of sequences,total,716,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W31,SARS-CoV-2,2-week count of sequences,total,875,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W30,SARS-CoV-2,2-week count of sequences,total,1014,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W29,SARS-CoV-2,2-week count of sequences,total,1031,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W28,SARS-CoV-2,2-week count of sequences,total,958,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W27,SARS-CoV-2,2-week count of sequences,total,775,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W26,SARS-CoV-2,2-week count of sequences,total,610,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W25,SARS-CoV-2,2-week count of sequences,total,419,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W24,SARS-CoV-2,2-week count of sequences,total,292,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W23,SARS-CoV-2,2-week count of sequences,total,256,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W22,SARS-CoV-2,2-week count of sequences,total,244,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W21,SARS-CoV-2,2-week count of sequences,total,271,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W20,SARS-CoV-2,2-week count of sequences,total,373,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W19,SARS-CoV-2,2-week count of sequences,total,465,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W18,SARS-CoV-2,2-week count of sequences,total,553,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W17,SARS-CoV-2,2-week count of sequences,total,753,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W16,SARS-CoV-2,2-week count of sequences,total,974,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W15,SARS-CoV-2,2-week count of sequences,total,1180,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W14,SARS-CoV-2,2-week count of sequences,total,1620,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W13,SARS-CoV-2,2-week count of sequences,total,1888,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W12,SARS-CoV-2,2-week count of sequences,total,1949,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W11,SARS-CoV-2,2-week count of sequences,total,2069,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W10,SARS-CoV-2,2-week count of sequences,total,1794,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W09,SARS-CoV-2,2-week count of sequences,total,1551,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W08,SARS-CoV-2,2-week count of sequences,total,2149,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W07,SARS-CoV-2,2-week count of sequences,total,2840,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W06,SARS-CoV-2,2-week count of sequences,total,2620,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W05,SARS-CoV-2,2-week count of sequences,total,2440,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W04,SARS-CoV-2,2-week count of sequences,total,2414,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W03,SARS-CoV-2,2-week count of sequences,total,3249,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W02,SARS-CoV-2,2-week count of sequences,total,4298,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2022-W01,SARS-CoV-2,2-week count of sequences,total,4862,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W52,SARS-CoV-2,2-week count of sequences,total,3923,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W51,SARS-CoV-2,2-week count of sequences,total,2193,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W50,SARS-CoV-2,2-week count of sequences,total,2160,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W49,SARS-CoV-2,2-week count of sequences,total,2574,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W48,SARS-CoV-2,2-week count of sequences,total,2778,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W47,SARS-CoV-2,2-week count of sequences,total,2951,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W46,SARS-CoV-2,2-week count of sequences,total,2837,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W45,SARS-CoV-2,2-week count of sequences,total,2530,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W44,SARS-CoV-2,2-week count of sequences,total,2701,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W43,SARS-CoV-2,2-week count of sequences,total,2924,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W42,SARS-CoV-2,2-week count of sequences,total,2888,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W41,SARS-CoV-2,2-week count of sequences,total,2797,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W40,SARS-CoV-2,2-week count of sequences,total,2701,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W39,SARS-CoV-2,2-week count of sequences,total,2371,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W38,SARS-CoV-2,2-week count of sequences,total,2177,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W37,SARS-CoV-2,2-week count of sequences,total,2396,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W36,SARS-CoV-2,2-week count of sequences,total,2554,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W35,SARS-CoV-2,2-week count of sequences,total,2633,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W34,SARS-CoV-2,2-week count of sequences,total,2373,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W33,SARS-CoV-2,2-week count of sequences,total,2055,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W32,SARS-CoV-2,2-week count of sequences,total,1808,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W31,SARS-CoV-2,2-week count of sequences,total,1356,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W30,SARS-CoV-2,2-week count of sequences,total,1003,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W29,SARS-CoV-2,2-week count of sequences,total,765,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W28,SARS-CoV-2,2-week count of sequences,total,656,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W27,SARS-CoV-2,2-week count of sequences,total,483,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W26,SARS-CoV-2,2-week count of sequences,total,407,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W25,SARS-CoV-2,2-week count of sequences,total,387,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W24,SARS-CoV-2,2-week count of sequences,total,451,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W23,SARS-CoV-2,2-week count of sequences,total,656,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W22,SARS-CoV-2,2-week count of sequences,total,688,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W21,SARS-CoV-2,2-week count of sequences,total,708,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W20,SARS-CoV-2,2-week count of sequences,total,1073,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W19,SARS-CoV-2,2-week count of sequences,total,1328,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W18,SARS-CoV-2,2-week count of sequences,total,1621,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W17,SARS-CoV-2,2-week count of sequences,total,2006,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W16,SARS-CoV-2,2-week count of sequences,total,2074,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W15,SARS-CoV-2,2-week count of sequences,total,2077,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W14,SARS-CoV-2,2-week count of sequences,total,1683,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W13,SARS-CoV-2,2-week count of sequences,total,1696,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W12,SARS-CoV-2,2-week count of sequences,total,1824,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W11,SARS-CoV-2,2-week count of sequences,total,1332,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W10,SARS-CoV-2,2-week count of sequences,total,1212,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W09,SARS-CoV-2,2-week count of sequences,total,1484,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W08,SARS-CoV-2,2-week count of sequences,total,1488,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W07,SARS-CoV-2,2-week count of sequences,total,1311,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W06,SARS-CoV-2,2-week count of sequences,total,1378,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W05,SARS-CoV-2,2-week count of sequences,total,1621,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W04,SARS-CoV-2,2-week count of sequences,total,1100,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W03,SARS-CoV-2,2-week count of sequences,total,394,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W02,SARS-CoV-2,2-week count of sequences,total,843,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2021-W01,SARS-CoV-2,2-week count of sequences,total,966,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W53,SARS-CoV-2,2-week count of sequences,total,467,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W52,SARS-CoV-2,2-week count of sequences,total,590,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W51,SARS-CoV-2,2-week count of sequences,total,919,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W50,SARS-CoV-2,2-week count of sequences,total,1047,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W49,SARS-CoV-2,2-week count of sequences,total,1004,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W48,SARS-CoV-2,2-week count of sequences,total,540,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W47,SARS-CoV-2,2-week count of sequences,total,163,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W46,SARS-CoV-2,2-week count of sequences,total,785,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W45,SARS-CoV-2,2-week count of sequences,total,931,≤1%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W44,SARS-CoV-2,2-week count of sequences,total,348,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W43,SARS-CoV-2,2-week count of sequences,total,461,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W42,SARS-CoV-2,2-week count of sequences,total,598,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W41,SARS-CoV-2,2-week count of sequences,total,360,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W40,SARS-CoV-2,2-week count of sequences,total,190,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W39,SARS-CoV-2,2-week count of sequences,total,173,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W38,SARS-CoV-2,2-week count of sequences,total,201,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W37,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W36,SARS-CoV-2,2-week count of sequences,total,112,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W35,SARS-CoV-2,2-week count of sequences,total,102,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W34,SARS-CoV-2,2-week count of sequences,total,108,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W33,SARS-CoV-2,2-week count of sequences,total,77,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W32,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W31,SARS-CoV-2,2-week count of sequences,total,66,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W30,SARS-CoV-2,2-week count of sequences,total,68,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W29,SARS-CoV-2,2-week count of sequences,total,58,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W28,SARS-CoV-2,2-week count of sequences,total,64,>5% to 10%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W27,SARS-CoV-2,2-week count of sequences,total,52,>10% to 15%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W26,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Slovenia,2020-W25,SARS-CoV-2,2-week count of sequences,total,8,>15%
SARS-CoV-2 variant,GISAID,Spain,2025-W04,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Spain,2025-W03,SARS-CoV-2,2-week count of sequences,total,59,>5% to 10%
SARS-CoV-2 variant,GISAID,Spain,2025-W02,SARS-CoV-2,2-week count of sequences,total,122,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2025-W01,SARS-CoV-2,2-week count of sequences,total,144,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W52,SARS-CoV-2,2-week count of sequences,total,122,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W51,SARS-CoV-2,2-week count of sequences,total,106,>5% to 10%
SARS-CoV-2 variant,GISAID,Spain,2024-W50,SARS-CoV-2,2-week count of sequences,total,110,>5% to 10%
SARS-CoV-2 variant,GISAID,Spain,2024-W49,SARS-CoV-2,2-week count of sequences,total,128,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W48,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W47,SARS-CoV-2,2-week count of sequences,total,187,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W46,SARS-CoV-2,2-week count of sequences,total,227,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W45,SARS-CoV-2,2-week count of sequences,total,279,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W44,SARS-CoV-2,2-week count of sequences,total,355,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W43,SARS-CoV-2,2-week count of sequences,total,518,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W42,SARS-CoV-2,2-week count of sequences,total,672,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W41,SARS-CoV-2,2-week count of sequences,total,741,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W40,SARS-CoV-2,2-week count of sequences,total,722,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W39,SARS-CoV-2,2-week count of sequences,total,708,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W38,SARS-CoV-2,2-week count of sequences,total,685,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W37,SARS-CoV-2,2-week count of sequences,total,751,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W36,SARS-CoV-2,2-week count of sequences,total,871,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W35,SARS-CoV-2,2-week count of sequences,total,865,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W34,SARS-CoV-2,2-week count of sequences,total,905,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W33,SARS-CoV-2,2-week count of sequences,total,1135,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W32,SARS-CoV-2,2-week count of sequences,total,1454,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W31,SARS-CoV-2,2-week count of sequences,total,1786,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W30,SARS-CoV-2,2-week count of sequences,total,1962,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W29,SARS-CoV-2,2-week count of sequences,total,2229,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W28,SARS-CoV-2,2-week count of sequences,total,2716,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W27,SARS-CoV-2,2-week count of sequences,total,2963,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W26,SARS-CoV-2,2-week count of sequences,total,2841,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W25,SARS-CoV-2,2-week count of sequences,total,2772,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W24,SARS-CoV-2,2-week count of sequences,total,2821,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W23,SARS-CoV-2,2-week count of sequences,total,2621,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W22,SARS-CoV-2,2-week count of sequences,total,2210,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W21,SARS-CoV-2,2-week count of sequences,total,1628,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W20,SARS-CoV-2,2-week count of sequences,total,1110,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W19,SARS-CoV-2,2-week count of sequences,total,723,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W18,SARS-CoV-2,2-week count of sequences,total,451,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W17,SARS-CoV-2,2-week count of sequences,total,307,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W16,SARS-CoV-2,2-week count of sequences,total,245,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W15,SARS-CoV-2,2-week count of sequences,total,238,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W14,SARS-CoV-2,2-week count of sequences,total,199,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W13,SARS-CoV-2,2-week count of sequences,total,191,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2024-W12,SARS-CoV-2,2-week count of sequences,total,255,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W11,SARS-CoV-2,2-week count of sequences,total,268,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W10,SARS-CoV-2,2-week count of sequences,total,255,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W09,SARS-CoV-2,2-week count of sequences,total,298,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W08,SARS-CoV-2,2-week count of sequences,total,418,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W07,SARS-CoV-2,2-week count of sequences,total,551,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2024-W06,SARS-CoV-2,2-week count of sequences,total,628,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W05,SARS-CoV-2,2-week count of sequences,total,800,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W04,SARS-CoV-2,2-week count of sequences,total,1274,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W03,SARS-CoV-2,2-week count of sequences,total,1869,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W02,SARS-CoV-2,2-week count of sequences,total,2356,≤1%
SARS-CoV-2 variant,GISAID,Spain,2024-W01,SARS-CoV-2,2-week count of sequences,total,2621,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W52,SARS-CoV-2,2-week count of sequences,total,2369,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W51,SARS-CoV-2,2-week count of sequences,total,2015,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W50,SARS-CoV-2,2-week count of sequences,total,1671,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W49,SARS-CoV-2,2-week count of sequences,total,1487,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W48,SARS-CoV-2,2-week count of sequences,total,1318,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W47,SARS-CoV-2,2-week count of sequences,total,1075,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W46,SARS-CoV-2,2-week count of sequences,total,1168,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W45,SARS-CoV-2,2-week count of sequences,total,1237,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W44,SARS-CoV-2,2-week count of sequences,total,1348,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W43,SARS-CoV-2,2-week count of sequences,total,1547,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W42,SARS-CoV-2,2-week count of sequences,total,1739,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W41,SARS-CoV-2,2-week count of sequences,total,1928,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W40,SARS-CoV-2,2-week count of sequences,total,2051,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W39,SARS-CoV-2,2-week count of sequences,total,2132,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W38,SARS-CoV-2,2-week count of sequences,total,2252,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W37,SARS-CoV-2,2-week count of sequences,total,2356,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W36,SARS-CoV-2,2-week count of sequences,total,2531,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W35,SARS-CoV-2,2-week count of sequences,total,2450,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W34,SARS-CoV-2,2-week count of sequences,total,2116,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W33,SARS-CoV-2,2-week count of sequences,total,2066,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W32,SARS-CoV-2,2-week count of sequences,total,2037,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W31,SARS-CoV-2,2-week count of sequences,total,1649,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W30,SARS-CoV-2,2-week count of sequences,total,1218,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W29,SARS-CoV-2,2-week count of sequences,total,1023,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W28,SARS-CoV-2,2-week count of sequences,total,845,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W27,SARS-CoV-2,2-week count of sequences,total,733,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W26,SARS-CoV-2,2-week count of sequences,total,813,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W25,SARS-CoV-2,2-week count of sequences,total,965,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W24,SARS-CoV-2,2-week count of sequences,total,1180,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W23,SARS-CoV-2,2-week count of sequences,total,1510,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W22,SARS-CoV-2,2-week count of sequences,total,1843,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W21,SARS-CoV-2,2-week count of sequences,total,1959,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W20,SARS-CoV-2,2-week count of sequences,total,2026,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W19,SARS-CoV-2,2-week count of sequences,total,2089,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W18,SARS-CoV-2,2-week count of sequences,total,2220,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W17,SARS-CoV-2,2-week count of sequences,total,2320,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W16,SARS-CoV-2,2-week count of sequences,total,2099,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W15,SARS-CoV-2,2-week count of sequences,total,1696,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W14,SARS-CoV-2,2-week count of sequences,total,1573,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W13,SARS-CoV-2,2-week count of sequences,total,1641,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W12,SARS-CoV-2,2-week count of sequences,total,1602,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W11,SARS-CoV-2,2-week count of sequences,total,1691,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W10,SARS-CoV-2,2-week count of sequences,total,1568,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W09,SARS-CoV-2,2-week count of sequences,total,1351,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W08,SARS-CoV-2,2-week count of sequences,total,1385,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W07,SARS-CoV-2,2-week count of sequences,total,1381,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W06,SARS-CoV-2,2-week count of sequences,total,1332,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W05,SARS-CoV-2,2-week count of sequences,total,1298,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W04,SARS-CoV-2,2-week count of sequences,total,1437,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W03,SARS-CoV-2,2-week count of sequences,total,2024,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W02,SARS-CoV-2,2-week count of sequences,total,2164,≤1%
SARS-CoV-2 variant,GISAID,Spain,2023-W01,SARS-CoV-2,2-week count of sequences,total,1929,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W52,SARS-CoV-2,2-week count of sequences,total,2257,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W51,SARS-CoV-2,2-week count of sequences,total,3364,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W50,SARS-CoV-2,2-week count of sequences,total,3281,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W49,SARS-CoV-2,2-week count of sequences,total,2425,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W48,SARS-CoV-2,2-week count of sequences,total,2486,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W47,SARS-CoV-2,2-week count of sequences,total,2627,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W46,SARS-CoV-2,2-week count of sequences,total,2594,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W45,SARS-CoV-2,2-week count of sequences,total,2277,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W44,SARS-CoV-2,2-week count of sequences,total,2216,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W43,SARS-CoV-2,2-week count of sequences,total,2695,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W42,SARS-CoV-2,2-week count of sequences,total,2673,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W41,SARS-CoV-2,2-week count of sequences,total,2216,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W40,SARS-CoV-2,2-week count of sequences,total,1897,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W39,SARS-CoV-2,2-week count of sequences,total,1625,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W38,SARS-CoV-2,2-week count of sequences,total,1635,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W37,SARS-CoV-2,2-week count of sequences,total,1552,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W36,SARS-CoV-2,2-week count of sequences,total,1609,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W35,SARS-CoV-2,2-week count of sequences,total,1910,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W34,SARS-CoV-2,2-week count of sequences,total,2028,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W33,SARS-CoV-2,2-week count of sequences,total,2258,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W32,SARS-CoV-2,2-week count of sequences,total,2934,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W31,SARS-CoV-2,2-week count of sequences,total,3594,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W30,SARS-CoV-2,2-week count of sequences,total,4216,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W29,SARS-CoV-2,2-week count of sequences,total,5230,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W28,SARS-CoV-2,2-week count of sequences,total,5805,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W27,SARS-CoV-2,2-week count of sequences,total,5783,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W26,SARS-CoV-2,2-week count of sequences,total,5340,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W25,SARS-CoV-2,2-week count of sequences,total,4730,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W24,SARS-CoV-2,2-week count of sequences,total,4335,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W23,SARS-CoV-2,2-week count of sequences,total,4344,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W22,SARS-CoV-2,2-week count of sequences,total,4354,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W21,SARS-CoV-2,2-week count of sequences,total,4437,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W20,SARS-CoV-2,2-week count of sequences,total,4974,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W19,SARS-CoV-2,2-week count of sequences,total,5086,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W18,SARS-CoV-2,2-week count of sequences,total,4929,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W17,SARS-CoV-2,2-week count of sequences,total,4743,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W16,SARS-CoV-2,2-week count of sequences,total,3798,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W15,SARS-CoV-2,2-week count of sequences,total,3333,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W14,SARS-CoV-2,2-week count of sequences,total,4063,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W13,SARS-CoV-2,2-week count of sequences,total,4344,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W12,SARS-CoV-2,2-week count of sequences,total,4608,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W11,SARS-CoV-2,2-week count of sequences,total,4807,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W10,SARS-CoV-2,2-week count of sequences,total,4397,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W09,SARS-CoV-2,2-week count of sequences,total,4265,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W08,SARS-CoV-2,2-week count of sequences,total,4538,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W07,SARS-CoV-2,2-week count of sequences,total,5112,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W06,SARS-CoV-2,2-week count of sequences,total,5242,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W05,SARS-CoV-2,2-week count of sequences,total,5281,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W04,SARS-CoV-2,2-week count of sequences,total,5751,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W03,SARS-CoV-2,2-week count of sequences,total,6194,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W02,SARS-CoV-2,2-week count of sequences,total,6246,≤1%
SARS-CoV-2 variant,GISAID,Spain,2022-W01,SARS-CoV-2,2-week count of sequences,total,5805,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W52,SARS-CoV-2,2-week count of sequences,total,5981,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W51,SARS-CoV-2,2-week count of sequences,total,6846,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W50,SARS-CoV-2,2-week count of sequences,total,6521,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W49,SARS-CoV-2,2-week count of sequences,total,5805,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W48,SARS-CoV-2,2-week count of sequences,total,5205,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W47,SARS-CoV-2,2-week count of sequences,total,4865,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W46,SARS-CoV-2,2-week count of sequences,total,4501,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W45,SARS-CoV-2,2-week count of sequences,total,3550,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W44,SARS-CoV-2,2-week count of sequences,total,3164,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W43,SARS-CoV-2,2-week count of sequences,total,3005,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W42,SARS-CoV-2,2-week count of sequences,total,2652,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W41,SARS-CoV-2,2-week count of sequences,total,2283,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W40,SARS-CoV-2,2-week count of sequences,total,2496,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W39,SARS-CoV-2,2-week count of sequences,total,2979,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W38,SARS-CoV-2,2-week count of sequences,total,3187,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W37,SARS-CoV-2,2-week count of sequences,total,3680,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W36,SARS-CoV-2,2-week count of sequences,total,4272,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W35,SARS-CoV-2,2-week count of sequences,total,4621,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W34,SARS-CoV-2,2-week count of sequences,total,4810,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W33,SARS-CoV-2,2-week count of sequences,total,5033,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W32,SARS-CoV-2,2-week count of sequences,total,6175,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W31,SARS-CoV-2,2-week count of sequences,total,7414,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W30,SARS-CoV-2,2-week count of sequences,total,7727,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W29,SARS-CoV-2,2-week count of sequences,total,8215,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W28,SARS-CoV-2,2-week count of sequences,total,8414,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W27,SARS-CoV-2,2-week count of sequences,total,7941,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W26,SARS-CoV-2,2-week count of sequences,total,6020,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W25,SARS-CoV-2,2-week count of sequences,total,4002,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W24,SARS-CoV-2,2-week count of sequences,total,3791,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W23,SARS-CoV-2,2-week count of sequences,total,4161,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W22,SARS-CoV-2,2-week count of sequences,total,4047,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W21,SARS-CoV-2,2-week count of sequences,total,3673,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W20,SARS-CoV-2,2-week count of sequences,total,4027,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W19,SARS-CoV-2,2-week count of sequences,total,4345,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W18,SARS-CoV-2,2-week count of sequences,total,4358,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W17,SARS-CoV-2,2-week count of sequences,total,3995,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W16,SARS-CoV-2,2-week count of sequences,total,4058,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W15,SARS-CoV-2,2-week count of sequences,total,4043,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W14,SARS-CoV-2,2-week count of sequences,total,3533,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W13,SARS-CoV-2,2-week count of sequences,total,3582,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W12,SARS-CoV-2,2-week count of sequences,total,3376,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W11,SARS-CoV-2,2-week count of sequences,total,3178,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W10,SARS-CoV-2,2-week count of sequences,total,3263,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W09,SARS-CoV-2,2-week count of sequences,total,3217,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W08,SARS-CoV-2,2-week count of sequences,total,3283,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W07,SARS-CoV-2,2-week count of sequences,total,3049,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W06,SARS-CoV-2,2-week count of sequences,total,3151,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W05,SARS-CoV-2,2-week count of sequences,total,3405,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W04,SARS-CoV-2,2-week count of sequences,total,3378,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W03,SARS-CoV-2,2-week count of sequences,total,3002,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W02,SARS-CoV-2,2-week count of sequences,total,2241,≤1%
SARS-CoV-2 variant,GISAID,Spain,2021-W01,SARS-CoV-2,2-week count of sequences,total,2007,≤1%
SARS-CoV-2 variant,GISAID,Spain,2020-W53,SARS-CoV-2,2-week count of sequences,total,1725,≤1%
SARS-CoV-2 variant,GISAID,Spain,2020-W52,SARS-CoV-2,2-week count of sequences,total,1333,≤1%
SARS-CoV-2 variant,GISAID,Spain,2020-W51,SARS-CoV-2,2-week count of sequences,total,1156,≤1%
SARS-CoV-2 variant,GISAID,Spain,2020-W50,SARS-CoV-2,2-week count of sequences,total,842,≤1%
SARS-CoV-2 variant,GISAID,Spain,2020-W49,SARS-CoV-2,2-week count of sequences,total,521,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W48,SARS-CoV-2,2-week count of sequences,total,381,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W47,SARS-CoV-2,2-week count of sequences,total,477,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W46,SARS-CoV-2,2-week count of sequences,total,525,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W45,SARS-CoV-2,2-week count of sequences,total,443,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W44,SARS-CoV-2,2-week count of sequences,total,434,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W43,SARS-CoV-2,2-week count of sequences,total,813,≤1%
SARS-CoV-2 variant,GISAID,Spain,2020-W42,SARS-CoV-2,2-week count of sequences,total,895,≤1%
SARS-CoV-2 variant,GISAID,Spain,2020-W41,SARS-CoV-2,2-week count of sequences,total,663,≤1%
SARS-CoV-2 variant,GISAID,Spain,2020-W40,SARS-CoV-2,2-week count of sequences,total,596,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W39,SARS-CoV-2,2-week count of sequences,total,494,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W38,SARS-CoV-2,2-week count of sequences,total,495,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W37,SARS-CoV-2,2-week count of sequences,total,490,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W36,SARS-CoV-2,2-week count of sequences,total,360,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W35,SARS-CoV-2,2-week count of sequences,total,417,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W34,SARS-CoV-2,2-week count of sequences,total,575,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W33,SARS-CoV-2,2-week count of sequences,total,509,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W32,SARS-CoV-2,2-week count of sequences,total,321,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Spain,2020-W31,SARS-CoV-2,2-week count of sequences,total,204,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2020-W30,SARS-CoV-2,2-week count of sequences,total,188,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2020-W29,SARS-CoV-2,2-week count of sequences,total,210,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2020-W28,SARS-CoV-2,2-week count of sequences,total,181,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2020-W27,SARS-CoV-2,2-week count of sequences,total,178,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2020-W26,SARS-CoV-2,2-week count of sequences,total,148,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Spain,2020-W25,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2025-W04,SARS-CoV-2,2-week count of sequences,total,0,No data
SARS-CoV-2 variant,GISAID,Sweden,2025-W03,SARS-CoV-2,2-week count of sequences,total,1,>15%
SARS-CoV-2 variant,GISAID,Sweden,2025-W02,SARS-CoV-2,2-week count of sequences,total,7,>15%
SARS-CoV-2 variant,GISAID,Sweden,2025-W01,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2024-W52,SARS-CoV-2,2-week count of sequences,total,144,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W51,SARS-CoV-2,2-week count of sequences,total,327,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W50,SARS-CoV-2,2-week count of sequences,total,450,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W49,SARS-CoV-2,2-week count of sequences,total,444,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W48,SARS-CoV-2,2-week count of sequences,total,441,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W47,SARS-CoV-2,2-week count of sequences,total,473,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W46,SARS-CoV-2,2-week count of sequences,total,517,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W45,SARS-CoV-2,2-week count of sequences,total,536,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W44,SARS-CoV-2,2-week count of sequences,total,611,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W43,SARS-CoV-2,2-week count of sequences,total,682,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W42,SARS-CoV-2,2-week count of sequences,total,669,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W41,SARS-CoV-2,2-week count of sequences,total,653,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W40,SARS-CoV-2,2-week count of sequences,total,588,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W39,SARS-CoV-2,2-week count of sequences,total,530,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W38,SARS-CoV-2,2-week count of sequences,total,565,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W37,SARS-CoV-2,2-week count of sequences,total,725,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W36,SARS-CoV-2,2-week count of sequences,total,770,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W35,SARS-CoV-2,2-week count of sequences,total,678,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W34,SARS-CoV-2,2-week count of sequences,total,679,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W33,SARS-CoV-2,2-week count of sequences,total,645,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W32,SARS-CoV-2,2-week count of sequences,total,575,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W31,SARS-CoV-2,2-week count of sequences,total,549,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W30,SARS-CoV-2,2-week count of sequences,total,434,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W29,SARS-CoV-2,2-week count of sequences,total,302,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W28,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W27,SARS-CoV-2,2-week count of sequences,total,217,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W26,SARS-CoV-2,2-week count of sequences,total,223,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W25,SARS-CoV-2,2-week count of sequences,total,154,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W24,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Sweden,2024-W23,SARS-CoV-2,2-week count of sequences,total,120,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W22,SARS-CoV-2,2-week count of sequences,total,141,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W21,SARS-CoV-2,2-week count of sequences,total,133,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W20,SARS-CoV-2,2-week count of sequences,total,121,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W19,SARS-CoV-2,2-week count of sequences,total,127,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W18,SARS-CoV-2,2-week count of sequences,total,99,>5% to 10%
SARS-CoV-2 variant,GISAID,Sweden,2024-W17,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2024-W16,SARS-CoV-2,2-week count of sequences,total,39,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2024-W15,SARS-CoV-2,2-week count of sequences,total,35,>15%
SARS-CoV-2 variant,GISAID,Sweden,2024-W14,SARS-CoV-2,2-week count of sequences,total,50,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2024-W13,SARS-CoV-2,2-week count of sequences,total,61,>5% to 10%
SARS-CoV-2 variant,GISAID,Sweden,2024-W12,SARS-CoV-2,2-week count of sequences,total,57,>5% to 10%
SARS-CoV-2 variant,GISAID,Sweden,2024-W11,SARS-CoV-2,2-week count of sequences,total,74,>5% to 10%
SARS-CoV-2 variant,GISAID,Sweden,2024-W10,SARS-CoV-2,2-week count of sequences,total,121,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W09,SARS-CoV-2,2-week count of sequences,total,138,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W08,SARS-CoV-2,2-week count of sequences,total,159,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W07,SARS-CoV-2,2-week count of sequences,total,170,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W06,SARS-CoV-2,2-week count of sequences,total,228,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W05,SARS-CoV-2,2-week count of sequences,total,265,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W04,SARS-CoV-2,2-week count of sequences,total,299,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2024-W03,SARS-CoV-2,2-week count of sequences,total,675,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W02,SARS-CoV-2,2-week count of sequences,total,867,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2024-W01,SARS-CoV-2,2-week count of sequences,total,827,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W52,SARS-CoV-2,2-week count of sequences,total,931,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W51,SARS-CoV-2,2-week count of sequences,total,1899,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W50,SARS-CoV-2,2-week count of sequences,total,2414,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W49,SARS-CoV-2,2-week count of sequences,total,1922,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W48,SARS-CoV-2,2-week count of sequences,total,2105,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W47,SARS-CoV-2,2-week count of sequences,total,2291,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W46,SARS-CoV-2,2-week count of sequences,total,2414,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W45,SARS-CoV-2,2-week count of sequences,total,2179,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W44,SARS-CoV-2,2-week count of sequences,total,1779,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W43,SARS-CoV-2,2-week count of sequences,total,1465,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W42,SARS-CoV-2,2-week count of sequences,total,1154,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W41,SARS-CoV-2,2-week count of sequences,total,1050,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W40,SARS-CoV-2,2-week count of sequences,total,816,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W39,SARS-CoV-2,2-week count of sequences,total,767,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W38,SARS-CoV-2,2-week count of sequences,total,730,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W37,SARS-CoV-2,2-week count of sequences,total,751,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W36,SARS-CoV-2,2-week count of sequences,total,752,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W35,SARS-CoV-2,2-week count of sequences,total,582,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W34,SARS-CoV-2,2-week count of sequences,total,465,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W33,SARS-CoV-2,2-week count of sequences,total,354,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W32,SARS-CoV-2,2-week count of sequences,total,319,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W31,SARS-CoV-2,2-week count of sequences,total,286,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W30,SARS-CoV-2,2-week count of sequences,total,194,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W29,SARS-CoV-2,2-week count of sequences,total,180,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W28,SARS-CoV-2,2-week count of sequences,total,219,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W27,SARS-CoV-2,2-week count of sequences,total,243,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W26,SARS-CoV-2,2-week count of sequences,total,302,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W25,SARS-CoV-2,2-week count of sequences,total,408,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W24,SARS-CoV-2,2-week count of sequences,total,573,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2023-W23,SARS-CoV-2,2-week count of sequences,total,626,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W22,SARS-CoV-2,2-week count of sequences,total,649,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W21,SARS-CoV-2,2-week count of sequences,total,765,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W20,SARS-CoV-2,2-week count of sequences,total,1017,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W19,SARS-CoV-2,2-week count of sequences,total,1019,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W18,SARS-CoV-2,2-week count of sequences,total,1044,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W17,SARS-CoV-2,2-week count of sequences,total,1277,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W16,SARS-CoV-2,2-week count of sequences,total,1322,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W15,SARS-CoV-2,2-week count of sequences,total,1293,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W14,SARS-CoV-2,2-week count of sequences,total,1180,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W13,SARS-CoV-2,2-week count of sequences,total,1337,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W12,SARS-CoV-2,2-week count of sequences,total,1263,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W11,SARS-CoV-2,2-week count of sequences,total,914,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W10,SARS-CoV-2,2-week count of sequences,total,839,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W09,SARS-CoV-2,2-week count of sequences,total,755,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W08,SARS-CoV-2,2-week count of sequences,total,768,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W07,SARS-CoV-2,2-week count of sequences,total,947,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W06,SARS-CoV-2,2-week count of sequences,total,1291,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W05,SARS-CoV-2,2-week count of sequences,total,1430,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W04,SARS-CoV-2,2-week count of sequences,total,1663,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W03,SARS-CoV-2,2-week count of sequences,total,2622,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W02,SARS-CoV-2,2-week count of sequences,total,2820,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2023-W01,SARS-CoV-2,2-week count of sequences,total,2492,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W52,SARS-CoV-2,2-week count of sequences,total,3061,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W51,SARS-CoV-2,2-week count of sequences,total,3938,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W50,SARS-CoV-2,2-week count of sequences,total,4286,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W49,SARS-CoV-2,2-week count of sequences,total,4154,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W48,SARS-CoV-2,2-week count of sequences,total,3622,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W47,SARS-CoV-2,2-week count of sequences,total,2958,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W46,SARS-CoV-2,2-week count of sequences,total,2768,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W45,SARS-CoV-2,2-week count of sequences,total,2731,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W44,SARS-CoV-2,2-week count of sequences,total,2732,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W43,SARS-CoV-2,2-week count of sequences,total,2716,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W42,SARS-CoV-2,2-week count of sequences,total,2653,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W41,SARS-CoV-2,2-week count of sequences,total,2755,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W40,SARS-CoV-2,2-week count of sequences,total,2787,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W39,SARS-CoV-2,2-week count of sequences,total,2651,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W38,SARS-CoV-2,2-week count of sequences,total,2792,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W37,SARS-CoV-2,2-week count of sequences,total,2959,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W36,SARS-CoV-2,2-week count of sequences,total,2761,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W35,SARS-CoV-2,2-week count of sequences,total,2542,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W34,SARS-CoV-2,2-week count of sequences,total,2681,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W33,SARS-CoV-2,2-week count of sequences,total,3132,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W32,SARS-CoV-2,2-week count of sequences,total,3269,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W31,SARS-CoV-2,2-week count of sequences,total,3418,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W30,SARS-CoV-2,2-week count of sequences,total,3989,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W29,SARS-CoV-2,2-week count of sequences,total,4321,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W28,SARS-CoV-2,2-week count of sequences,total,3879,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W27,SARS-CoV-2,2-week count of sequences,total,3356,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W26,SARS-CoV-2,2-week count of sequences,total,2857,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W25,SARS-CoV-2,2-week count of sequences,total,2266,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W24,SARS-CoV-2,2-week count of sequences,total,1656,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W23,SARS-CoV-2,2-week count of sequences,total,1205,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W22,SARS-CoV-2,2-week count of sequences,total,1143,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W21,SARS-CoV-2,2-week count of sequences,total,1193,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W20,SARS-CoV-2,2-week count of sequences,total,1289,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W19,SARS-CoV-2,2-week count of sequences,total,1306,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W18,SARS-CoV-2,2-week count of sequences,total,1349,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W17,SARS-CoV-2,2-week count of sequences,total,1415,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W16,SARS-CoV-2,2-week count of sequences,total,1658,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W15,SARS-CoV-2,2-week count of sequences,total,2120,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W14,SARS-CoV-2,2-week count of sequences,total,2568,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W13,SARS-CoV-2,2-week count of sequences,total,3197,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W12,SARS-CoV-2,2-week count of sequences,total,4081,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W11,SARS-CoV-2,2-week count of sequences,total,5060,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W10,SARS-CoV-2,2-week count of sequences,total,6073,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W09,SARS-CoV-2,2-week count of sequences,total,6521,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W08,SARS-CoV-2,2-week count of sequences,total,6600,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W07,SARS-CoV-2,2-week count of sequences,total,7577,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W06,SARS-CoV-2,2-week count of sequences,total,9131,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W05,SARS-CoV-2,2-week count of sequences,total,8686,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W04,SARS-CoV-2,2-week count of sequences,total,7496,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W03,SARS-CoV-2,2-week count of sequences,total,7751,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W02,SARS-CoV-2,2-week count of sequences,total,7578,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2022-W01,SARS-CoV-2,2-week count of sequences,total,6247,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W52,SARS-CoV-2,2-week count of sequences,total,6078,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W51,SARS-CoV-2,2-week count of sequences,total,6700,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W50,SARS-CoV-2,2-week count of sequences,total,6549,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W49,SARS-CoV-2,2-week count of sequences,total,6243,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W48,SARS-CoV-2,2-week count of sequences,total,5060,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W47,SARS-CoV-2,2-week count of sequences,total,4707,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W46,SARS-CoV-2,2-week count of sequences,total,5306,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W45,SARS-CoV-2,2-week count of sequences,total,4935,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W44,SARS-CoV-2,2-week count of sequences,total,4914,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W43,SARS-CoV-2,2-week count of sequences,total,4985,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W42,SARS-CoV-2,2-week count of sequences,total,4355,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W41,SARS-CoV-2,2-week count of sequences,total,2858,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W40,SARS-CoV-2,2-week count of sequences,total,2654,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W39,SARS-CoV-2,2-week count of sequences,total,3376,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W38,SARS-CoV-2,2-week count of sequences,total,3603,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W37,SARS-CoV-2,2-week count of sequences,total,4206,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W36,SARS-CoV-2,2-week count of sequences,total,4670,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W35,SARS-CoV-2,2-week count of sequences,total,5036,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W34,SARS-CoV-2,2-week count of sequences,total,5310,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W33,SARS-CoV-2,2-week count of sequences,total,6152,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W32,SARS-CoV-2,2-week count of sequences,total,6092,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W31,SARS-CoV-2,2-week count of sequences,total,4613,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W30,SARS-CoV-2,2-week count of sequences,total,3743,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W29,SARS-CoV-2,2-week count of sequences,total,3366,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W28,SARS-CoV-2,2-week count of sequences,total,2626,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W27,SARS-CoV-2,2-week count of sequences,total,2252,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W26,SARS-CoV-2,2-week count of sequences,total,2454,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W25,SARS-CoV-2,2-week count of sequences,total,3338,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W24,SARS-CoV-2,2-week count of sequences,total,4380,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W23,SARS-CoV-2,2-week count of sequences,total,3876,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W22,SARS-CoV-2,2-week count of sequences,total,3658,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W21,SARS-CoV-2,2-week count of sequences,total,5268,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W20,SARS-CoV-2,2-week count of sequences,total,6293,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W19,SARS-CoV-2,2-week count of sequences,total,7048,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W18,SARS-CoV-2,2-week count of sequences,total,7333,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W17,SARS-CoV-2,2-week count of sequences,total,6787,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W16,SARS-CoV-2,2-week count of sequences,total,6900,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W15,SARS-CoV-2,2-week count of sequences,total,7417,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W14,SARS-CoV-2,2-week count of sequences,total,7616,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W13,SARS-CoV-2,2-week count of sequences,total,10367,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W12,SARS-CoV-2,2-week count of sequences,total,13124,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W11,SARS-CoV-2,2-week count of sequences,total,13404,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W10,SARS-CoV-2,2-week count of sequences,total,12356,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W09,SARS-CoV-2,2-week count of sequences,total,11288,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W08,SARS-CoV-2,2-week count of sequences,total,10734,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W07,SARS-CoV-2,2-week count of sequences,total,9307,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W06,SARS-CoV-2,2-week count of sequences,total,7756,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W05,SARS-CoV-2,2-week count of sequences,total,5546,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W04,SARS-CoV-2,2-week count of sequences,total,3369,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W03,SARS-CoV-2,2-week count of sequences,total,2201,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W02,SARS-CoV-2,2-week count of sequences,total,1328,≤1%
SARS-CoV-2 variant,GISAID,Sweden,2021-W01,SARS-CoV-2,2-week count of sequences,total,570,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W53,SARS-CoV-2,2-week count of sequences,total,535,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W52,SARS-CoV-2,2-week count of sequences,total,364,>1% to 2.5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W51,SARS-CoV-2,2-week count of sequences,total,174,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W50,SARS-CoV-2,2-week count of sequences,total,130,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W49,SARS-CoV-2,2-week count of sequences,total,145,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W48,SARS-CoV-2,2-week count of sequences,total,126,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W47,SARS-CoV-2,2-week count of sequences,total,107,>5% to 10%
SARS-CoV-2 variant,GISAID,Sweden,2020-W46,SARS-CoV-2,2-week count of sequences,total,124,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W45,SARS-CoV-2,2-week count of sequences,total,125,>2.5% to 5%
SARS-CoV-2 variant,GISAID,Sweden,2020-W44,SARS-CoV-2,2-week count of sequences,total,91,>5% to 10%
SARS-CoV-2 variant,GISAID,Sweden,2020-W43,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W42,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W41,SARS-CoV-2,2-week count of sequences,total,45,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W40,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W39,SARS-CoV-2,2-week count of sequences,total,54,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W38,SARS-CoV-2,2-week count of sequences,total,53,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W37,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W36,SARS-CoV-2,2-week count of sequences,total,48,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W35,SARS-CoV-2,2-week count of sequences,total,43,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W34,SARS-CoV-2,2-week count of sequences,total,29,>15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W33,SARS-CoV-2,2-week count of sequences,total,41,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W32,SARS-CoV-2,2-week count of sequences,total,38,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W31,SARS-CoV-2,2-week count of sequences,total,15,>15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W30,SARS-CoV-2,2-week count of sequences,total,25,>15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W29,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W28,SARS-CoV-2,2-week count of sequences,total,40,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W27,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W26,SARS-CoV-2,2-week count of sequences,total,44,>10% to 15%
SARS-CoV-2 variant,GISAID,Sweden,2020-W25,SARS-CoV-2,2-week count of sequences,total,22,>15%
